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Introducción 
  
El trabajo de investigación de la presente Tesis doctoral realizado por 
Javier Gilabert Juan, ha estado centrado en el estudio de la plasticidad 
estructural neuronal de interneuronas en trastornos psiquiátricos, abordado 
desde diferentes estrategias de estudio: modelos animales, estudios en muestras 
de cerebro postmortem de pacientes con enfermedades psiquiátricas y estudios 
de asociación. 
 
Durante los últimos años, diversos trabajos han puesto de manifiesto que 
ciertas neuronas del sistema nervioso central (SNC) adulto son capaces de 
remodelar su estructura y cambiar sus conexiones. Esta plasticidad estructural 
subyace a fenómenos cognitivos y se produce también como respuesta a 
experiencias aversivas, como el miedo o la ansiedad, en animales de 
experimentación y en modelos animales de esquizofrenia y de depresión. Más 
aún, se han detectado cambios estructurales similares en el cerebro de 
pacientes, y los antipsicóticos comunes y los fármacos que inducen psicosis 
también son capaces de modular la plasticidad estructural neuronal. Estos 
descubrimientos han dado lugar a una nueva hipótesis, denominada hipótesis 
neuroplástica, para explicar el origen de diferentes trastornos psiquiátricos 
como la esquizofrenia o la depresión.  
 
Algunas de las regiones más afectadas en los modelos animales de 
esquizofrenia, depresión o estrés y en pacientes con estos trastornos son la 
corteza prefrontal y el sistema límbico: hay un gran número de evidencias de 
que estas regiones sufren remodelado dendrítico y de espinas. Estos cambios 
morfológicos están normalmente mediados por cambios en la expresión de 
proteínas de adhesión, como la molécula neural de adhesión celular (NCAM). 
Ésta es particularmente interesante porque es capaz de incorporar largas 
cadenas de ácido polisiálico (PSA) que le confiere propiedades anti-adhesivas y, 
por tanto, promueve la capacidad de remodelado estructural de las neuronas 
que la expresan o de aquellas que están en contacto con ellas. 
Consecuentemente, tanto la corteza prefrontal como la amígdala o el 
hipocampo muestran niveles elevados de expresión de PSA-NCAM en el 
cerebro de roedores adultos, estas estructuras son moduladas paralelamente al 
remodelado estructural sufrido tras la exposición a experiencias aversivas. 
4 
 
 Los objetivos de este estudio han sido: (i) Estudio del efecto del estrés 
crónico sobre sobre la plasticidad estructural y sobre la transmisión inhibitoria 
en la amígdala y la corteza prefrontal de roedores. (ii) Estudio de la plasticidad 
estructural en interneuronas en modelos experimentales de esquizofrenia. (iii) 
Análisis de la posible alteración de marcadores de plasticidad y de transmisión 
inhibitoria en muestras de cerebro postmortem de pacientes con diferentes 
enfermedades mentales. (iv) Estudio de la asociación caso-control entre la 
esquizofrenia y el gen ST8SIAII que codifica para una de las enzimas 
responsables de la polisialización de la molécula NCAM. 
 
 
Metodología y Resultados  
 
ARTÍCULO 1. ANÁLISIS DE LA EXPRESIÓN DE PSA-NCAM Y LA 
ARBORIZACIÓN DE INTERNEURONAS EN LA AMÍGDALA DE UN 
MODELO ANIMAL DE ESTRÉS CRÓNICO. 
 
El objetivo de este trabajo es estudiar si existen diferencias en la 
expresión de PSA-NCAM o de diferentes moléculas relacionadas con la 
neurotransmisión inhibitoria en la amígdala de ratones transgénicos portadores 
de la proteína verde fluorescente (EGFP) en una población de interneuronas 
(GIN) expuestos a estrés crónico, un modelo de depresión o ansiedad. 
RESULTADOS: Encontramos una disminución de las proteínas PSA-NCAM, 
GAD67 y sinaptofisina en la amígdala de estos ratones. Además, estas 
disminuciones en la expresión de estas moléculas van acompañadas de un 
descenso en la expresión de los genes de la polisialiltransferasa St8SiaII y de 
GAD67. En cuanto a la arborización dendrítica de las interneuronas, 
encontramos que existe una menor arborización  en individuos estresados 
respecto a la de individuos control. 
 
Publicación: Chronic stress induces changes in the structure of interneurons and 
in the expression of molecules related to neuronal structural plasticity and 
inhibitory neurotransmission in the amígdala of adult mice. Gilabert-Juan J, 
Castillo-Gomez E, Pérez-Rando M, Moltó MD, Nacher J. Experimental  
Neurology 2011 Nov;232(1):33-44. 
 
Resumen · 5 
 
 
 
ARTÍCULO 2. ANÁLISIS DE LA EXPRESIÓN DE PSA-NCAM Y LA 
ARBORIZACIÓN DE INTERNEURONAS EN LA CORTEZA PREFRONTAL 
DE UN MODELO ANIMAL DE ESTRÉS CRÓNICO. 
 
En este trabajo se ha estudiado la arborización dendrítica de 
interneuronas de la corteza prefrontal. Además, se ha realizado una 
comparación de la expresión génica de diferentes marcadores de 
neurotransmisión inhibitoria y plasticidad neuronal, junto con recuentos de 
somas neuronales que expresan GAD67 y PSA-NCAM. RESULTADOS: 
Encontramos una disminución del número de somas que expresan GAD67, sin 
detectar cambios en el número de somas PSA-NCAM inmunoreactivos. 
Además, estas disminuciones en el número de somas van acompañadas de un 
aumento en la arborización dendrítica de interneuronas. En lo que respecta a la 
expresión génica, vemos un aumento de expresión de NCAM, sinaptofisina y la 
subunidad alfa del receptor A de GABA. 
 
Publicación: Chronic stress alters inhibitory networks in the medial prefrontal 
cortex of adult mice. Gilabert-Juan J, Castillo-Gomez E, Guirado R, Moltó MD, 
Nacher J.  Brain Structure and Function. 2012 Nov 21. 
 
 
ARTÍCULO 3. ANÁLISIS DE MARCADORES RELACIONADOS CON LA 
NEUROTRANSMISIÓN INHIBITORIA Y LA EXPRESIÓN DE PSA-NCAM EN 
LA AMIGDALA DE UN MODELO ANIMAL DE ESQUIZOFRENIA: 
AISLAMIENTO SOCIAL PROLONGADO TRAS EL DESTETE.  
 
El este caso, el objetivo general ha sido determinar las posibles 
alteraciones en la expresión de diversos genes relacionados con la 
neurotransmisión inhibitoria y la plasticidad estructural en la amígdala de ratas 
aisladas socialmente después del destete. RESULTADOS: En la amígdala de 
ratas sometidas a aislamiento encontramos un aumento de la expresión de las 
proteínas NCAM, PSA-NCAM y GAD67, sin cambios en expresión de ARNm. 
 
Publicación: Post-weaning social isolation rearing influences the expression of 
molecules related to inhibitory neurotransmission and structural plasticity in 
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the amígdala of adult rats. Gilabert-Juan J, Moltó MD, Nacher J. Brain Research. 
2012 Apr 11;1448:129-136.  
 
ARTÍCULO 4. ANÁLISIS DE CAMBIOS ESTRUCTURALES Y FUNCIONALES 
EN UN MODELO  ANIMAL “DE DOBLE IMPACTO” DE ESQUIZOFRENIA.  
 
Este estudio ha consistido en la valoración de diferentes cambios 
estructurales y bioquímicos en la corteza prefrontal medial y el hipocampo de 
ratas sometidas a aislamiento social perinatal y a antagonistas de receptores 
NMDA durante el desarrollo. RESULTADOS: En el modelo doble observamos 
reducción del volumen de la corteza prefrontal y el hipocampo, diferencias de 
peso entre los individuos, alteraciones en la expresión génica de calbindina, 
calretinina y ErbB4 en la corteza prefrontal y reducción del número de células 
parvalbumina positivas. También se detectan disminuciones en el número de 
células inmaduras que expresan la proteína doblecortina en el hipocampo y 
activación de neuronas excitadoras en la corteza prefrontal medial.  
 
Publicación: A “double hit” murine model for schizophrenia shows alterations 
in the structure and neurochemistry of the medial prefrontal cortex and the 
hippocampus. Gilabert-Juan J, Belles M, Saez AR, Carceller H, Moltó MD, 
Nacher J. Neurobiology of disease. En revisión 
 
 
ARTÍCULO 5. ANÁLISIS DE LA EXPRESIÓN DE MARCADORES DE 
TRANSMISIÓN INHIBITORIA EN LA CORTEZA PREFRONTAL DE 
PACIENTES CON DEPRESIÓN GRAVE, ESQUIZOFRENIA Y DESORDEN 
BIPOLAR, PROCEDENTES DEL STANLEY NEUROPATHOLOGY 
CONSORTIUM. 
 
El objetivo de este estudio es analizar si existen diferencias en la 
expresión de la molécula PSA-NCAM en la corteza prefrontal de cerebros 
postmortem procedentes de pacientes psiquiátricos y controles cedidos por el 
Stanley Neuropathology Consortium de la Fundación Stanley. Este análisis implicó 
el estudio de la expresión y distribución de PSA-NCAM y otras moléculas 
relacionadas con la plasticidad neuronal, tanto en somas neuronales como en el 
neuropilo. RESULTADOS: Encontramos una disminución de la expresión de las 
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proteínas sinaptofisina y GAD67 en los pacientes de esquizofrenia, que es 
similar a la encontrada en los pacientes con desorden bipolar. En cuanto a los 
individuos que cursan con depresión mayor, hay una disminución en la 
expresión de PSA-NCAM, sinaptofisina y GAD67, junto con un aumento en la 
expresión del marcador de sinapsis excitadoras VGLUT1.  
 
Publicación: Alterations in the expression of PSA-NCAM and synaptic proteins 
in the dorsolateral prefrontal cortex of psychiatric disorder patients. Gilabert-
Juan J, Varea E, Guirado R, Blasco-Ibáñez JM, Crespo C, Nácher J. Neuroscience 
Letters. 2012 Nov 14;530(1):97-102. 
 
 
ARTÍCULO 6. ESTUDIO DE ASOCIACIÓN CASO-CONTROL ENTRE LA 
ESQUIZOFRENIA Y EL GEN ST8SIAII. 
 
Este trabajo de asociación caso-control pretende replicar las asociaciones 
encontradas previamente en dos poblaciones asiáticas entre la esquizofrenia y el 
gen ST8SIAII. Este gen codifica para una de las enzimas responsables de la 
polisialización de la molécula NCAM. Asimismo, otro objetivo del presente 
estudio ha sido identificar nuevos alelos, genotipos y haplotipos de ST8SIAII 
que puedan constituir factores de vulnerabilidad genética en la esquizofrenia. 
Se ha partido de una muestra de 508 pacientes diagnosticados de esquizofrenia 
según criterios DSMIV (36.4% mujeres y 63.6% hombres) y 428 controles sanos 
sin antecedentes familiares de enfermedad mental (30.8% mujeres y 69.2% 
hombres). Resultados: Se encuentra diferente asociación de polimorfismos de 
un solo nucleótido (Single Nucleotide Polimorphisms, SNPs), situados en el 
promotor del gen, en hombres y mujeres con esquizofrenia. Además se 
identifica un haplotipo de riesgo en hombres afectados por la enfermedad. 
Dicho haplotipo se construye a partir de varios polimorfismos del promotor y 
un SNP de la región codificante del gen. 
 
Publicación: Sex-specific Association of the ST8SIAII Gene with Schizophrenia 
in a Spanish population. Gilabert-Juan J, Nacher J, Sanjuan J, Molto MD. 
American Journal of Medical Genetics part B. En revisión. 
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Discusión 
 
De acuerdo a los resultados obtenidos en este trabajo, la expresión de la 
molécula PSA-NCAM se encuentra alterada en los diferentes modelos de 
enfermedades psiquiátricas estudiados y en las diferentes áreas del cerebro 
implicadas en la etiopatología de estos desordenes. Además, como hemos 
comprobado, esta molécula implicada en la plasticidad estructural neuronal se 
haya estrechamente ligada a las alteraciones en el sistema de neurotransmisión 
inhibitoria. Por lo tanto podemos afirmar que existe una estrecha relación entre 
el correcto funcionamiento de este sistema y su plasticidad. Asimismo, vemos 
que los resultados obtenidos en los modelos animales estudiados en esta tesis 
son en cierto modo similares a los que se obtienen en los estudios de muestras 
post-mortem de pacientes, lo cual apoya el uso de estos modelos en el estudio 
de las enfermedades psiquiátricas de las que pretenden reproducir algunos 
aspectos. Finalmente, se ha comprobado que en la población caucásica también 
se encuentra asociación entre el gen ST8SIAII y la esquizofrenia, en los 
polimorfismos situados en el promotor. Este resultado indica, por un lado que 
variaciones en la expresión del gen ST8SIAII pueden ser críticas para el buen 
funcionamiento del sistema nervioso, y por otra parte, que dicho gen puede 
presentar alelos que confieran vulnerabilidad a la esquizofrenia. 
 
 
Conclusiones 
 
1. Las células que expresan la proteína verde fluorescente (EGFP) en la 
corteza prefrontal medial (CPM) de ratones GIN adultos corresponden 
principalmente a una subpoblación de interneuronas Martinotti. 
 
2. El estrés crónico en ratones GIN adultos induce hipertrofia dendrítica 
en interneuronas que expresan EGFP  en la CPM. 
 
3. El estrés crónico en ratones GIN adultos disminuye el número de 
interneuronas que expresan GAD67 y GAD-EGFP en la CPM. 
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4. El estrés crónico provoca hipotrofia dendrítica en las interneuronas 
que expresan EGFP en el núcleo basomedial de la amígdala de ratones GIN 
adultos. 
 
5. El estrés crónico induce una disminución en la expresión de distintos 
marcadores moleculares de plasticidad estructural neuronal y de 
neurotransmisión inhibitoria (NCAM, sinaptofisina y receptor GABAA alfa) en 
la amígdala de ratones GIN adultos. 
 
6. El aislamiento social prolongado tras el destete en ratas Lister Hooded 
induce aumentos en la expresión de las proteínas GAD67, PSA-NCAM y 
NCAM en los núcleos amigdalinos. 
 
7. La combinación de una inyección perinatal del antagonista del 
receptor de NMDA, MK-801 y el aislamiento social prolongado tras el destete 
en ratas Lister Hooded, es un modelo animal de esquizofrenia “de doble 
impacto”, que reproduce un espectro más amplio de alteraciones estructurales y 
moleculares que cualquiera de los modelos individuales por sí mismo. 
 
8. El modelo animal de esquizofrenia “de doble impacto” desarrollado en 
esta tesis presenta reducciones en el volumen de la CPM y el hipocampo. 
 
9. El modelo “de doble impacto” muestra una reducción en el número de 
interneuronas que expresan parvalbúmina, altera la expresión génica de 
calbindina, calretinina y ErbB4 y reduce la expresión de PSA-NCAM y GAD67 en 
la CPM. La expresión de PSA-NCAM también se encuentra reducida en el 
hipocampo en este modelo. 
 
10. El modelo “de doble impacto” muestra un aumento en el número de 
neuronas granulares inmaduras que expresan la proteína doblecortina en el 
hipocampo. 
 
11. El modelo “de doble impacto” presenta un aumento del número de 
neuronas que coexpresan el gen de expresión temprana “c-fos” y el marcador 
de neuronas excitadoras “CaMKII” en la CPM. 
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12. La expresión de distintos marcadores sinápticos y de plasticidad 
estructural neuronal se encuentra alterada en la corteza prefrontal dorsolateral 
de pacientes con trastornos psiquiátricos. Concretamente está reducida la 
expresión de PSA-NCAM se encuentra reducida en pacientes esquizofrénicos, 
la de sinaptofisina en pacientes de depresión mayor, la de VGLUT1 en 
pacientes con trastorno bipolares y en pacientes con depresión, y la de GAD67 
en todos los grupos de pacientes estudiados. 
 
13. El polimorfismo rs3759916 del gen ST8SIAII, situado en su región 
promotora, se encuentra asociado a esquizofrenia en la población femenina 
española, y un haplotipo de este gen también se asocia a la enfermedad en la 
población masculina española, sugiriendo que ST8SIAII podría representar un 
factor de riesgo genético en el desarrollo de la esquizofrenia, afectando de 
forma diferente dependiendo del sexo del individuo. 
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1. NEURAL PLASTICITY AND INHIBITORY NEUROTRANSMISSION 
IN PSYCHIATRIC DISORDERS 
 
 Nowadays it is well known that brain plasticity is essential for the 
development of the Central Nervous System (CNS) or to its adaptation to new 
environments, for learning and for the basic survival of individuals. Some of 
these plastic changes imply new synaptic connections, cell migration, axon 
guidance and neurogenesis, which not only occur during development but also 
in the adulthood (Hensch, 2004; De Magalhaes and Sandberg, 2005).  
 
 The limbic system is one of the most plastic regions in the brain, with a 
high presence of molecules implicated in structural as well as molecular 
plasticity (Bonfanti, 2006). An important number of studies have been 
performed on the alterations in plasticity and excitatory neurotransmission that 
occur in psychiatric or mood disorders such as stress, anxiety, depression or 
schizophrenia, in which the limbic system and the prefrontal cortex (PFC) play 
a crucial role. However, there is an increasing interest concerning the changes 
occurring in the inhibitory neurotransmission in these disorders, in which fewer 
studies have been conducted until now.  
 
 In order to show the objectives of this doctoral thesis, this introduction is 
going to highlight the most important features of the limbic system and the 
mPFC, its inhibitory neurotransmission and its plasticity, and the psychiatric 
disorders studied: the chronic stress as a model of depression and 
schizophrenia.  
  
  
 
2. THE LIMBIC SYSTEM AND THE PREFRONTAL CORTEX 
 
 The limbic system is composed by different brain areas, being some of 
the most important regions, the hypothalamus, the hippocampus and the 
amygdala. The hippocampus and the prefrontal cortex are portions of the 
cerebral cortex, while the hypothalamus and the amygdala are part of the 
subcortical portions of the limbic system. These four regions are functionally 
and anatomically interconnected and have several functions, necessary for self-
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preservation and species preservation. They regulate the autonomic and 
endocrine functions, responding to environmental stimuli and regulating the 
emotions. This regulation affects the level of arousal and motivation and 
reinforces behaviors involved in some type of memory. 
 
 This system involving the prefrontal cortex and the limbic system has 
two differentiate parts, the input and processing side, composed by the 
prefrontal cortex, amygdala and hippocampus, in which this thesis is focused, 
and the output side composed by the hypothalamus and other nuclei.  
 
 
2.1. Amygdala 
 
 The amygdala is a complex structure located in the anterior temporal 
lobe of the brain, within the uncus. The rodent amygdala is composed by many 
subnuclei, each one with a differentiate structure and composition, which 
receives or send projections to different brain areas. This complexity makes this 
region one of the hardest to study in the brain. We distinguish two different 
regions in the amygdala, the striatal amygdala (central and medial nuclei), with 
a high density of interneurons, and the rest of the amygdala (cortical amygdala) 
with more excitatory elements (Figure 1).  
 
 
Figure 1. (A) Image of the amygdala stained using PSA-NCAM immunohistochemistry. (B) 
Schematic view of some of the subnuclei of the amygdala: marked in red the basal-lateral 
nucleus, in blue the central-medial nucleus, and in green the medial nucleus. 
 
 The regions, which receive connections from some nuclei of the 
amygdala, are the hypothalamus, thalamus, septal nuclei, frontal cortex, 
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cingulated gyrus, hippocampus, parahippocampal gyrus and brain stem. The 
amygdala also receives reciprocal connections from all these areas. 
 
 The main function of the amygdala is to coordinate behavioral, 
autonomic and endocrine responses to environmental stimuli, mainly fear and 
anxiety. Some of these stimuli are stressors, and, consequently, this region is 
very important for the survival of individuals and the appropriate and 
coordinated responses to these stressors. Lesions of the amygdala promote 
impaired responses to stress or anxiety with behavioral arousal and rage 
reactions (LaBar and LeDoux, 1996). 
 
 
2.2. Hippocampus 
  
 The hippocampus is located in the medial region of the temporal lobe of 
the brain, forming the medial wall of the lateral ventricle in this area. The 
hippocampus in rodents has 3 layers: molecular, pyramidal and polymorphic; 
and several parts: the dentate gyrus and the Cornu Ammonis (CA), divided in 
four regions (CA1-CA4). The CA blends into the adjacent subiculum, which is 
connected to the entorhinal cortex (Figure 2). 
 
 
Figure 2. (A) Image of the ventral 
hippocampus with its different layers and 
most important regions, extracted from 
Kauselmann et al., 1999. CA1-3, 
hippocampal fields; dg, dentate gyrus; g, 
granular cell layer; p, pyramidal cell layer; 
slm, stratum lacunosum moleculare; sm, 
stratum moleculare; sr, stratum radiatum. 
(B) Schematic view of the hippocampus by 
Ramon y Cajal, 1911. EC, entorhinal cortex; 
Sub, subiculum. 
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 The hippocampus receives inputs from the septum and the 
hypothalamus via the fornix and the entorhinal cortex, from the neocortex and 
the amygdala. All these connections are involved in memory formation, mainly 
involving long-term potentiation. The outputs of the hippocampus go via the 
fornix to the mamillary bodies, septal nuclei, preoptic nucleus of the 
hypothalamus, ventral striatum and to portions of the frontal lobe. Other 
projections go back to the entorhinal cortex.  
 
 The hippocampal functions are the control of corticosteroid production, 
the processing of spatial relationships within the environment and the storage 
of memories in the cerebral cortex (Eichenbaum, 2000).  
 
 
2.3. Prefrontal Cortex 
 
 The prefrontal cortex (PFC) is located anterior to the motor cortex and 
posterior to the orbital frontal cortex, receiving inputs from other limbic cortex 
regions, the amygdala and the septal nuclei. The PFC also projects to all these 
areas and to the dorsomedial nucleus of the thalamus. The prefrontal cortex in 
rodents is divided in four areas, prelimbic, infralimbic, cingulate 1 and 2. In 
general, the prelimbic region is involved in attentional functions and visual 
working memory. The cingulate regions participate in the generation of rules 
associated with temporal ordering and motor sequencing of behavior. Finally, 
the infralimbic region is associated to autonomic control and the response and 
modulation of fear (Uylings and Van Eden, 1990; Paxinos and Watson, 2007; 
Seamans et al., 2008). 
  
 The cells and fibers in the rodent medial prefrontal cortex (mPFC) follow 
the architectural distribution of the neocortical regions in mammals, without 
the layer IV of internal granule cells (Fuster, 2008). Basically, the distribution of 
the rodent mPFC is: layer I, molecular layer; layer II, external granule cell layer; 
layer III, external pyramidal cell layer; layer V, internal pyramidal cell layer and 
layer VI, polymorphic layer (Figure 3).  
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Figure 3. (A) An overview of the rat mPFC, with the regions (Prl, IL, Cg1 and Cg2) marked in different 
colors, adapted from the atlas of Paxinos and Watson, 2007. (B) Microscopic view of the rat mPFC 
layers and white matter (WM). Scale bar: 250μm. (C) Scheme of the neuronal types in the rat mPFC 
(modified from Fuster, 2008). 
 
 
 The functions of the prefrontal cortex are related with the judgment, 
insight, motivation and mood, explaining why this area is altered in mood 
disorders. For example, major depression is usually associated with an 
increased activity in portions of the frontal lobe and a decreased activity in the 
posterior cingulate gyrus (Fitzgerald et al., 2006). Some lesions of the mPFC 
affect emotional responses, such as fear, or engage sexual behavior (Blanco et 
al., 2009). Alcohol and drugs also modify this area and it is though that positive 
symptoms of psychosis (delusions and hallucinations) are also associated to this 
region (Gizewski et al., 2013). 
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3. INHIBITORY NEUROTRANSMISSION 
 
 The inhibitory neurotransmission system is based mainly on the 
transmission of the Gamma-aminobutyric acid (GABA). The GABAergic 
neurons synthesize GABA from glutamate by the action of the glutamic acid 
decarboxylase enzyme (GAD). This monomeric enzyme has two isoforms with 
different molecular weight called GAD65 (65 KDa) and GAD67 (67 KDa). The 
function of each isoform is not totally understood and each one plays a different 
role during development or in response to the environment. These enzymes are 
expressed in different synaptic terminals and during different periods of 
development (see Gonzalez-Burgos et al., 2011 for review).  
 
 The synthesis of GABA occurs in the cytosol and it is transported in 
vesicles to the synaptic cleft, by means of the vesicular transporter of GABA 
(vGAT). The GABA release is produced in a Ca2+ dependent manner after an 
action potential. Calcium binding proteins such as parvalbumin, calbindin or 
calretinin, present in different subpopulations of interneurons, bind Ca2+ after 
the activation of the Ca2+ cascade, acting as buffer molecules. After being 
released, the GABA molecule arrives to the postsynaptic density, where GABA 
receptors are located (Oláh et al., 2009).  
  
 
3.1. Functions of the Inhibitory Neurotransmission 
 
 From the 1980s it is widely assumed that the basic building blocks of 
neuronal representations are provided by synchronously firing neurons. The 
GABAergic neurons, or interneurons, have been studied for a long time in 
different areas of the brain and it has been assumed that they provide stability 
to the principal neurons using feedback and feedforward inhibition by means of 
somato-dendritic, axo-somatic and dendro-dendritic connections with other 
interneurons and with pyramidal cells. Some of these neurons receive 
dopaminergic or serotoninergic inputs (Mrzljak et al., 1996; Jakab and 
Goldman-Rakic, 1998), indicating a tight relationship with the monoaminergic 
neurotransmission and its regulatory control.  
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 The firing control regulated by interneurons is maintained by a network 
of cells interrelated with the GABAA receptors, by means of the GABA 
neurotransmitter (Buzsáki and Chrobak, 1995). This control is exerted by 
different integrated firing systems of oscillations in the theta (6-12 Hz), gamma 
(40-100 Hz) and ultrafast (200 Hz) frequency ranges (Bredkjaer, 1998). It has 
been demonstrated that the gamma frequency activity is implicated in the 
perception of auditory stimuli and the conscious somatic perception. The wide 
distribution of gamma frequency oscillations in all the cortical areas indicates a 
highly conserved GABAergic connections and the importance of the spatio-
temporal synchrony of the pyramidal cells for their correct functioning (von der 
Malsburg, 1995). Consequently, if this tigh regulation is altered, it may provoke 
disintegration of reality and susceptibility to psychiatric and mood disorders 
(for review see Keverne, 1999).  
 
 
3.2. Cell Subpopulations, Cytoarchitecture and Receptors 
 
 Interneurons were firstly described by Ramon y Cajal, who used the 
Golgi-impregnation technique, showing different morphologies in the cerebral 
cortex and hippocampus (Ramon y Cajal, 1893; 1911). The GABAergic neurons 
represent approximately 15-30% of the cortical neurons (Somogyi et al., 1998). 
These interneurons project internally to regions of the cortex, but in the 
amygdala, the connections of these neurons may project to other structures of 
the brain. The interneurons are mainly classified attending to their morphology, 
and the calcium binding proteins and the neuropeptides expressed (Figure 4) 
(see Benes and Berretta 2001 for review).  
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Figure 4. Schematic representation of the interneuronal subtypes around a pyramidal neuron of the mPFC 
attending to their morphology and calcium binding protein expression. Abbreviations: CB, calbindin; CR, 
calretinin; PV, parvalbumin. Adapted from Lewis and Gonzalez-Burgos, 2008. 
 
Regarding their morphology, interneurons are classified as: 
 
 Basket cells. These cells are the most common interneurons. They are 
multipolar, with big somata and are involved in innervations that form a 
basket-like arrangement around a large proportion of the surface of pyramidal 
cell bodies (Hendry and Jones, 1983). These cells are situated in the cerebral 
cortex layers III to V.   
 
 Chandelier cells. These cells receive their name from their candle-like 
morphology, which shows the axonal branches extending at right angles from 
the somata. These cells form axo-axonic synapses with the initial segment of 
pyramidal cell axons (Somogyi, 1979). In the cortex, chandelier cells are 
predominantly situated in layers II and III.  
 
 Double bouquet. Double bouquet cells have axonal arborizations that 
distribute themselves within narrow, radially oriented columns of the cortical 
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mantle (de Felipe and Fairen, 1982). These cells contact mainly dendritic shafts 
and spines on the side branches of apical dendrites or basal dendrites of 
pyramidal neurons (Somogyi and Cowey, 1981) and are situated in the cerebral 
cortex layer III.  
 
 Other Interneurons. There are other minor represented cell 
subpopulations, such as the Cajal-Retzius cells, situated in the layer I of the 
cortex. These cells contact with the distal dendrites of the pyramidal neurons or 
other interneurons. Finally, there are the neurogliaform cells and Martinotti 
cells situated in deep layers of the cortex, which innervate proximal and distal 
dendrites respectively of pyramidal cells.  
 
 Attending to their neurochemical markers, interneurons are also 
classified as follows: 
 
 Parvalbumin (PV) expressing interneurons. PV is expressed mainly in 
chandelier and basket cells (Gabbott and Bacon, 1996). These neurons are 
characterized as “fast-spiking” neurons, connected to other neurons through 
chemical as well as electrical synapses. It has been proposed that PV expressing 
cells form networks regulating synchronization (Gibson et al., 1999). PV 
neurons receive synaptic contacts from calretinin neurons, which inhibit them. 
Some of the PV expressing interneurons also express calbindin, but no 
neuropeptides (Kubota et al., 1994).  
 
 Calbindin (CB) expressing interneurons. CB is mainly expressed by 
double bouquet cells (Gabbott and Bacon, 1996) and by some Cajal-Retzius 
cells. Cells expressing CB are classified as “low threshold spike” cells, 
connected to other cells by electrical synapses and are proposed to play a role in 
generating synchronous inhibitory activity in the cortex (Gibson et al., 1999). 
These neurons receive calretinin contacts and projections from the Broca band.  
 
 Calretinin (CR) expressing interneurons. CR is expressed in double 
bouquet and bipolar cells, as well as in Cajal-Retzius neurons (Gabbott and 
Bacon, 1996). The cells expressing CR are classified as “regular spiking” cells 
and they contact PV and CB neurons, suggesting a role for these neurons in the 
control of disinhibition .  
22 
 
 Somatostatin (SOM) expressing interneurons. Cells expressing SOM co-
express CB, neuropeptide Y as well as nitric oxide synthase (NOS) (Kubota et 
al., 1994; Smiley et al., 2000). Morphologically, they are multipolar or bitufted 
cells, some of which have been identified as Martinotti cells (Kawaguchi and 
Kubota, 1996). SOM cells are “regular spiking” cells found in layers II and III 
and sometimes in layer V. Some of them have also been classified as  “burst 
spiking” cells and are located exclusively in layer V. Some of these SOM 
expressing cells also express calretinin and vasoactive intestinal polypeptide 
(VIP). 
 
 Vasoactive Intestinal Polypeptide (VIP) expressing interneurons. Cells 
expressing VIP co-express SOM and PV and are bipolar, double bouquet and 
basket cells. They are considered “regular spiking” or “burst spiking” cells.  
  
 Regarding the GABA receptors, we are going to focus our attention on 
the GABAA receptors, because of their main implication in the inhibitory 
neurotransmission in the cerebral cortex. The GABAA receptors are 
heteropentamers composed of subunits from 7 different families (α1 to α 6, β1 
to β3, γ1 to γ3, δ, ε, θ, ρ1 to ρ3). The most common combination is 2α:2β:γ 
forming a GABA-activated chloride channel (Farrant and Kaila, 2007; Olsen and 
Sieghart, 2009). The composition of these receptors influences their activity and 
their functional properties: For example, receptors containing α1 subunit have 
much faster decay kinetics than those containing other α subunits (Farrant and 
Kaila, 2007). The effect of some drugs, such as benzodiazepines, also depends 
on the subunit composition of the GABAA receptors (for review see Mohler, 
2011). 
  
 
 
4. NEURONAL PLASTICITY 
 
There are different levels of neuronal plasticity, ranging from molecular 
to structural changes. The molecular plasticity is based in complex mechanisms 
and pathways, being among the most important those involved in protein 
dynamics in synapses, such as the neurotransmitter receptors and their 
associated proteins (Renner et al., 2008). Changes in these proteins affect 
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directly the remodeling of neurites or synapses, mostly by means of changes in 
the expression or the organization of cytoskeletal proteins and/or adhesion 
molecules. One of the most studied cell adhesion molecules (CAMs) is the 
neural cell adhesion molecule (NCAM). It has been demonstrated that NCAM 
is necessary for some plastic processes, such as synaptogenesis, growth cone 
development, neurite outgrowth (Maness et al., 1996) and dendritic remodeling 
(Stewart et al., 2010). 
 
Regarding the structural plasticity, there are several brain processes that 
usually fall under this definition, all of them referring to changes in the shape 
and structure of the adult CNS. One of these processes is neurogenesis, which 
occurs mainly in two regions of the adult brain, the subventricular zone of the 
lateral ventricle (SVZ) (Alvarez-Buylla et al., 2000), and the subgranular zone of 
the dentate gyrus (SGZ) (Gage et al., 1998). Other structural changes occurring 
in the adult CNS are the remodeling of neurites and the turnover of synapses. 
The first one involves the modification of the structure of dendrites, axons and 
spines in neurons. Synapse turnover can be described as a change in the efficacy 
of synaptic transmission due to the structural reorganization of synapses and it 
involves synaptic facilitation, synaptic depression and potentiation (Zucker and 
Regehr, 2002). 
 
 Traditionally neuronal plasticity and specifically structural plasticity 
have been studied in excitatory neurons. However, nowadays it is becoming 
essential to improve our knowledge about interneuronal plasticity, specially 
because of the evidence of the implication of interneurons in the regulation of 
the excitatory/inhibitory balance, which is proposed to be involved in the 
etiology of different psychiatric disorders (Sun and Zhan, 2011). Some studies 
have shown that interneuron remodeling also occurs in the adult brain, both in 
control conditions and after experimental perturbations, including changes in 
dendritic arborization, or the dynamics of dendritic branch tips (Lee et al., 2008; 
Chen et al., 2011). A recent study has described also a dynamic behavior of the 
spine turnover rate in interneurons of the visual cortex co-expressing VIP (Keck 
et al., 2011). 
 
 In the same line, studies on an animal model of epilepsy have 
demonstrated that interneurons show shrinkage of dendrites, decreased axon 
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length, and axonal buttons and inhibitory contacts with excitatory neurons 
(Prince et al., 2009). Reductions in soma size and dendritic arbour in 
interneurons, or in the total number of these inhibitory neurons have been 
observed in the brains of schizophrenic patients (Kalus et al., 2002; Benes and 
Berretta, 2001). All these structural changes may involve the participation of cell 
adhesion molecules. Among them, one of the most interesting regarding the 
plasticity of interneurons is NCAM and its polysialylated form (PSA-NCAM).  
  
 
 
5. THE NEURAL CELL ADHESSION MOLECULE AND ITS 
POLYSIALYLATED FORM 
 
NCAM protein is a surface glycoprotein with three isoforms, differing in 
their molecular weight (120, 140, 180 KDa), generated by alternative splicing in 
the NCAM gene (Gascon et al., 2007). The extracellular domain shared by the 
three isoforms is a globular structure, immunoglobulin-like, composed by 
around 70-110 amino acids. NCAM180 has a long cytoplasmic domain and it is 
predominantly expressed in mature neurons in cell contacts and postsynaptic 
densities (Persohn et al., 1989). NCAM140 has a shorter cytoplasmic domain 
and is mainly expressed in developing neurons. Finally, NCAM120 is expressed 
mainly in glial cells (Bhat and Silberberg, 1986; Walmod et al., 2004). NCAM has 
homophilic and heterophilic interactions with other adhesion molecules or with 
diverse signal transduction proteins (Walmod et al., 2004).  
 
One of the main modifications suffered by the NCAM proteins is the 
addition of the polysialic acid (PSA) by the action of the polysialyltransferase 
enzymes, St8SiaII and St8SiaIV. The PSA is a linear homopolymer of α-2,8-
linked N-acetylneuraminic acid, which can form chains ranging from 50 to 150 
units. It is attached to NCAM at the fifth immunoglobulin-like domain (Kiss 
and Rougon, 1997; Acheson et al., 1991). This unique post-translational 
modification of NCAM is absolutely necessary for the correct development and 
function of the brain, including processes such as learning and memory (Figure 
5) (Bork et al., 2007; Hildebrandt et al., 2007). 
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Figure 5. Representation of the the NCAM molecule and the two polysialyltransferases adding 
the PSA sugar to the molecule and conferring antiadhesive properties. 
 
 
 In the adult brain PSA-NCAM is expressed intensely in immature 
neurons of the hippocampus, the olfactory bulb/rostral migratory 
stream/subventricular zone axis or the paleocortex layer II (See Bonfanti and 
Nacher 2012 for review). Apart from these immature neurons, PSA-NCAM is 
also found in a population of larger cells that show multipolar morphology and 
are heterogeneously distributed in the brain. In the mPFC, there is a higher 
density of PSA-NCAM expressing cells in deep layers than in superficial layers 
(Varea et al., 2005). In the hippocampus, the highest density of these cells is 
located in ventral region (Nacher et al., 2002a) being more abundant in stratum 
lucidum or lacunosum moleculare. In the amygdala, there are more cells 
expressing PSA-NCAM in its medial division than in its basal region (Nacher et 
al., 2002b). In the hypothalamus, PSA-NCAM expression is detected in neurons 
and glial cells (Theodosis et al., 1991). There is also expression of PSA-NCAM in 
other regions of the adult nervous system such as the spinal cord, the optic 
nerve, different retinal layers and others.  
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 PSA carries carboxyl groups conferring negative charge and attracting 
water and ionic molecules, which hydrate the molecule. This impedes cell-cell 
and cell-extracellular matrix adhesion, preventing both the homotypic and the 
heterotypic binding of NCAM (Yang et al., 1992). Such anti-adhesive properties 
are critical in cell migration, axophilic migration, axon guidance, synaptic 
modulation or in other kinds of plasticity (Rutishauser, 1996; 2008). In contrast, 
the removal of PSA from NCAM induces neuronal differentiation (Seidenfaden 
et al., 2003; Petridis et al., 2004). With these evidences, apart from the facilitation 
of plastic processes, it was formulated the “shielding” hypothesis of PSA: The 
addition of PSA to NCAM may difficult the accessibility to NCAM of some 
membrane receptors. The function of brain-derived neurotrophic factor (BDNF) 
and other neurotrophins are also affected, and, as a result, increase dendritic 
spine density (Tyler and Pozzo-Miller, 2003) in a process that is likely regulated 
by PSA-NCAM. Moreover, PSA-NCAM interacts with other receptors 
participating in synaptic plasticity processes, such as α-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid receptors (AMPA receptors), N-methyl-D-
aspartate (NMDA receptors) and others, that play important roles in 
mechanisms of memory and learning (Vaithianathan et al., 2004; Hoffman et al., 
1998; Muller, 2000). Another evidence of the importance of PSA-NCAM in the 
correct brain function is the genetic association found between NCAM and 
schizophrenia (Vawter, 2000; Sullivan et al., 2007) and between the 
polysialyltransferase II (ST8SIAII) and different psychiatric disorders such as 
schizophrenia (Arai et al., 2006; Tao et al., 2007; Isomura et al., 2011), autism 
(Anney et al., 2010) and bipolar disorder (Lee et al., 2011). A reduction in the 
amount of PSA-NCAM in the hippocampus and the amygdala of schizophrenic 
patients has been demonstrated (Barbeau et al., 1995; Varea et al., 2012), as well 
as increases of the level of expression of this protein in the amygdala of 
depressed patients (Varea et al., 2012). 
 
 Previous studies in our laboratory indicate that the mature neurons 
expressing PSA-NCAM in the cerebral cortex of rodents are mainly 
interneurons (Gomez-Climent et al., 2011). Moreover, there are several 
subpopulation of interneurons expressing PSA-NCAM in the hippocampus, the 
amygdala and the mPFC of humans (Nacher et al., 2002a; Varea et al., 2007c; 
2012). 
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6. STRESS AND DEPRESSION 
  
 Stress is an essential complex process necessary for survival in humans 
and other animals. There are several components defining the stress response, 
but is hard to measure the importance of the impact of each one (see McEwen, 
2008b for review). In this way, we have focused our attention in one of these 
factors affecting the stress response, the time of the stressor exposition. It is well 
known the need of the stress hormone cortisol to survive, consequently, the 
acute stress response during a discrete time, mediated by this hormone, is 
essential and adaptative. Nevertheless, if the exposure to the stressor is 
maintained for a prolonged time, it turns out in chronic stress and may become 
deleterious for the organism, having effects on the structure and function of the 
brain. 
 
 Psychosocial research in the late 1970s emphasized the importance of the 
stressful events in the development of major depression (Brown and Harris, 
1978). In addition, Carroll pointed out the presence of alterations in the 
hypothalamic-pituitary-adrenal axis (HPA), finding increased cortisol 
concentrations in depressed patients (Carroll, 1982). These two findings 
constituted the basis to relate stress with the appearance of a depression-like 
phenotype. Follow-up studies in depressed subjects with a history of childhood 
abuse have shown an enhanced HPA axis response to psychosocial stress; 
however, this does not occur in non-depressed individuals with a history of 
childhood abuse (Heim et al., 2000; Newport et al., 2004). These and other 
studies suggest a high relationship between stressful events during life and the 
development of depressive disorders.  
 
 
6.1. Hypothesis on Etiology and Risk Factors 
 
Depression is a multifaceted condition promoted by genetic and 
environmental factors, such as stress. The depressive disorder has been 
estimated by the World Health Organization as one of the 10 leading medical 
causes of disability in the world and the major cause of morbidity worldwide 
(World Health Organization, 2001). The risk of suffering depression for a 
human along the life span is about 20% (Kessler et al., 2005), and the patients 
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suffering from depressive disorder usually develop other health problems 
(Evans et al., 2005). The prevalence of the disease is more common in women 
(7%) than in men (3%).   
 
 Attending to the four edition of the Diagnostic and Statistical Manual of 
Mental Disorders or DSM-IV (American Psychiatric Association, 2002), the 
Major Depression symptoms are characterized by a depressive status during 
most of the day and a reduced interest for pleasure (anhedonia). It may affect 
appetite, weight and sleep. Other symptoms described are getting tired, slower, 
and feeling a loss of energy. Regarding the mental aspects of the disease, the 
depressive patient has blame thinking, sometimes delusions, less ability to 
think and concentrate, and suicide attempts in some severe cases.  
 
 Depression is usually a chronic disease, with a significant morbidity and 
mortality. The majority of the major-depression patients suffer more than one 
episode of depression and the risk of recurrence is higher if the patient is young 
or has a family history of depression, or with each new episode, or with the 
intensity of each episode (Hollon et al., 2006; Kendler et al., 2000). Long term 
depression (more than 2 years), has more clinical symptoms and worst 
prognosis with high comorbidity (respiratory and cardiac symptoms), being 
stress or anxiety high risk factors for chronicity in depression (Merikangas et al., 
2003). 
 
 Similar to other complex psychiatric diseases, there is not a single 
hypothesis on the basis of depression, but in all of them it is assumed that 
individuals suffering from this disorder have emotional problems altering the 
stress-alarm signaling system, the executive functions/cognitive appraisal 
system and the mood regulation system (for review see Sjöberg and Blomstedt, 
2011). From these facts, two main hypotheses on the neurobiological basis of 
depression have been postulated: 
 
 Monoamine hypothesis: This hypothesis is based on the mode of action 
of antidepressant drugs, which act over the monoaminergic pathways. Such 
drugs increase the monoamine transmission acutely, either by means of the 
inhibition of the reuptake or the degradation of monoamines. This hypothesis 
was postulated when the first antidepressant medication used was shown to act 
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inhibiting the monoamine oxidase enzyme (MAO)( Dick, 1959). Therefore, this 
hypothesis postulates that depression is due mainly to a decrease in 
catecholamine availability (Schildkraut, 1965). 
 
Neuroplastic hypothesis: The neuroplastic hypothesis of depression is 
currently one of the most accepted hypotheses, because structural plasticity 
plays an important role in the response to stress or fear as indicated above. This 
hypothesis, formulated by Duman in 2002 and amplified by Castren in 2004 and 
2005, suggests that depression is promoted by alterations in neuron structure, 
mainly by a reduction in neuronal connectivity (Figure 6). In agreement with 
this hypothesis, antidepressant may act increasing neuronal branching and 
connectivity (Hayley et al., 2005). This hypothesis is also supported by the fact 
that chronic stress induces dendritic atrophy and retraction in excitatory 
neurons in the hippocampus (McEwen, 1999) and in the medial prefrontal 
cortex (Radley et al., 2004; Cook and Wellman, 2004). However, it has been 
described that chronic stress promotes dendritic growth in some regions of the 
amygdala (Vyas et al., 2002). 
 
 
 
 
Figure 6. “Neuroplastic” hypothesis of depression, showing a retraction of 
the arborization in pyramidal neurons and a decreased number of synaptic 
buttons. Modified from Castren, 2005. 
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6.2. Physiological and Anatomical Alterations 
 
 As mentioned above, the limbic system and the mPFC, which are crucial 
in the experience of emotions and in memory storage, are among the most 
affected regions in depressive disorders. By means of the use of neuroimaging 
techniques in depressed patients, some changes in the structure and function of 
these regions have been described.  
 
First, it has been observed that the volume of the PFC of patients is 
reduced, mainly the anterior cingulate and orbitofrontal cortex and other 
regions such as the hippocampus, putamen and caudate nuclei (Koolschijn et 
al., 2009). Other studies have shown reductions in the blood flow and glucose 
metabolism in some of these regions (see Drevets, 1992 for review). The white 
matter volume is also increased in the frontal lobe, impairing some of the 
functions dependent on this area (Tullberg et al., 2004). 
 
 The diverse symptomatology of depression and affective disorders has 
been recognized for decades. Nevertheless, the precise neurobiological basis of 
these disorders is not yet known. However, some of the post-mortem studies 
performed in patients with major depression have thrown some light on the 
systems that are altered in this disease.  
  
 Some of the changes found in post-mortem brains in major depression 
are reduced number of glial cells in the cortex and the hippocampus, reduced 
neuronal density, predominantly in layer II of orbitofrontal cortex or increased 
neuronal and glial density in the hippocampus with a decreased soma size and 
apoptosis. Furthermore, it has been shown a significant reduction in the 
number of pyramidal neurons and reduced pyramidal neuronal size in the 
orbitofrontal cortex, specially in layers III and V. The amygdala of depressed 
patients also presented a reduction in glial density (see Sacher et al., 2012 for 
review). 
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6.3. Animal Models  
 
 Due to the complex etiology of the disease, several animal models of 
depression have been generated (see Krishnan and Nestler, 2011 for review). 
Here we describe some of the most important animal models: 
 
 Models of Secondary Depression. Because overactivation or 
hypofunction of the HPA axis is a common feature of depressed patients, 
deregulation of the HPA axis is a strategy to develop models of depression. 
Several efforts have been done in this direction, being the most important 
achievement the knockout mouse of the glucocorticoid receptor (GR), which 
shows altered glucocorticoid function. These mice develop a number of both 
physiological and behavioral abnormalities that mimic major depressive 
symptoms in humans, including hyperactivity of the HPA axis, impaired 
negative feedback regulation of this axis and increased depression-like 
behavior. Alternatively, chemical treatments, such as the use of isotretinoin or 
proinflamatory cytokines, can generate similar models of depression. 
 
 Models of Acute Stress. These models are based on the effect produced 
by some stressors and are the most used models in the tests of antidepressant 
drugs. Two of the most widely used acute stressors are the forced swim test and 
the tail suspension test. In both cases, mice are submitted to adverse conditions 
during a short time period. Other model of acute stress is the learned 
helplessness model, in which the animal is exposed to an uncontrollable and 
inescapable stress such as different electric shocks. When the animal is re-
exposed to the same stressor but has the possibility to escape, it will either 
display increased escape latency or completely fail to escape.  
 
 Models of Chronic Stress. These models are similar to the ones 
described above, but in this case the animals are exposed to the stressors for a 
longer time, promoting an anthropomorphized reaction of despair. The chronic 
mild stress is applied by means of different stressors or the same stressor 
intermittently during a period between 1 and 7 weeks. The stressors can be 
physical of psychosocial agents. The last ones are performed by the interaction 
of the rodent with natural wild predators or by promoting agonistic encounters 
between individuals of the same species. In the physical stressor paradigms, 
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rodents are exposed to damaging environments or extreme situations, such as 
strobe lights, swim, abrupt circadian disruptions and restraint or 
immobilization.  
 
 The chronic immobilization model of depression is a model of chronic 
stress based on the application of immobilization to the rodent during 1 to 6 
hours a day in a period of 1 to 7 weeks. There are different ways to immobilize 
the animals, depending if the species is rat or mouse and the strategy also varies 
in the time of stress duration.   
 
 Alternatively, immobilization can be combined with other physical 
stressors. This model is termed Chronic Unpredictable Stress (CUS), and has 
been widely used but with poor reproducibility (Willner, 2005).  
 
 Table 1 shows the different phenotypes observed in the chronic 
immobilization model, parallel to human traits of depression.  
 
    Table 1. Phenotypes of the chronic immobilization rodent model. 
Phenotypes Observed Reference 
Decreased sucrose preference (anhedonia) Strekalova and Steinbusch, 2010 
Reduced expression of pro-proliferative genes Bergstrom et al.,2007 
Reduction of the volume of hippocampus, amygdala 
and prefrontal cortex 
Isgor et al., 2004; McEwen et al.,2008 
Dendritic retraction in pyramidal neurons of CA3 
and CA1 regions 
McEwen et al., 1999; Sousa et al., 2000 
Dendritic retraction and spine reduction in 
excitatory neurons of the mPFC 
Radley et al., 2004; Perez-Cruz et al., 2009 
Dendritic growth and spinogenesis with activation 
of excitatory neurons in the amygdala and altered 
expression of PSA-NCAM 
Vyas et al., 2002; Mitra et al., 2005; 
Roozendaal et al., 2009; Cordero et al., 
2005; Sandi, 2004 for review  
 
 
 
7. SCHIZOPHRENIA 
 
Schizophrenia is a complex psychiatric disease affecting 0.72% of the 
total world population (Saha et al., 2005), although this percentage varies in 
different populations. Men are more frequently affected than women in a 1,4:1 
proportion (McGrath et al., 2008). The schizophrenic patients have a 
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misregulation of several mental processes, giving place to behavioral 
alterations. Usually the disease starts at adolescence or young adulthood and 
persists during the lifetime of the individual, with a chronic and deteriorating 
course. Due to the common onset in the early life stages, patients have in their 
infancy a prodromal stage with mild physical disturbances, altered social 
relationships and cognitive impairments (Figure 7) (Lewis and Lieberman, 
2000). 
 
 
Figure 7. Clinical course of psychosis prodrome. Adapted from Lewis & Lieberman (2000) and 
extracted from Addington and Heinsser, 2012. 
 
 
Schizophrenia was defined firstly by E. Kraepelin as Dementia Praecox 
(Kraepelin, 1971 for a translated version) to differentiate it from Manic-
Depresive insanity (currently Bipolar Disorder). E. Bleuler in 1908 proposed the 
term Schizophrenia to describe a group of disorders altering cognition and 
having emotional and behavioral symptoms (Bleuler, 1911). From that moment, 
the knowledge and redefinition of the disease has been increasing to fit the best 
diagnosis of the disease.  
 
The schizophrenic phenotype is very heterogeneous, with a high variety 
of symptoms and signs, which may vary in the same individual along his/her 
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life. For this reason, it may occur that two schizophrenic patients had few or 
none symptoms in common, complicating the study of this disease.  
 
In general, the symptoms and signs of the disease are classified in 3 
different groups included in the DSM-IV (American Psychiatric Association, 
2002): 
 
Positive Symptoms. Positive symptoms are the common denomination 
of the psychotic symptoms. They are an exacerbation of normal psychic 
elements not altered in healthy people, usually termed psychosis. Psychosis is 
an altered perception of the surrounding reality with hallucinations, delusions 
and thought disorder. Hallucinations consist of a false perception in a conscious 
state in the absence of external stimuli, which are felt as real by the person who 
suffers from them. Delusions of false beliefs are generally paranoid (persecution, 
grandiosity, personality substitution, thinking transmission…). Thought disorder 
consists in disorganization of thinking and behavior, affecting the development 
of ideas. 
 
 These are the most common positive symptoms and they appear also in 
other related diseases such as dementia or bipolar disorders, or in individuals 
with drug abuse or alcoholism (Carpenter, 2011). One of the most studied 
positive symptoms are the auditory hallucinations, which have been associated 
to several genetic risk factors and brain alterations (Sanjuan et al., 2004; 2006; 
Escartí et al., 2010) 
 
Negative Symptoms: These symptoms are related to personality traits 
present in healthy people, which are altered in patients suffering from the 
disease. Some of the negative symptoms are altered social interaction, 
motivation, expression of affect or empathy, ability to experience pleasure and 
spontaneous speech, among many others. These symptoms promote deep social 
isolation of the individual, making very difficult the integration of the 
schizophrenic patients in society.  
 
Cognitive Symptoms: They affect mainly the attention, information 
processing, executive function (mental processes involved in the environmental 
adaptation and response to some situations), working memory (short term 
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memory necessary to develop discrete tasks) and other processes such as 
associative impairment, inability to develop new ideas, learning difficulties, bad 
concentration… These are the most characteristic symptoms of schizophrenic 
patients, because they are present in almost all patients in all the disease course, 
appearing usually surrounding the adolescence or in the late infancy 6-14 years 
(Carpenter, 2011). 
 
Other important symptoms or signs of the disease are grossly, 
disorganized and catatonic behavior, disorganized thoughts, limited speaking 
flow, unhopefulness or suicide attempts. 
 
 
7.1. Hypothesis on Etiology and Risk Factors 
  
 The cause of schizophrenia is unknown yet. Current hypothesis postulate 
the existence of a genetic basis conferring susceptibility to the disease, together 
with environmental events that may act as precipitating factors of the psychotic 
processes.  
 
 The epidemiological studies, including studies of familiar aggregation, 
studies in monozygotic and dizygotic twins and studies of adoptions, have 
allowed the evaluation of the genetic and the environmental components of 
schizophrenia, suggesting an important participation of a genetic component in 
the development of the disease, with an heritability around 80% and indicating 
a modulating role, enhancing or silencing, of the environmental factors (Cardno 
et al., 1999; Sullivan et al., 2003).  
 
As a complex psychiatric disease, the environmental risk is very 
important in the onset. Some studies have described diverse susceptibility 
environmental factors with different weight. For example, the prevalence is 
higher in males, developed countries, urban areas, immigrant population, drug 
abuse people and singles, perinatal complications and maternal depression, 
winter birth and elevated father age (see Vilain et al., 2012 for review). But none 
of these environmental factors has more influence in the development of the 
disease than having a schizophrenic first degree relative (Riley and Kendler, 
2006), pointing to the genetic factors as the main risk factors in schizophrenia.   
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 Once the involvement of a genetic component has been established in 
schizophrenia, it has been suggested that the disease model is in agreement 
with the complex multifactorial diseases. The common disease-common 
variant (often abbreviated CD-CV) hypothesis predicts that common disease-
causing alleles are widespread in human populations and have small effect on 
the phenotype. The common disease-rare variant (CD-RV) hypothesis, on the 
contrary, argues that multiple rare DNA sequence variations, each with 
relatively high penetrance, are the major contributors to genetic susceptibility to 
common diseases (Schork, 2009). Both hypotheses are combined with some 
genetic risk factors conferring susceptibility to the disease and with vital events 
that unleash it. This fact difficults the study of schizophrenia, because not all 
patients have the same genetic risk factors and it one of the altered genes is not 
sufficient to set up the disease but it increases the likelihood. In addition, it is 
necessary to take into account the interaction between genes (G X G) and 
between genes and environment (G X E) to detect the risk combinations. These 
are the reasons why each risk factor in this disease has a limited power for 
diagnosis or prognosis (Kraft and Hunter, 2009).  
  
 Several genes have been associated with schizophrenia, first with the 
linkage studies in the 1980s and after that with the association studies of genetic 
variants, with the most common study case-control association test, associating 
insertions-deletions (Indels), variable number of tandem repeats (VNTRs) and 
more commonly, single nucleotide polymorphisms (SNPs). One of the most 
studied genes has been DISC1 (disrupted in schizophrenia 1), a gene that is 
involved in neuronal generation and was described by Blackwood et al. in 2001 
in a Scottish family with psychiatric disorders. Other genes participating in 
some neuronal developmental processes have been studied such as DARPP32 
(Reiner et al., 1998), Neuregulin 1 (Stefansson et al., 2003), Reelin (Rice and 
Curran, 2001).  
 
 Several hypotheses on the origin of schizophrenia have been proposed 
and they can be organized in two groups: genetic hypotheses or 
neurodevelopmental hypotheses.  
  
 Genetic Hypotheses: This group of hypothesis includes those involved 
in neurotransmission, which implicate alterations in genes participating in the 
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pathway of the neurotransmitter. Here we found the Dopamine hypothesis, the 
Serotonin hypothesis and the Glutamate hypothesis. This group of hypotheses is 
based on the convincement that the alterations in some genes are sufficient 
(combined with the environmental effects) to promote the onset of the disease. 
Some of the studied genes have been traditionally genes involved in 
neurotransmission, or genes involved in brain connectivity. First, based on 
evidences on the mode of action of antipsychotics, the dopamine receptors were 
studied in relation to the disease (Seeman et al., 1975), focusing the attention on 
D1 and D2 receptors (Pani, 2002). Later, it was found that the antipsychotics of 
second generation, showed a high affinity for serotonin receptors, indicating 
that this neurotransmitter was a candidate for the susceptibility to the disease 
(Geyer and Vollenweider, 2008). Finally, the glutamate hypothesis was 
developed after studies analyzing the effect on the glutamatergic system of 
some propsychotic drugs (Coyle, 2006).  
 
 These hypotheses are interrelated, because there is a high regulation 
between all the neurotransmitter systems, indicating a functional association 
(Yao et al., 2008; Frigourg et al., 2011). 
 
 Neurodevelopmental Hypotheses: One of the most accepted theories for 
schizophrenia nowadays is the one involving genetic risk factors combined 
with damage during early development and the influence of an adverse 
environment (Murray and Lewis, 1987; Weinberger et al., 1986). It is based on 
the prodromical symptoms associated to the later onset of the disease (cognitive 
and negative symptoms…) and it is linked to the apparent lack of big neuro-
pathological changes in the schizophrenic individuals (Weinberger and 
McClure, 2002). Consequently, it has been postulated that schizophrenia may be 
the result of early alterations in brain development, which appear to develop 
symptoms only  late in the adolescence or in adulthood, resulting in alterations 
in the “social brain” and cognitive deficits (Owen et al., 2011). The reason why 
the disease onset occurs mainly during adolescence or early adulthood is 
unknown, but several studies suggest a deficit in the normal brain maturation, 
causing a deregulation in certain neuronal systems (Inta et al., 2010).  
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This hypothesis does not exclude those described above, because some of 
the genes participating in basic neural processes and neurotransmission are also 
implicated in the neurodevelopment. 
 
 
7.2. Physiological and Anatomical Alterations 
  
 As mentioned above, there are few clear neurophysiological alterations 
in the patients suffering from schizophrenia. The complex etiology of the 
disease difficults the identification of such alterations, because schizophrenia 
shows a high diversity of symptoms and patients may not show the same 
clinical and pathological alterations. Some of the most robust alterations found 
in patients are described below.  
   
 Since the 1920s there is evidence of a reduction in the brain volume in 
schizophrenic patients. Subsequent studies, using magnetic resonance imaging 
(MRI), showed specifically reductions in the hippocampus, amygdala, superior 
temporal gyri (STG), prefrontal cortex, thalamus, anterior cingulate cortex, 
white matter structures such as the corpus callosum and an increase in 
ventricular volumes (for review see Jaaro-Peled et al., 2010).  
 
 Some other brain imaging studies have found lack of activation of the 
dorsolateral prefrontal cortex (DLPFC) in response to cognitive tasks mediated 
by this region, which is called hypofrontality (Meyer-Lindenberg et al., 2002; 
Davidson and Heinrichs, 2003). However, other studies have shown the 
opposite results (Manoach et al., 1999). This conflictive data on the prefrontal 
response to cognitive tests suggests an increased background noise leading to 
inefficient information processing (Winterer et al., 2004). Furthermore, there are 
signs of altered GABA concentrations in some brain areas of the patients (Yoon 
et al., 2010). 
 
 Regarding brain physiology, abnormalities in the P-50 and P-300 
latencies and amplitudes of event-related potentials, including the mismatch 
negativity (MMN), have been found in schizophrenic patients (Umbricht and 
Krljes, 2005). In this way, sleep abnormalities, eye movement alterations (Monti 
and Monti, 2005) and impairments of neural synchrony, such as gamma 
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oscillations (Uhlhaas and Singer, 2010; Farzan et al., 2010) or theta frequencies 
(Winterer et al., 2000), are common in patients suffering from schizophrenia. 
Another remarkable trait is the increased amygdala and parahippocampal 
gyrus activation observed in patients (Escarti et al., 2010). Finally, alterations in 
the the pre-pulse inhibition (PPI) are also common in these patients. This shows 
that the reaction after a given stimuli is reduced in schizophrenia (Braff and 
Light, 2005). PPI is one of the most consistent alterations shown both by treated 
and naïve-medication patients and by their healthy relatives (Cadenhead, 2002).  
All these physiological changes must have neurochemical bases, probably 
involving glutamatergic, serotoninergic, cholinergic, dopaminergic and 
GABAergic systems (Javitt, 2008).  
 
 Postmortem studies of the brains of schizophrenic patients have 
replicated some of the observations found in vivo using neuroimaging: These 
include the reduction in gray matter volume (Harrison, 2004), or in those of the 
white matter (Gogtay et al., 2008) in some areas and the increase in the volume 
of the ventricles. Some other studies have studied the density of some 
neurotransmitters and their receptors at the mRNA and protein levels.  
 
Some of the most interesting results are the alterations of some 
serotoninergic pathway genes in the prefrontal cortex of schizophrenic patients 
(Abi-Dargham, 2007), and the decrease in the expression of several markers of 
inhibitory transmission, such as GAD67 or parvalbumin expression (Lewis et 
al., 2012). 
 
 Table 2 shows the most interesting findings in genetic and post-mortem 
studies in pathways implicated in inhibitory neurotransmission and neural 
plasticity in schizophrenia. 
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            Table 2. Findings in genetic and post-mortem studies in inhibitory neurotransmission  
            and plasticity in schizophrenia. 
Marker Finding Reference 
GAD67 
Reduced GAD67 mRNA in prefrontal cortex 
Reduced GAD67 level in PV cells in the 
cortex 
Preserved number of PV cells in the cortex 
Associated polymorphysms of GAD67 
promoter 
Volk et al., 2000 
Akbarian et al.,1995 
Woo et al.,1997 
Hashimoto et al., 2003 
Addington et al., 2004 
Woo et al., 1998 
Chandelier 
Decreased chandelier cartridges (GAT1+) in 
prefrontal cortex 
Volk et al., 2001 
SST 
Decreased SST mRNA, cells in prefrontal 
cortex 
Hashimoto et al., 2007 
NPY/CCK Decreased levels of NPY and CCK mRNAs Hashimoto et al., 2007 
NRG1 Association of the NRG1 gene 
Wang et al., 2009 
Yang et al.,  2003 
ERB4 Association of the ERB4 gene Silberberg et al., 2006 
BDNF/Trkb Downregulation of BDNF in prefrontal cortex 
Wong et al., 2010 
Takahashi et al., 2000 
PSA-NCAM 
Downregulation of PSA-NCAM in 
hippocampus and amygdala 
Barbeau et al., 1995 
Varea et al., 2012 
 
 
7.3. Animal Models 
 
Some of the most useful tools for the study of schizophrenia and other 
psychiatric disorders are the animal models of these diseases, which usually are 
developed in rodents. However, the heterogeneity of schizophrenia makes 
extremely difficult the development of a unique animal model and, 
consequently, researchers have to investigate different models to reproduce 
different hallmarks of the disease. Currently there is no animal model capable 
of reproduce exactly all the symptoms and alterations found in schizophrenic 
patients. Very few models show altered social behavior, learning or memory 
impairment, which are the negative and cognitive symptoms of schizophrenia 
and are resistant to the treatment with antipsychotics, even after remission of 
the positive symptoms. Consequently,  the search for new animal models, 
which will be able to reproduce some of the negative and cognitive symptoms 
is absolutely necessary in order to understand the disease and evaluate possible 
new therapies (for review see Jones et al., 2011). 
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The animal models for schizophrenia used in experimental research have 
been classified in four types, althought some of them can be placed in more 
than one group: 
 
Neuronal Lesion Models. The main strategy used for neuronal injury is 
the lesion of the ventral hippocampal areas in neonates. This model is based on 
the hypothesis that postulates the involvement of the hippocampus in the 
development of schizophrenia. It was in 1995 when Lipska and Weinberger 
developed this model in rats administrating ibotenic acid in the CA1 and 
subicular areas of the hippocampus at postnatal day 7 (P7). Other similar 
models result from the acute injection of the GABAA receptor antagonist, 
picrotoxin, into the ventral hippocampus (Bast et al., 2001). 
 
Mutant Models. These models result from mutations in genes potentially 
implicated in the disease. Some examples are the heterozygote mice for 
neuroregulin 1 (NRG1), a protein implicated in glutamate neurotransmission 
(Stefansson et al., 2002) and also in the development of cortical inhibitory 
networks (Fazzari et al., 2010); the DISC1 partially-deficient mouse (for review 
see Jaaro-Peled, 2009); the hypofunctional model for the NR1 subunit of the 
NMDA receptor (Mohn et al., 1999). Other models include the reeler mice 
(Impagnatiello et al., 1998), which shows a decreased expression of reelin, a 
molecule implicated in neuronal migration, and the mutant mouse for the 
Dysbindin gene (Papaleo et al., 2012), which is implicated in neurotransmitter 
release. 
 
Behavioral or Neurodevelopmental Models. To generate these models 
animals are submitted during their embryonic development, infancy or early 
adolescence to stressors or adverse environmental insults. They are based on 
the hypothesis that the risk of developing schizophrenia is enhanced by 
alterations during early development. Administration of methylazoxymethanol 
(MAM), a DNA methylase with anti-proliferative properties, to pregnant rats 
has been used to affect the brain development of the litter (Moore et al., 2006). 
Other models are based on maternal exposure to bacterial or viral infection 
(Khandaker et al., 2012). The social isolation rearing model, in which we have 
based some of our research, is included in this type of models. 
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Drug Administration Models. Some models have been developed by 
means of the administration of toxic substances, which mimic some of the 
symptoms suffered by schizophrenic patients. The most common and one of the 
first models obtained is based on amphetamine administration (Robinson and 
Becker, 1986). Other recently used models, which we have also used in this 
thesis, result from the administration of non-competitive antagonists of NMDA 
receptors such as ketamine or phencyclidine and other derivates (MK801) in 
order to alter the glutamatergic system and the normal neurodevelopment. 
 
 
7.3.1. Social Isolation Rearing Model 
  
 One of the simplest models used in the study of schizophrenia is the 
Social Isolation Rearing Model; this model consists in the social isolation of the 
rodent from their littermates after weaning. The isolated animal is able to see, 
smell and listen to the other animals, but is unable to have any physical contact. 
This situation promotes the development of psychotic-like behaviors.  
 
 Rats have a social structure resulting in a marked hierarchy. The 
establishment of this social system is very important for the correct 
development of the animal. Consequently, the isolation from the littermates 
causes severe deficits in the CNS and the development of altered behavior. The 
most relevant alterations found in this model are listed in table 3. 
 
    Table 3. Phenotypes of the social isolation rodent model.   
Phenotypes Observed Reference 
Disrupted prepulse inhibition Geyer et al., 1993 
Reduced prefrontal cortex volume Day-Wilson et al., 2006 
Reduced expression of AMPA glutamate receptors 
in hippocampus 
Sestito et al., 2011 
Impaired spatial cognition with affected prefrontal 
cortical synaptic plasticity 
Quan et al., 2010 
Altered novel object recognition McLean et al., 2010 
Increased aggression  Ferdman et al., 2007 
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7.3.2. Perinatal MK-801 Administration Model 
 
 In accordance with the neurodevelopmental hypothesis of schizophrenia, 
some models that alter the regular development of the brain have been 
proposed. Adverse events during the prenatal, perinatal or postnatal period 
may affect brain development in a way that could culminate in the 
manifestation of symptoms in the adulthood (Weimberger, 1996; Lewis and 
Levitt, 2002). 
 
 The administration of NMDA receptor antagonists, such as MK-801, to 
young rodents during their early postnatal developmental period not only 
results in NMDA receptor hypofunction, but also alters neurodevelopmental 
components (Stefani and Moghaddam, 2005; Baier, 2009). 
 
 Different kinds of MK-801 administration regimes have been proposed 
by different authors, differing in the day or days of intraperitoneal 
administration and in the dose, althoug almost all the models suggest that the 
administration of the MK-801 should be done during the early infancy of the 
rodent: from the 3rd to 19th day after birth, being more common the procedure 
around the 7th day. The dosis used also varies in different studies: from 0.13 
mg/Kg to 1mg/Kg in one or more doses (for review see Lim et al., 2012).  
 
 Some of the features seen in these models of schizophrenia involving 
perinatal MK-801 administration in rodents are listed in the recent review of Lin 
et al. in 2012: reduced weight during treatment, apoptosis in the 24h post 
injection, altered prepulse inhibition and locomotor activity in adulthood, 
impairments in novel object recognition, spatial memory, cognitive flexibility 
and increased anxiety with altered social behavior in adulthood, reduced brain 
volume, altered expression of NR1 subunit of NMDA receptor, augmented 
dopamine, serotonine and noradrenaline turnover, loss of prefrontal 
parvalbumin interneurons, changes in BDNF expression and altered number of 
glial cells. 
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7.3.3. Combined or “Double Hit” Model 
 
 Nowadays there is only one double hit model described combining social 
isolation with the administration of antagonists of NMDA receptors (MK-801). 
The researchers administered the MK-801 during adulthood in a subchronic (7 
days) dose of 0.5 mg/Kg twice daily (Ashby et al., 2010; Hickey et al., 2012). In 
these studies, Beninger and col. show that the effects of isolation and the 
antagonists of NMDA receptors produce complementary, although not very 
robust, behavioral alterations, indicating that the two manipulations are acting 
through different pathways.  
 
 Some of the main features of this model are: increased locomotor activity, 
increased GABA transporter-1 (GAT-1) activity in frontal cortex and 
hippocampus, upregulation of GABAA receptor expression, increased long term 
potentiation in CA1. 
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The main objective of this thesis is to study potential alterations in 
neuronal plasticity and inhibitory neurotransmission in the adult brain and 
their implication in psychiatric disorders. This objective is approached from the 
study of animal models of these disorders, the analysis of postmortem patient 
brains and genetic association studies. From this main objective, derive the 
subsequent specific objectives: 
 
1. To evaluate the changes in the expression of PSA-NCAM induced by 
chronic stress in the amygdala and mPFC of adult mice, and to study 
the effects of this aversive experience on the structure of interneurons 
and molecules implicated in inhibitory neurotransmission. 
 
2. To determine the existence of specific changes in the expression of 
different molecules involved in structural plasticity and inhibitory 
neurotransmission in the amygdala of rats reared in isolation. 
 
3. To find whether the combination of a perinatal injection of MK-801 
(P7), and a postweaning social isolation rearing reproduces some of 
the structural and molecular changes found in the mPFC and the 
hippocampus of schizophrenic patients, particularly in their 
inhibitory networks. 
 
4. To compare changes in the expression of PSA-NCAM, 
synaptophysin, vesicular glutamate transporter type 1 (VGLUT1) and 
GAD67, in the dorsolateral PFC from post-mortem samples of 
patients of Major Depression, Bipolar Disorder and Schizophrenia. 
 
5. To evaluate the involvement of ST8SIAII gene in the etiology of 
schizophrenia in the Spanish population, taking into account the 
gender of the individuals. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Articles 
 
 
 
 
 
 
 
 
 
 
 
 
 
Article 1: Chronic stress induces changes in the structure of 
interneurons and in the expression of molecules related to neuronal 
structural plasticity and inhibitory neurotransmission in the 
amygdala of adult mice 
 
 
 
 
 
 
 
  
 
 
 
Experimental Neurology 232 (2011) 33–40
Contents lists available at ScienceDirect
Experimental Neurology
j ou rna l homepage: www.e lsev ie r.com/ locate /yexnrRegular Article
Chronic stress induces changes in the structure of interneurons and in the expression
of molecules related to neuronal structural plasticity and inhibitory
neurotransmission in the amygdala of adult mice☆
Javier Gilabert-Juan a,b,c,1, Esther Castillo-Gomez a,c,1, Marta Pérez-Rando a,
María Dolores Moltó b,c, Juan Nacher a,c,⁎
a Neurobiology Unit and Program in Basic and Applied Neurosciences, Cell Biology Dpt., Universitat de València, Spain
b CIBERSAM, Genetics Dpt., Universitat de València, Spain
c Fundación Investigación Clínico de Valencia, INCLIVA, Spain☆ Grant Support: Spanish Ministry of Science and
BFU2009-12284/BFI, MICINN-PIM2010ERN-00577/NEUC
NET NEURON, Generalitat ValencianaCS2009-AP-127 a
Stanley Medical Research Institute to JN. Javier Gilabert-J
have a FPU predoctoral fellowships from the Spanish Min
(AP2008-00937 and AP2006-01953).
⁎ Corresponding author at: Neurobiology Unit, Cel
València, Dr. Moliner, 50, Burjassot, 46100, Spain. Fax: +
E-mail address: nacher@uv.es (J. Nacher).
1 These authors have contributed equally to this work
0014-4886/$ – see front matter © 2011 Elsevier Inc. Al
doi:10.1016/j.expneurol.2011.07.009a b s t r a c ta r t i c l e i n f oArticle history:
Received 26 January 2011
Revised 17 June 2011
Accepted 19 July 2011
Available online 28 July 2011
Keywords:
Interneuron
Polysialyltransferase
Glutamic acid decarboxylase
SynaptophysinChronic stress in experimental animals, one of the most accepted models of chronic anxiety and depression,
induces structural remodeling of principal neurons in the amygdala and increases its excitation by reducing
inhibitory tone. These changes may be mediated by the polysialylated form of the neural cell adhesion
molecule (PSA-NCAM), a molecule related to neuronal structural plasticity and expressed by interneurons in
the adult CNS, which is downregulated in the amygdala after chronic stress. We have analyzed the amygdala
of adult mice after 21 days of restraint stress, studying with qRT-PCR the expression of genes related to
general and inhibitory neurotransmission, and of PSA synthesizing enzymes. The expression of GAD67,
synaptophysin and PSA-NCAM was also studied in speciﬁc amygdaloid nuclei using immunohistochemistry.
We also analyzed dendritic arborization and spine density, and cell activity, monitoring c-Fos expression, in
amygdaloid interneurons. At the mRNA level, the expression of GAD67 and of St8SiaII was signiﬁcantly
reduced. At the protein level there was an overall reduction in the expression of GAD67, synaptophysin and
PSA-NCAM, but signiﬁcant changes were only detected in speciﬁc amygdaloid regions. Chronic stress did not
affect dendritic spine density, but reduced dendritic arborization in interneurons of the lateral and basolateral
amygdala. These results indicate that chronic stress modulates inhibitory neurotransmission in the amygdala
by regulating the expression of molecules involved in this process and by promoting the structural
remodeling of interneurons. The addition of PSA to NCAM by St8SiaII may be involved in these changes.Innovation (MICINN-FEDER)
ONNECT in the frame of ERA-
nd ACOMP2009/271 and the
uan and Esther Castillo-Gómez
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Aversive experiences, such as stress or fear can induce neuronal
structural plasticity, which may act as a neuroprotective mechanism
(McEwen, 2000; McEwen, 2005; McEwen and Chattarji, 2004;
Roozendaal, et al., 2009). In particular, chronic stress induces
dendritic atrophy and decreases spine density in principal neurons
of the medial prefrontal cortex (mPFC) (Cook and Wellman, 2004;
Radley, et al., 2004; Radley, et al., 2005; Seib andWellman, 2003) andthe hippocampus (Sousa, et al., 2000; Watanabe, et al., 1992). By
contrast, chronic stress induces opposite effects in principal neurons
of the basolateral amygdala (Vyas, et al., 2002). However these
structural effects of chronic stress in the amygdala are more complex,
since the same paradigm induces loss of spines in the medial
amygdaloid nucleus (Bennur, et al., 2007) and leaves the central
nucleus unaffected (Vyas, et al., 2003).
In addition to these structural changes, different electrophysio-
logical experiments indicate that stress or high levels of corticoste-
roids induce activation of the amygdala, leading to an increase in the
excitability of principal neurons (Duvarci and Pare, 2007; Roozendaal,
et al., 2009). This increase in excitability can be also the result of a
stress-induced reduction in inhibitory neurotransmission, which has
also been reported in the amygdala (see Davis, et al., 1994) for review.
Although, to our knowledge, all the studies on the stress-induced
neuronal structural plasticity have been focused on principal neurons,
it is also possible that changes in the structure of interneurons may
mediate the effects of stress on the amygdala, especially those
affecting inhibitory networks. In fact, recent reports have found that,
Table 1
Sequences of gene speciﬁc primers and associated amplicon lengths for qRT-PCR.
Target gene Primers Sequence (5′→3′) Amplicon size(1)
ST8SiaII Forward GGCTGTGGCCAGGAGATTG 72
Reverse GGCATACTCCTGAACTGGAGCC
ST8SiaIV Forward GCACCAAGAGACGCAACTCATC 68
Reverse CAGAGCTGTTGACAAGTGATCTGC
NCAM Forward GGATGCCTCCATCCACCTC 67
Reverse GGCCGTCTGATTCTCTACATAGG
GAD67 Forward GGGTTCCAGATAGCCCTGAGCGA 120
Reverse TGGCCTTGTCCCCTTGAGGCT
GAD65 Forward AGCCTCAACACACAAATGTCTGCTTCT 135
Reverse TGGTCCCATACTCCATCATTCTGGCT
SYN Forward TCTTTGTCACCGTGGCTGTGTT 268
Reverse TCCCTCAGTTCCTTGCATGTGT
GABAAα1 Forward GCCATGGACTGGTTTATTGC 99
Reverse CCACGCATACCCTCTCTTGGTG
GAT Forward TCTGCCCGCCTTGGCTCTGA 134
Reverse TGGGGGTGGGTCCTGGAAGC
RELN Forward CGGAAGGAAGGCGTGCTGCT 125
Reverse GCCCCCTCAGGCAGGAGGAT
TATABP Forward CACTTCGTGCAAGAAATGCTG 89
Reverse AATCAACGCAGTTGTCCGTG
(1) Amplicon length in base pairs.
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their structure in the adult cerebral cortex (Lee, et al., 2006; Lee, et al.,
2008).
Different molecules have been studied in order to understand the
molecular bases of these changes in the structure of amygdaloid
neurons and in the physiology of inhibitory and excitatory circuits of
the amygdala. The polysialylated form of the neural cell adhesion
molecule (PSA-NCAM) is a very promising candidate to mediate these
changes, because it is intensely expressed in the different nuclei of the
amygdala of rodents (Nacher et al., 2002b) and its expression is
regulated by chronic stress in the amygdala (Cordero, et al., 2005) and
other cerebral regions (see Sandi, 2004, for review). The addition of
PSA to NCAM confers it anti-adhesive properties and consequently,
facilitates plastic processes, such as neurite and spine remodeling or
synaptogenesis (see Rutishauser, 2008 for review). Moreover, in
different regions of the cerebral cortex this molecule is expressed
exclusively in interneurons (Gomez-Climent et al., 2011; Nacher et al.,
2002a; Varea, et al., 2005) and, consequently, changes in its
expression may inﬂuence inhibitory neurotransmission. In fact, we
have recently reported that PSA-NCAM expressing interneurons have
reduced synaptic input and less dendritic arborization and spine
density than interneurons lacking PSA-NCAM (Gomez-Climent et al.,
2011). Changes in PSA-NCAM expression induced by different
experimental manipulations are accompanied by changes in the
expression of markers of synaptic density in the amygdala and
different cortical regions (Varea et al., 2007a, 2007b). Moreover,
consequent with its presence in interneurons, at least in themPFC, the
modulation of PSA-NCAM expression is also accompanied by changes
in the expression of molecules related to inhibitory neurotransmis-
sion (Castillo-Gomez, et al., 2008).
In order to understand the role of PSA-NCAM in the response of the
amygdala to chronic stress and to study the effects of this aversive
experience on the structure of interneurons andmolecules implicated
in inhibitory neurotransmission, we have subjectedmice to 21 days of
chronic restrain stress. These mice belong to a strain in which the
expression of the enhanced green ﬂuorescent protein (GFP) is under
the control of the glutamic acid decarboxylase gene and thus the
complete morphology of these inhibitory neurons can be observed.
We have studied the effects of stress on the dendritic arborization and
spine density of these cells using confocal microscopy and we have
also analyzed the expression of different molecules related to
inhibitory neurotransmission and PSA synthesis using immunohisto-
chemistry and quantitative RT-PCR.
Material and methods
Animals
Male GINmice (3 months-old; GFP-expressing Inhibitory Neurons,
(Tg(GadGFP)45704Swn)) were purchased from Jackson laboratories
(Bar Harbor, Maine, USA) and bred in our animal facility. Animals
were housed in groups of 5 to 7 per cage, at a room temperature of
25 °C and on a 12-h light/dark cycle with food and water available ad
libitum, and were assigned randomly to control or stress group.
Animals were weighed at day 1, 2, 6, 9, 13, 16, 20 from the start of
stress procedure. All efforts were made to minimize the number and
suffering of animals used. All animal experimentation was conducted
in accordance with the Directive 2010/63/EU of the European
Parliament and of the Council of 22 September 2010 on the protection
of animals used for scientiﬁc purposes and was approved by the
Committee on Bioethics of the Universitat de València.
Chronic immobilization stress procedure
Fourteen mice were subjected to chronic immobilization stress
similar to a published procedure (Patel, et al., 2004), but with somemodiﬁcations. Brieﬂy, mice were immobilized for 1 h per day for
21 days (from 11 to 12 am) in modiﬁed, transparent 50 ml plastic
conical tubes with many air holes to allow ventilation. Animals inside
the tube were placed on the bench top, close to a sonicator bath.
Control animals (n=11) were handled daily, but were left undis-
turbed in their cages after less than 1 min. Mice were euthanized 24 h
after the last stress session, in a different room than the one in which
restraints were carried out in a random order.
Quantitative retrotranscription-polymerase chain reaction
The mice used for qRT-PCR were sacriﬁced by decapitation using a
guillotine. After that, brains were removed from the skull and the
whole amygdalae of 5 control mice and 7 stressed mice were
extracted. Each amygdala was individually analyzed in this experi-
ment. Total mRNA from amygdala was extracted using TriPure
reagent (Roche Applied Science, Indianapolis, IN) following manufac-
turer's instructions. The concentration and purity of total RNA for each
sample were determined by Eppendorf BioPhotometer plus (Eppen-
dorf AG, Hamburg, Germany). cDNA synthesis was performed using
the Expand reverse transcriptase (Roche Applied Science).
For qRT-PCR analyses, each sample was run in triplicates. qPCR
was carried out with the ABI PRISM 7700 Sequence Detector (Applied
Biosystems) using SYBR Green PCR master mix (Applied Biosystems),
speciﬁc primers for all genes (Table 1) at a concentration of 240 nM,
and cDNA of each sample. TATA binding protein gene was used as a
reference gene. Following a 95 °C denaturation for 10 min, the
reactions were cycled 40 times with a 95 °C denaturation for 15 s,
and a 60 °C annealing step for 1 min. After this, a melt curve was
performed to assess the speciﬁcity of primers.
Relative quantiﬁcation was performed using the comparative
threshold (Ct) method according to the 2-ΔΔCt method (Pfafﬂ, 2001).
Changes in gene expression were reported as fold changes relative to
controls. ANOVA study followed by Student–Newman–Keuls post-hoc
test was performed to analyze the statistical signiﬁcance of results.
Immunohistochemistry
Six control mice and 7 stressed mice were perfused transcardially
with a 4% paraformaldehyde solution in phosphate buffer (PB, 0.1 M,
pH 7.4). Brains were removed from the cranium and the hemispheres
were separated. The right hemisphere was cryoprotected in a 30%
sucrose solution in PB and cut in a sliding microtome at 50 μm. These
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contralateral hemisphere was cut in 100 μm sectionswith a vibratome
and the resulting sections were used to analyze dendritic spine
density on GFP expressing interneurons.
The immunohistochemistry protocol was performed as follows:
Brieﬂy, ﬂoating sections were incubated for 1 min in an antigen
unmasking solution (0.01 M citrate buffer, pH 6 at 100 °C). After cooling
down the sections to room temperature, they were incubated with 3%
H2O2 inphosphatebuffered saline (PBS) for 10 min toblockendogenous
peroxidase activity. After this, sections were treated for 1 h with 10%
normal donkey serum (NDS) (Jackson ImmunoResearch Laboratories)
in PBSwith 0.2%Triton-X-100 (Sigma-Aldrich) and theywere incubated
overnight at room temperature with one of these antibodies: anti-PSA-
NCAM (AbCys, 1:700), anti-GAD67 (Chemicon, 1:500), anti-SYN
(Sigma, 1:200) with PBS containing 0.2% Triton-X-100 and 3% NDS.
The secondday sectionswere incubated for 1 hwith either donkey anti-
mouse IgM or IgG biotinylated antibodies (1:200; Jackson ImmunoR-
esearch Laboratories) in PBS with 0.2% Triton-X-100 and 5% NDS. Then,
sections were incubated in an avidin–biotin–peroxidase complex
(Vector Laboratories) for 30 min in PBS. Color development was
achieved by incubating with 3,3-diaminobenzidine tetrahydrochloride
(Sigma-Aldrich) and 0.033% hydrogen peroxide in PB for 4 min. Finally,
sections were mounted on slides, dried for 1 day at room temperature,
dehydrated with ascending alcohols and rinsed in xilol. After this,
sections were coverslipped using Eukkit mounting medium.
In order to amplify the GFP ﬂuorescent signal in interneurons, a
ﬂuorescent immunohistochemistry against GFP was performed.
Brieﬂy, ﬂoating sections were blocked with NDS in buffer as above
and incubated overnight with chicken anti-GFP antibody (Millipore,
1:500). The day after, the sections were incubated for 1 h with an
Alexa Fluor 488 conjugated antibody against chicken (Molecular
Probes,1:500). Finally, sections were mounted on slides using
DakoCytomation ﬂuorescent mounting medium (Dako North America,
Inc., Carpinteria, CA).
In order to characterize neurochemically the somata expressing
PSA-NCAM in the amygdala, we have performed double ﬂuorescence
immunohistochemistry and confocal analysis. The ﬁrst day, sections
were incubated overnight at room temperature with mouse mono-
clonal IgM anti-PSA antibody and either mouse monoclonal IgG2a
anti-GAD67 or mouse monoclonal IgG1 anti-Ca(2+)/CaM dependent
protein kinase II (CAMKII). The second day sections were washed
and incubated for 1 h with donkey anti-mouse IgM in combination
with either donkey anti-mouse IgG1, or donkey anti-mouse IgG2a
secondary antibodies conjugated with Alexa 555 or Alexa 647 (1:200;
Molecular Probes, Eugene, OR) in PBS containing 0.2% Triton-X-100
and 3% NDS. All sections were processed as described above and then
observed under a confocal microscope (Leica TCS SPE) using a 63X oil
objective. Z-series of optical sections (1 μm apart) were obtained
using the sequential scanning mode. These stacks were processed
with LSM 5 image software. One in 10 series of coronal telencephalic
sections from 3 control animals was double-labeled as described. Fifty
randomly-selected immunoreactive cells were analyzed in each case
to determine the co-expression of PSA and the markers described
above.
To identify c-Fos expression in GFP labeled interneurons and to
compare the percentages of these c-Fos/GFP expressing cells between
stressed and control mice, a ﬂuorescent immunohistochemistry
against c-Fos was performed as described above, using a polyclonal
IgG antibody generated in rabbit (1:2000, Santa Cruz Biotechnology
Inc.) and an Alexa Fluor 555 conjugated secondary antibody against
rabbit IgG (Molecular Probes,1:500).
Quantiﬁcation of neuropil immunoreactivity
From each immunostaining (PSA-NCAM, GAD67, SYN), 3 amyg-
daloid nuclei were selected in order to measure immunoreactivity aspreviously described (Varea et al., 2007a, 2007b): Centromedial,
Basolateral and Medial nuclei (CeM, BLa and Me). Sections were
examined with an Olympus CX41 microscope under bright-ﬁeld
illumination, homogeneously lighted and digitalized using a CCD
camera. Photographs to the different areas and layers were taken at
20× magniﬁcation. Gray levels were measured using Image J software
(NIH). Means were determined for each experimental group and data
were analyzed by means of ANOVA followed by Student–Newman–
Keuls post-hoc test.
Analysis of dendritic arborization and spine density
Dendritic arborization and spine density were studied using
confocal microscopy (Leica TCS SPE). Z-series of optical sections
(0.2 μm apart for spine density and 1 μm for dendritic arborization)
covering the dendritic tree of selected interneurons were obtained
using the sequential scanning mode and a 63× objective. From each
animal, an average of 4 GAD-GFP expressing neurons were selected
from the basolateral and lateral amygdaloid nuclei from control and
stress groups. The analysis was focused in these 2 amygdaloid nuclei
because most GAD-GFP expressing neurons in GIN mice are located in
them and are almost absent from the rest of amygdaloid regions. A
total of 40 neurons were analyzed from the 2 groups. In order to be
analyzed, GFP-expressing cells had to fulﬁll the following features:
(1) the cell must not show any truncated dendrites, (2) the dendritic
arbor of the cell must show at least a process with a length greater
than 120 μm and (3) the soma must be located at least 30 μm deep
from the surface of the tissue. The stacks obtained were then
processed using ImageJ software (NIH) in order to render 2D
reconstructions, in which the exact distance of the branching and
terminal points of the dendrites of a given interneuronwere analyzed.
The degree of dendritic arborization was analyzed using a procedure
for deriving the Sholl proﬁle. The Sholl analysis consists on the
measure of the number of intersections of the dendrites with circles of
increasing radius centered in the soma (Sholl, 1953). Spines were
quantiﬁed in 3 successive segments of 50 μm distances up to a total
length of 150 μm. Overall spine density values or densities per
segment were expressed as number of spines/μm. For each experi-
mental group, mean±S.E.M. was determined and the resulting values
was analyzed by one-way ANOVA (followed by Student-Newman-
Keuls post-hoc test) with the number of neurons as the “n”
(Magarinos et al., 1999; Guirado et al., 2009).
Quantiﬁcation of GFP/cFos expressing cells
In order to compare the number of GFP cells expressing c-Fos, 25
GFP-expressing interneurons per animal were randomly selected in
all amygdaloidal nuclei. Then, the number of c-Fos co-expressing cells
was counted, andmeans were obtained and compared using unpaired
Student's t-test analysis.
Results
Chronic stress does not induce changes in body weight gain
Body weight changes were measured at 0, 1, 2, 6, 9, 13, 16 and
20 days from the start of the stress procedure. This chronic immobili-
zation stress paradigm did not induce any signiﬁcant change in body
weightgainwhengroupswere comparedafterANOVAanalysis of all the
monitored days of the stress-induction protocol (p≥0.05).
qRT-PCR analysis reveals a decrease in the mRNA expression of ST8SiaII
and GAD67 genes in the amygdala of stressed mice
Polysialyltransferase II (ST8SiaII) gene expression in the amygdala
was signiﬁcantly decreased (p=0.024) by chronic stress when
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direction, glutamic acid decarboxylase 67 (GAD67) gene expression was
also signiﬁcantly repressed in stressed individuals (p=0.042; Table 2;
Fig. 1). The remaining genes: polysialyltransferase IV (ST8SiaIV), neural
cell adhesion molecule (NCAM), glutamic acid decarboxylase 65 (GAD65),
synaptophysin (SYN),GABA vesicular transporter (GAT), reelin (RELN) and
theGABA(A)α1 receptor (GABAAα1) did not showany signiﬁcant change
between stressed and control mice.Fig. 1. qRT-PCR mRNA fold change data shown as stressed mice group versus control
mice gene expression. All genes expression were normalized using TATA binding
protein as a control gene.The expression of PSA-NCAM, GAD67 and synaptophysin is altered by
chronic stress in some of the amygdaloid nuclei
In consonance with previous results using chronically stressed rats
(Cordero et al., 2005), in GINmice chronic stress induced a decrease in
the expression of PSA-NCAM, and also in that of GAD67 and SYN in all
the 3 amygdaloid nuclei studied (Fig. 2). However, this down-
regulation was not signiﬁcant for all these 3 nuclei. For PSA-NCAM
expression, we found a signiﬁcant decrease in CeM nuclei (p=0.0041),
but only a tendency toward a decrease in the other 2 remaining nuclei
(p=0.25; 0.19 for Me and BLa respectively). GAD67 expression was
signiﬁcantly reduced in theMe nuclei (p=0.021), but not in CeMor BLa
nuclei (p=0.32; 0.36, respectively). Finally, the reduction in SYN
expression was signiﬁcant in the Me nuclei (p=0.012) but not in the
CeM (p=0.34) or BLa (p=0.32) nuclei.PSA-NCAM expressing cells in the amygdala express markers of interneurons
and lack markers of principal cells
Many PSA-NCAM expressing cells in the amygdala co-expressed
GAD67 (38%±1.73, Fig. 3A) but none of them co-expressed Ca(2+)/
CaM dependent protein kinase II (CAMKII) a protein exclusively found
in principal neurons (Fig. 3B).Chronic stress reduces dendritic arborization but does not change spine
density in GAD-GFP expressing interneurons of the amygdala
Dendritic arborization and spine density were analyzed in in-
terneurons expressing GFP in the lateral and basolateral nuclei. Sholl
analysis revealed reduced dendritic arborization in the GFP-labeled
interneurons of stressed mice (Figs. 3C & D). These differences were
signiﬁcant in the 40–60 μm segment (p=0.013) of distance from the
soma. Selected dendrites were divided for analysis into three
segments of 50 μm from the soma. We did not ﬁnd signiﬁcant
differences in dendritic spine density between control and stressed
groups in the whole 150 μm dendrite segment or in any of the three
subsegments (p=0.71; 0.09; 0.33 respectively, Figs. 3E–G).Table 2
qRT-PCR results for tested genes in stress mice vs. control.
Total amygdala
Δ p-value
ST8SiaII 0.27 0.024
ST8SiaIV 0.73 0.54
NCAM 1.26 0.39
GAD67 0.57 0.042
GAD65 0.91 0.88
Synaptophysin 1.19 0.98
GABAAα1 0.77 0.24
GAT 1.08 0.59
RELN 0.83 0.29
Δ, change in gene relative to normalize. Information in bold represents signiﬁcant
changes.Chronic stress does not induce changes in the number of c-Fos expressing
interneurons of the amygdala
The number of c-Fos positive interneurons expressing GFP and the
total number of interneurons expressing GFP were quantiﬁed in all the
extension of the amygdala. Stressed mice did not differ signiﬁcantly
neither in thenumberof interneurons expressingGFP (p=0.947) nor in
the number of c-Fos positive interneurons expressing GFP (p=0.405).
Discussion
The present results in mice conﬁrm previous studies on the effects
of chronic stress on amygdaloid PSA-NCAM expression in rats and
expand them studying the expression of the enzymes responsible
of its polysialylation. These effects on PSA-NCAM expression are
paralleled by changes in molecules related to inhibitory neurotrans-
mission, but not by structural changes in amygdaloid interneurons.
PSA-NCAM a putative mediator of the effects of chronic stress in the
adult amygdala
Given its anti-adhesive properties, PSA-NCAM was one of the ﬁrst
molecules related to structural plasticity studied after chronic stress in
experimental animals (Sandi, et al., 2001) and has remained the focus
of several studies in different cerebral regions since then (Sandi,
2004). The distribution of PSA-NCAM expression in the amygdala of
GIN mice is similar to that described previously in a different mouse
strain (Nacher, et al., 2010) and in rats (Nacher et al., 2002b). As it has
been demonstrated for many PSA-NCAM expressing structures in the
cerebral cortex (excluding those of immature neurons) (Gomez-
Climent et al., 2011; Nacher et al., 2002a; Varea, et al., 2005), many
PSA-NCAM expressing neurons in the amygdala (present results)
express markers of interneurons and lack expression of molecules
exclusively found in principal neurons. Consequently, changes in PSA-
NCAM expression should primarily affect the structure of interneu-
rons, rather than that of principal neurons. In this line, we have
recently reported that PSA-NCAM expressing cortical interneurons
have reduced synaptic input and decreased dendritic arborization and
spine density when compared with neighboring interneurons lacking
PSA-NCAM (Gomez-Climent et al., 2011). It is possible then, that the
stress-induced reductions in PSA-NCAM expression observed in the
present study affect the connectivity of certain amygdaloid in-
terneurons, leaving more plasma membrane extension free for the
establishment of new synaptic contacts. Another non-excluding
Fig. 2. Neuropil immunoreactivity of PSA-NCAM, GAD67 and SYN in the amygdala.
Histogram bars show the gray level measured in amygdaloid nuclei (Me, CeM, BLa) of
control (white bar) and stressed mice (black bar) groups. Data are the mean±S.E.M.
from 6 control mice and 7 stressed mice in each group. * pb0.05 vs the control group.
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PSA-NCAM expression may limit the ability of certain interneurons to
remodel their structure in response to different stimuli. However, it is
possible that these structural changes occur in an earlier timewindow
during the stress procedure, in which changes in PSA-NCAM
expression occur in a different direction, or only in certain amygdaloid
nuclei and, consequently, we may have missed them studying the
amygdala as a whole. The inﬂuence of PSA-NCAM on amygdaloid
interneurons may also occur by the interference of the PSA in certain
signaling cascades mediated by NCAM, especially those affecting
inhibitory circuits (see (Maness and Schachner, 2007; Rutishauser,
2008) for review). However, future experiments manipulating PSA-
NCAM expression are needed to understand whether this molecule
plays a role in the remodeling of amygdaloid interneurons and how itsdirect effects on these inhibitory cells translate into structural changes
in principal neurons.
Our present results are similar to those reported by Cordero et al.
(2005), who described reductions in the expression of PSA-NCAM in
the amygdala of chronically stressed rats, especially in their central
and medial nuclei. However, although there is a general reduction in
PSA-NCAM expression, we have only found signiﬁcant changes in the
central but not in the medial amygdaloid nucleus. This discrepancy
may be due to species differences in the response to stress or to the
fact that the chronic stress paradigm used in our mice is less intense
(in terms of the duration of the stressor) than that used in rats. It is
interesting to note that chronic stress induces dendritic spine loss in
principal neurons of the medial amygdala of rats and mice and this
structural plasticity appears to be mediated by tissue plasminogen
activator (TPA) (Bennur, et al., 2007; Pawlak, et al., 2005). This
extracellular matrix protease is increased in this amygdaloid region
after stress (Pawlak, et al., 2005) andmay be responsible of the stress-
induced reduction in PSA-NCAM expression (Endo, et al., 1998).
Our results suggest that the decrease in polysialylation detected in
the amygdala after chronic stress may be caused by the observed
downregulation of polysialyltransferase St8SiaII expression, since
St8SiaIV mRNA levels are not affected. These results are interesting,
because the analysis of single polysialyltransferase knockout mice
revealed that most PSA-NCAM expressing structures in the amygdala
of adult control mice are polysialylated by St8SiaIV (Nacher, et al.,
2010). However, it is possible that, although St8SiaIV may function as
the “main” polysialyltransferase in the amygdala during normal
circumstances, St8SiaII may take care of the addition of PSA to NCAM
when the system is challenged, for instance by stress. In this regard, it
is very interesting to note that St8SiaII, but not St8SiaIV, is a candidate
susceptibility gene for schizophrenia and bipolar disorder (Arai, et al.,
2004; Tao, et al., 2007). These two mental disorders share abnormal-
ities in amygdaloid structure and function, and stress is considered a
precipitating factor in both of them. The observed reductions in PSA-
NCAM expression in the amygdala after chronic stress must have
consequences on behaviors dependent on this cerebral region. In fact,
previous studies in naive rodents with reduced PSA-NCAM expression
indicate a potentiation of amygdala-dependent behaviors: PSA
depletion in the amygdala of rats results in enhanced fear extinction
(Markram et al., 2007) and St8SiaII knockoutmice displayed increased
agression (Calandreau et al., 2010).
Chronic stress may affect synapses and inhibitory neurotransmission in
the amygdala
There are no previous reports showing changes in synaptophysin
expression or in synaptic density in the amygdala after chronic stress.
Our ﬁnding of a reduction in synaptophysin expression in the medial
amygdala may indicate a reduction in active synapses, because the
expression of this synaptic vesicle membrane protein is linked to
synaptic remodeling (Greengard, et al., 1993) and it is considered a
reliable index of synaptic density (Eastwood and Harrison, 2001;
Masliah, et al., 1990). Since this decrease coincides with the
previously reported reduction in dendritic spine density in principal
neurons of the medial amygdala (Bennur, et al., 2007), it is possible
that some of the lost synapses corresponded to those established on
the lost spines. However, we have not observed increases in
synaptophysin expression in the basolateral amygdala, where the
density of spines in principal neurons is increased after chronic stress
(Mitra, et al., 2005). Another possibility is that the synapses that
disappear after stress were inhibitory. This would be in agreement
with the parallel reductions observed in GAD67 expressing elements
in the medial amygdala. In fact, different studies have demonstrated
that stress can induce amygdala activation, affecting inhibitory
neurotransmission, which in turn has an important role in stress-
induced synaptic plasticity (Davis, et al., 1994). Moreover, an inverse
Fig. 3. A & B: Confocal microscopic analysis of the phenotype of PSA expressing cells in the amygdala. A: PSA-NCAM expressing interneuron coexpressing GAD67. B: PSA-NCAM
expressing interneuron lacking CAMKII expression; note the presence of CAMKII expressing somata in the bottom left of the picture. C: Sholl analysis of GFP expressing interneurons,
showing intersection number per 20 μmdendritic radial unit distance from the soma. D: 2D reconstructions of GFP expressing interneurons in the lateral and basolateral amygdala of
control (D1) and chronically stressed animals (D2). E–G: Confocal microscopic analysis of dendritic spine number in GAD-GFP expressing interneurons from the amygdala. E & F:
Histograms of the differences in the total density of dendritic spines (E) and the dendritic spine density in segments at different distances from the soma (F). Spines were counted in
three 50 μm-length segments located 0–50, 50–100 and 100–150 μm from the interneuron soma, respectively. Unpaired Student t-test showed no statistically signiﬁcant differences
in any of the segments analyzed. G: Compositions, using fragments of different confocal planes, of spinous dendrites of GAD-GFP expressing interneurons in the amygdala of control
(G1) and stressed animals (G2). Scale bar: 10 μm for A, B & D; 5 μm for G. Confocal images are 2D projections of 8 (A & B) and 20 (D),consecutive confocal planes located 1 μm apart;
images in G are 2D projection of 25 confocal planes located 0.2 μm apart.
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anxiety in the basolateral nucleus of the amygdala (Roozendaal, et al.,
2009). In fact, electrophysiological experiments in amygdala slices
have shown that stress levels of corticosterone can reduce inhibitory
neurotransmission and increase the excitability of principal amygda-
loid neurons (Duvarci and Pare, 2007). However, these results and
our ﬁndings on the expression of molecules related to inhibitory
neurotransmission are apparently in contrast with reports of a
reduced response of the amygdala to corticotropin releasing factor
(CRF) after chronic stress (Sandi et al., 2008). CRF increases the
excitability of principal neurons in the BLA (Rainnie et al., 1992)
and, consequently, a reduced response to this factor may result in
decreased excitability. Further analysis evaluating the expression of
CRF and their receptors in relation to inhibitory neurotransmission
during stress are necessary to understand this complex interactions.
The changes in the expression ofmolecules implicated in GABAergic
neurotransmission described in our study are only restricted to GAD67
expression and other molecules, such as GAD65, GAT or GABAA(1)
receptor do not show signiﬁcant changes, at least at the mRNA level.
Experiments evaluating different time points during the stressprocedure will be necessary to discard any effect on the expression of
these genes.
The effects observed in GAD67 expression may be mediated by the
monoaminergic system, since it is known that stress enhances the
release of monoamines in the amygdala (Goto, et al., 2007; Maier and
Watkins, 2005) and these monoamines, in turn, affect amygdaloid
inhibitory circuits (Braga, et al., 2004; Marowsky, et al., 2005). The
stress-induced changes in the expression of GAD67 in the amygdala
occur in parallel to the downregulation of PSA-NCAM expression and
similar concomitant decreases in the expression of both molecules
have been observed in the mPFC after dopaminergic depletion or
chronic treatment with a dopamine D2 receptor antagonist (Castillo-
Gomez, et al., 2008).
Changes in PSA-NCAM expression may promote remodeling of
inhibitory circuits, whichmay lead to the observed decrease in GAD67
expression. We have observed a signiﬁcant reduction in dendritic
arborization in interneurons of the basolateral and lateral amygdala.
This is, to our knowledge, the ﬁrst report describing dendritic
remodeling in interneurons after chronic stress. All the previous
studies have been focused on the structure of principal neurons.
39J. Gilabert-Juan et al. / Experimental Neurology 232 (2011) 33–40Particularly, in the basolateral amygdala chronic stress induces
dendritic hypertrophy of stellate and pyramidal neurons (Vyas,
et al., 2002). This dendritic growth of principal neurons, has been
interpreted as a structural strengthening of excitatory neurotrans-
mission in the basolateral amygdala, which may represent a cellular
substrate for enhanced anxiety (Roozendaal et al., 2009). In the same
way, the retraction of the dendrites of interneurons, which may also
reduce inhibition on principal cells, can also contribute to this
strengthening of excitatory neurotransmission. Whether this remo-
deling is due to increased corticosterone levels, as it has been
demonstrated for the hypertrophy of principal neurons (Mitra and
Sapolsky, 2008), still remains to be studied.
Unfortunately, we have not been able to study interneuron
structure in the centromedial nucleus, where signiﬁcant changes in
PSA-NCAM expression have been detected, because very few in-
terneurons express GFP in this nucleus in GIN mice. Future studies
using different transgenic strains in which more amygdaloid in-
terneurons appear labeled should shed light in this matter.
Our results on the amygdala of mice subjected to chronic stress
may increase our understanding of the molecular and structural
plasticity associated to the development of anxiety and mood
disorders, specially that involving amygdaloid inhibitory circuits.
This plasticity may be a substrate for the increases in anxiety-like
behaviors, cognitive changes and mood alterations observed in this
animal model and in these psychiatric disorders. In fact, although
there are no studies on the expression of molecules related to
inhibitory neurotransmission in these disorders, patients show
overactivity in the amygdala, probably due to a reduction in inhibitory
tone (Bremner, 2002; Phillips, et al., 2003).
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Abstract Chronic stress in experimental animals induces
dendritic atrophy and decreases spine density in principal
neurons of the medial prefrontal cortex (mPFC). This
structural plasticity may play a neuroprotective role and
underlie stress-induced behavioral changes. Different evi-
dences indicate that the prefrontocortical GABA system is
also altered by stress and in major depression patients. In
the amygdala, chronic stress induces dendritic remodeling
both in principal neurons and in interneurons. However, it
is not known whether similar structural changes occur in
mPFC interneurons. The polysialylated form of the neural
cell adhesion molecule (PSA-NCAM) may mediate these
changes, because it is known to influence the dendritic
organization of adult cortical interneurons. We have ana-
lyzed the dendritic arborization and spine density of mPFC
interneurons in adult mice after 21 days of restraint stress
and have found dendritic hypertrophy in a subpopulation of
interneurons identified mainly as Martinotti cells. This
aversive experience also decreases the number of gluta-
mate decarboxylase enzyme, 67 kDa isoform (GAD67)
expressing somata, without affecting different parameters
related to apoptosis, but does not alter the number of
interneurons expressing PSA-NCAM. Quantitative retro-
transcription-polymerase chain reaction (qRT-PCR) anal-
ysis of genes related to general and inhibitory
neurotransmission and of PSA synthesizing enzymes
reveals increases in the expression of NCAM, synapto-
physin and GABA(A)a1. Together these results show that
mPFC inhibitory networks are affected by chronic stress
and suggest that structural plasticity may be an important
feature of stress-related psychiatric disorders where this
cortical region, specially their GABAergic system, is
altered.
Keywords Interneuron  Glutamic acid decarboxylase 
Synaptophysin  Structural plasticity  Dendritic spines 
Somatostatin  Calretinin
Introduction
Aversive experiences, such as stress or fear can induce
neuronal structural plasticity, which may act as a neuro-
protective mechanism (McEwen 2000, 2008; Shansky and
Morrison 2009). In particular, chronic stress induces den-
dritic atrophy and decreases spine density in principal
neurons of the medial prefrontal cortex (mPFC) (Cook and
Wellman 2004; Radley et al. 2004; Radley and Morrison
2005; Seib and Wellman 2003) and the hippocampus
(Sousa et al. 2000; Watanabe et al. 1992) of adult male rats.
By contrast, the opposite effects have been observed in
principal neurons of the orbitofrontal cortex (Liston et al.
2006) or the basolateral amygdala (Vyas et al. 2002).
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Most of the studies on the stress-induced neuronal
structural plasticity have been focused on principal neu-
rons, but a recent study from our laboratory has shown that
chronic stress induces decreases in dendritic arborization in
interneurons of the lateral and basolateral amygdala
(Gilabert-Juan et al. 2011), the opposite effect to that
observed in principal neurons of this region (Vyas et al.
2002). In fact, there are also recent reports that have found
that, as it occurs with principal neurons, cortical interneu-
rons can also remodel their structure in the adult cerebral
cortex in normal circumstances (Lee et al. 2006, 2008;
Chen et al. 2011) and after loss of sensory input (Keck
et al. 2011). Chronic psychosocial stress also affects the
density of interneurons in adult tree shrews, at least in the
hippocampus, reducing the number of parvalbumin
expressing neurons (Czeh et al. 2005; Hu et al. 2010). An
observed increase in apoptosis in the hilus has been sug-
gested as one possible cause of this decrease in interneu-
rons and a similar increase in apoptosis has been reported
in the neocortex (Lucassen et al. 2001).
Different molecules have been studied to understand the
molecular bases of changes in the structure of mPFC
neurons; the polysialylated form of the neural cell adhesion
molecule (PSA-NCAM) is a very promising candidate to
mediate these changes, because it is intensely expressed in
interneurons of the mPFC of rodents (Gomez-Climent et al.
2011; Varea et al. 2005, 2007a) and humans (Varea et al.
2007b) and its expression is regulated by chronic stress in
the hippocampus (Pham et al. 2003; Sandi et al. 2001), the
amygdala, the piriform cortex (Nacher et al. 2004) and
other cerebral regions (see Sandi 2004, for review). How-
ever, despite the implication of the mPFC in the response
to chronic stress, PSA-NCAM expression has not been
studied yet in this cortical region after this aversive
experience.
In order to understand the effects of chronic stress on the
structure of mPFC interneurons and in molecules impli-
cated in inhibitory neurotransmission, as well as the role of
PSA-NCAM in the response to this aversive experience,
we have subjected mice to 21 days of chronic restraint
stress. These mice belong to a strain in which the expres-
sion of the enhanced green fluorescent protein (EGFP) is
under the control of the glutamic acid decarboxylase 67
(GAD67) gene (Oliva et al. 2000) and thus the complete
morphology of these inhibitory neurons can be observed.
After determining the neurochemical phenotype of these
GAD67-EGFP expressing interneurons, we have studied
the effects of stress on their dendritic arborization and
spine density using confocal microscopy. We have also
quantified changes in the total number of interneurons and
of those expressing PSA-NCAM in the mPFC, and have
determined with different methodologies the presence of
interneuronal degeneration and apoptosis in this cortical
region. Finally, we have analyzed the expression of dif-
ferent molecules related to inhibitory neurotransmission
and PSA synthesis using quantitative RT-PCR.
Materials and methods
Animals
Male GIN mice (3-month-old; EGFP-expressing inhibitory
neurons, Tg(GadGFP)45704Swn), in which EGFP expres-
sion is under the GAD67 promoter, were purchased from
Jackson laboratories (Bar Harbor, Maine, USA) and bred in
our animal facility. Twenty-five mice were used for the
chronic restraint stress experiment and four animals were
used to study the neurochemical phenotype of GAD67-
EGFP-expressing neurons in the mPFC. Animals were
housed in groups of 5–7 per cage, at a room temperature of
25 C and on a 12-h light/dark cycle with food and water
available ad libitum, and were assigned randomly to con-
trol or stress group. All animal experimentation was con-
ducted in accordance with the Directive 2010/63/EU of the
European Parliament and of the Council of 22 September
2010 on the protection of animals used for scientific pur-
poses and was approved by the Committee on Bioethics of
the Universitat de Vale`ncia.
Chronic restraint stress procedure
Fourteen mice were subjected to chronic restraint stress
similar to a published procedure (Patel et al. 2004), but
with some modifications as described before (Gilabert-Juan
et al. 2011). Briefly, mice were immobilized for 1 h per
day for 21 days (from 11 to 12 am) in transparent 50-ml
plastic conical tubes with many air holes to allow venti-
lation. Animals inside the tube were placed on the bench
top, close to a sonicator bath. Control animals (n = 11)
were handled daily, but were left undisturbed in their cages
after less than 1 min. Mice were euthanized 24 h after the
last stress session in a random order, in a different room
than the one in which restraints were carried out.
Histological procedures
Fresh tissue extraction and dissection of mPFC
Mice used for gene expression analysis (5 control and 7
stressed mice) were killed by decapitation using a guillo-
tine. Brains were immediately removed from the skull and
placed on Petri dishes filled with cold sterile phosphate
buffer (PB). Under a stereo microscope (SZX7; Olympus),
the overlying pia was removed and coronal cuts were made
to remove portions of the rostral and caudal poles.
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The mPFC from the left and right cortices were dissected
with a microscalpel in sterile conditions and then stored on
separated microcentrifuge tubes. Tissue was frozen in
liquid nitrogen and kept at -80 C until used. The whole
procedure was performed at cold temperature and under
RNAse-free conditions to prevent RNA degradation.
Perfusion and microtomy techniques
Thirteen mice from the chronic restrain stress experiment
(six control and seven stressed mice) and four mice for the
neurochemical phenotype study were perfused transcar-
dially under deep chloral hydrate anesthesia, first for 1 min
with NaCl 0.9 % and then for 30 min with 4 % parafor-
maldehyde in PB 0.1 M, pH 7.4. Thirty minutes after
perfusion, brains were extracted from the skull and their
hemispheres were separated.
One hemisphere was cryoprotected with 30 % sucrose
in cold PB 0.1 M (4 C) for 48 h and then cut in 50-lm
thick coronal sections with a freezing-sliding microtome
(Leica SM2000R, Leica, Nussloch, Germany). Slices were
collected in 10 subseries and stored at -20 C in a cryo-
protective solution until used (30 % glycerol, 30 % ethyl-
ene glycol in PB 0.1 M). These sections were destined to
immunohistochemical analyses. The other hemisphere was
cut into 100 lm sections with a vibratome and the resulting
sections were used to analyze dendritic spine density and
dendritic arborization on EGFP-expressing interneurons.
Immunohistochemistry for conventional light
microscopy
Four subseries (50-lm thick sections) from each animal
from the chronic restraint stress experiment were processed
‘‘free-floating’’ for immunohistochemistry using the avi-
din–biotin-peroxidase complex (ABC) method as follows.
Sections were first incubated for 1 min in an antigen
unmasking solution (0.01 M citrate buffer, pH 6) at
100 C. After cooling down the sections to room temper-
ature, they were incubated with 3 % H2O2 in phosphate
buffered saline (PBS) for 10 min to block endogenous
peroxidase activity. After this, sections were treated for 1 h
with 10 % normal donkey serum (NDS) (Jackson Immu-
noResearch Laboratories, West Grove, PA) in PBS with
0.2 % Triton X-100 (Sigma-Aldrich, St. Louis, MO) and
were incubated for 24 or 48 h (Table 1) at 4 C in primary
antibody (anti-PSA-NCAM or anti-GAD67). After wash-
ing, sections were incubated for 2 h (room temperature)
with the proper biotinylated secondary antibody (anti-
mouse IgM, or anti-mouse IgG), followed by ABC (Vector
Laboratories, Peterborough, UK) for 1 h in PBS. Color
development was achieved by incubating with 3,30-diam-
inobenzidine tetrahydrochloride (DAB; Sigma-Aldrich)
and 0.033 % H2O2 for 4 min. PBS containing 0.2 % Triton
X-100 and 3 % NDS was used for primary and secondary
antibodies dilution. Please, see Table 1 for further infor-
mation about antibodies.
All the studied sections passed through all procedures
simultaneously to minimize any difference from immuno-
histochemical staining itself. To avoid any bias in the
analysis, all slides were coded prior to analysis and the
codes were not broken until the experiment was finished.
Immunohistochemistry for confocal microscopy
In general, tissue was processed ‘‘free-floating’’ for
immunohistochemistry as described above but omitting the
endogenous peroxidase block. Sections were incubated for
24 or 48 h at 4 C with proper primary antibody cocktails
(see text below and Table 1). After been washed, sections
were incubated at room temperature and light-protected
with proper fluorescent secondary antibody cocktails (see
Table 1) for 2 h.
In order to amplify the EGFP fluorescent signal in
interneurons destined to morphological analysis (dendritic
spine density and dendritic arborization), a simple fluo-
rescent immunohistochemistry against EGFP was per-
formed (see Table 1).
In order to characterize neurochemically the somata
expressing GAD67-EGFP in the mPFC, we have per-
formed seven different double immunostainings using a
tissue from non-treated mice: anti-GFP primary antibody in
combination with anti- (1) calbindin (anti-CB), (2) calre-
tinin (anti-CR), (3) parvalbumin (anti-PV), (4) somatostatin
(anti-SOM28), (5) neuropeptide Y (anti-NPY), (6) vaso-
intestinal peptide (anti-VIP) or (7) anti-Cholecystokinin
(anti-CCK) primary antibodies (see Table 1).
All sections processed for fluorescent immunohisto-
chemistry were mounted on slides and coverslipped using
DakoCytomation fluorescent mounting medium (Dako
North America Inc., Carpinteria, CA, USA).
Analysis of the neurochemical phenotype of GAD67-
EGFP expressing neurons in non-treated animals
Sections double labeled for GFP and interneuronal sub-
population markers [parvalbumin (PV), calbindin (CB),
calretinin (CR), somatostatin (SOM), neuropeptide Y
(NPY), cholecystokinin (CCK) and vasointestinal peptide
(VIP)] or PSA-NCAM were observed under a confocal
microscope (Leica TCS-SPE) using a 639 oil objective.
Z-series of optical sections (0.5 lm apart) were obtained
using sequential scanning mode and stacks were then
processed with Zeiss LSM 5 image software. Fifty GAD67-
EGFP-expressing neurons within the mPFC were randomly
selected from each animal (non-treated mice) and each
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immunostaining to determine the co-expression of GAD67-
EGFP and each marker. Percentages of co-localization
were determined for each animal and mean ± SEM were
calculated.
Analysis of dendritic arborization and spine density
Dendritic arborization and spine density were studied using
confocal microscopy (Leica TCS-SPE) as previously
described (Gilabert-Juan et al. 2011, Gomez-Climent et al.
2011). Z-series of optical sections (0.2 lm apart) covering
the dendritic tree of selected interneurons were obtained
using the sequential scanning mode and a 639 objective.
From each animal, six GAD67-GFP expressing neurons
were selected from the whole mPFC; no distinction was
made to choose the neurons between layers and regions. In
order to be analyzed, GFP-expressing cells had to fulfill the
following features: (1) the cell must not show any truncated
dendrites, (2) the dendritic arbor of the cell must show at
least a process with a length greater than 150 lm and (3)
the soma must be located at least 30 lm deep from the
surface of the tissue. The stacks obtained were then pro-
cessed using ImageJ software (NIH) to obtain 2D projec-
tions, in which the distance of the branching and terminal
points of the dendrites of a given interneuron was analyzed.
The degree of dendritic arborization was analyzed using a
procedure for deriving the Sholl profile (Gutierrez and
Davies 2007). The Sholl analysis consists of the measure of
the number of intersections of the dendrites with circles of
increasing radius centered in the soma (Sholl 1953). Spines
were defined as any kind of protrusion found in a dendrite
and were quantified in three successive segments of 50 lm
distances up to a total length of 150 lm. Overall spine
density values or densities per segment were expressed as
number of spines/lm. For each experimental group,
mean ± SEM was determined and the resulting values
were then subjected to unpaired Student’s t test statistical
analysis with the number of animals as the ‘‘n’’, using the
IBM SPSS statistics software (version 19).
Estimation of the total number of neuronal somata
expressing PSA-NCAM, GAD67 or GAD67-EGFP
The number of neuronal somata expressing PSA-NCAM,
GAD67 or GAD67-EGFP covering 100 % of the sample
area (mPFC) was estimated using a modified version of the
fractionator method (West et al. 1991), as described before
(Castillo-Gomez et al. 2011; Varea et al. 2007a, b). That is,
all labeled cells found in all mPFC within each 50-lm thick
section. The fractionator sampling scheme refers to the
methodology of examining one out of every six brain
sections. One from six systematic-random series of sec-
tions covering the whole rostral to caudal extension of
mPFC was viewed on an Olympus CX41 microscope for
Table 1 Primary and secondary antibodies
Host Isotype Dilution Incubation Company
Primary antibodies (abbreviated names)
Anti-CB Rabbit IgG 1:2000 O/N, 25 C Swant
Anti-CCK Mouse IgG 1:500 O/N, 25 C CURE
Anti-CR Rabbit IgG 1:2000 O/N, 25 C Swant
Anti-GAD67 Mouse IgG 1:500 O/N, 25 C DSHB
Anti-GFP Chicken IgY 1:1000 O/N, 25 C Chemicon-Millipore
Anti-NPY Rabbit IgG 1:500 O/N, 25 C Provided by Dr. T.J. Go¨rcs
Anti-PSA-NCAM Mouse IgM 1:700 36 h, 4 C Abcys
Anti-PV Rabbit IgG 1:2000 O/N, 25 C Swant
Anti-SOM28 Rabbit IgG 1:500 O/N, 25 C Abcam
Anti-VIP Rabbit IgG 1:200 O/N, 25 C CURE
Secondary antibodies
Anti-chicken IgY Donkey DyLightTM488 1:400 1 h, 25 C Jackson ImmunoResearch
Anti-mouse IgM Donkey Biotin-SP 1:400 1 h, 25 C Jackson ImmunoResearch
Anti-mouse IgG Donkey Biotin-SP 1:400 1 h, 25 C Jackson ImmunoResearch
Anti-mouse IgM Donkey Alexa Fluor 555 1:400 1 h, 25 C Molecular Probes
Anti-mouse IgG Donkey Alexa Fluor 555 1:400 1 h, 25 C Molecular Probes
Anti-rabbit IgG Donkey Alexa Fluor 555 1:400 1 h, 25 C Molecular Probes
CB calbindin-D28 k, CCK cholecystokinin, CR calretinin, GAD67 67 kDa isoform of the glutamate decarboxilase enzime, GFP green fluo-
rescent protein, NCAM neural cell adhesion molecules, NPY neuropeptide Y, PSA-NCAM polysialylated form of the NCAM, PV parvalbumin,
SOM28 somatostatin, SYN synaptophysin, VIP vasointestinal peptide
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PSA-NCAM and GAD67 and on an Olympus BX61 fluo-
rescent microscope for GAD67-EGFP cells. Cell somata
were identified and counted with a 409 objective. Cells
appearing in the upper focal plane were omitted to prevent
counting cell caps.
Means were determined for each experimental group
and data were then subjected to unpaired Student’s t test
statistical analysis using the IBM SPSS statistics software
(version 19).
Identification and quantification of pyknotic nuclei
A set of sections was stained with 40,6-diamidino-2-phe-
nylindole (DAPI, Sigma-Aldrich, St. Louis, MO) in a
concentration of 2 lg/ml during 10 min and used for the
detection of pyknotic cells in the mPFC. These degenerated
cells are characterized by intensely stained condensed
chromatin, which often appears in different small spherical
pyknotic bodies (Gould et al. 1991). The number of pyk-
notic nuclei covering 100 % of the sample area (mPFC)
was estimated using the same methodology described for
the quantification of neuronal somata described above.
Quantitative retrotranscription-polymerase chain
reaction
Total mRNA from mPFC was extracted using TriPure
reagent (Roche Applied Science, Indianapolis, IN) by
means of one-step sample homogenization/lysis procedure.
TriPure Isolation Reagent disrupted cells and denatured
endogenous nucleases. Then, chloroform was added to the
sample and the mixture was centrifuged. This step sepa-
rates the sample into three phases: a colorless aqueous
(upper) phase, a white interphase and a red organic (lower)
phase. The upper phase was placed in a separate tube and
RNA was recovered from it by isopropanol precipitation.
Finally, RNA was isolated by alcohol precipitation steps.
Purified total RNA was eluted in RNase-free water and
stored at -80 C. RNA concentration and purity was
measured in a spectrophotometer at 260 nm and
260/280 nm, respectively (Eppendorf BioPhotometer plus;
Eppendorf AG, Hamburg, Germany).
Reverse transcription (RT) reactions were performed as
follows: 2 ll oligo dTplus (10 pmol) were hybridized to
1 ll of total RNA (100 ng/ll) in 10.5 ll volume by heating
up to 65 C for 10 min. First strand cDNA was then syn-
thesized by incubating the hybridized RNA at 43 C for
60 min with dGTP, dTTP, dCTP, dATP (1 mM each),1 ll
expand reverse transcriptase (50 U/ll), 0,5 ll Protector
RNAse inhibitor (40 U/ll), 2 ll 1,4-dithio-DL-threitol
(DTT, 100 mM) in 20 ll Buffer for Expand reverse
transcriptase. All products were purchased from Roche
Applied Science (Indianapolis). cDNA reactions were then
diluted fivefold in nuclease-free water. The quality of
cDNA was checked by agarose gel electrophoresis after
PCR amplification. Only the former small amplicon but not
the latter larger amplicon was detected in all samples on
the agarose gel electrophoresis, demonstrating no con-
tamination of samples with genomic DNA.
For quantitative retrotranscription-polymerase chain
reaction (qRT-PCR) analyses, each sample was run in
triplicates. qPCR was carried out with the ABI PRISM
7700 Sequence Detector (Applied Biosystems) using
SYBR Green PCR master mix (Applied Biosystems),
specific primers for all genes (Table 2) at a concentration
of 240 nm, and 4 ll cDNA (50 ng) of each sample. These
genes included those related to inhibitory neurotransmis-
sion, GAD67, Glutamic acid decarboxylase 2 (GAD65),
GABA vesicular transporter (GAT1), Reelin (RELN), Can-
nabinoid receptor 1 (CB1), N-methyl-D-aspartic acid
receptor 1 (NMDAR1), GABAA receptors subunits, Syn-
aptophysin (SYN) and those of the polysialyltransferases
ST8SiaII and ST8SiaIV and NCAM. In order to evaluate the
presence of stress-induced apoptosis in the mPFC we also
analyzed the expression of the apoptosis related genes,
BCL2-associated X protein (Bax) and B cell leukemia/
lymphoma 2 (Bcl2). TATA box-binding protein gene (TBP)
was used as a reference gene. Following a 95 C denatur-
ation for 10 min, the reactions were cycled 40 times with a
95 C denaturation for 15 s, and a 60 C annealing step for
1 min. After that, a melt curve was performed to assess the
specificity of primers. Primers were designed by Primer-
Blast free software, between exons to avoid genomic DNA
amplification, using Ensembl data sequences. All DNA
oligonucleotide primers were custom synthesized by
Metabion international AG (Martinsried, Germany).
Relative quantification was performed using the com-
parative threshold (CT) method according to the 2-DDCt
method (Pfaffl 2001), where, DDCT = (CT, target gene -
CT, reference gene) exp. group - (CT, target gene - CT,
reference gene) control group. Changes in gene expression
were reported as fold changes relative to controls. Unpaired
Student’s t test was performed to analyze the statistical
significance of results.
Results
Characterization of GAD67-EGFP expressing neurons
in the mPFC
In the mPFC of GIN mice, most GAD67-EGFP
expressing neurons were located in layers II, III and
upper V, similar to what has been found in a previous
study of the somatosensory cortex of this transgenic mice
strain (Oliva et al. 2000; Ma et al. 2006). Most of these
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neurons had multipolar or bipolar morphology and all of
them displayed dendritic spines. After careful observa-
tion of these EGFP expressing interneurons in the mPFC,
we have found that none of them displayed degenerative
symptoms such as swollen dendrites or axons or the
presence of abnormal nuclei. In order to study to which
subpopulation of interneurons pertained the GAD67-
EGFP expressing neurons in the mPFC, we performed
double immunostainings against EGFP and different
calcium binding proteins or neuropeptides. Regarding the
expression of calcium binding proteins, GAD67-EGFP
expressing neurons in the mPFC mainly co-expressed CR
(64.8 ± 7.1 %; Fig. 1a1–a3) and less frequently CB
(16.8 ± 1.1 %; Fig. 1b1–b3), but none of them was
found to co-express PV (0 ± 0 %; Fig. 1c1–c3).
Regarding the expression of neuropeptides, a high per-
centage of GAD67-EGFP expressing neurons co-expres-
sed SOM (75.0 ± 0.5 %; Fig. 1d1–d3), but no co-
localization was found when studying all the other
neuropeptides (CCK, NPY, VIP; Fig. 1e–g).
Table 2 Sequences of gene specific primers and associated amplicon lengths for qRT-PCR
Target gene Primers Sequence (50 ? 30) Amplicon sizea
ST8SiaII Forward GGCTGTGGCCAGGAGATTG 72
Reverse GGCATACTCCTGAACTGGAGCC
ST8SiaIV Forward GCACCAAGAGACGCAACTCATC 68
Reverse CAGAGCTGTTGACAAGTGATCTGC
NCAM Forward GGATGCCTCCATCCACCTC 67
Reverse GGCCGTCTGATTCTCTACATAGG
GAD67 Forward GGGTTCCAGATAGCCCTGAGCGA 120
Reverse TGGCCTTGTCCCCTTGAGGCT
GAD65 Forward AGCCTCAACACACAAATGTCTGCTTCT 135
Reverse TGGTCCCATACTCCATCATTCTGGCT
SYN Forward TCTTTGTCACCGTGGCTGTGTT 268
Reverse TCCCTCAGTTCCTTGCATGTGT
GAT1 Forward TCTGCCCGCCTTGGCTCTGA 134
Reverse TGGGGGTGGGTCCTGGAAGC
RELN Forward CGGAAGGAAGGCGTGCTGCT 125
Reverse GCCCCCTCAGGCAGGAGGAT
CB1 Forward TGTCCCTCACCCTGGGCACC 134
Reverse TCCCAGGAGATCGGCCACCG
NMDAR1 Forward GAGGCCATCCAGGCTGTGCG 133
Reverse TGCCAAAGCCGGAGCGGAAG
GABAAa1 Forward GCCATGGACTGGTTTATTGC 99
Reverse CCACGCATACCCTCTCTTGGTG
GABAAa2 Forward AAGAGGATGGGCTTGGGACGGG 100
Reverse GGCAACAGCTACCGCATAGGCG
GABAAa3 Forward AACAGCCTCAGCCACTTTGGATCTG 122
Reverse AGCCTTGCTCAGTGAGTGGGC
GABAAa4 Forward CTGGGCCCTGGAGAGCCTAACA 120
Reverse AAGCAGACAAAAGGCCTGTGCAGA
GABAAc2 Forward TTGGATGGCAAGGACTGTGCCAG 131
Reverse GCGGTAGGGAAGAAGATCCGAGCAT
BAX Forward AAACTGGTGCTCAAGGCCCT 92
Reverse AGCAGCCGCTCACGGAG
BCL2 Forward CCGGGAGAACAGGGTATGATAA 81
Reverse CCCACTCGTAGCCCCTCTG
TATABP Forward CACTTCGTGCAAGAAATGCTG 89
Reverse AATCAACGCAGTTGTCCGTG
a Amplicon length in base pairs
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Fig. 1 Confocal microscopic analysis of the phenotype of GAD67-
EGFP expressing cells in the mPFC. GAD67-EGFP expressing
interneurons coexpressing calretinin (a), calbindin (b) or somatostatin
(d). GAD67-EGFP expressing interneurons lacking parvalbumin (c),
cholecystokinin (e), neuropeptide Y (f) or vasointestinal peptide
(g) expression. Scale bar 10 lm. Confocal images are 2D projections
of eight consecutive confocal planes located 1 lm apart
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In order to know whether the GAD67-EGFP expressing
interneurons in the mPFC expressed PSA-NCAM in their
soma or their neurites we performed double PSA-NCAM/
EGFP immunohistochemistry. None of these cells showed
PSA-NCAM immunoreactivity, neither in their somata nor
in their dendritic or axonal processes. Moreover, analysis
of the projection field of these neurons in layers I and II
also revealed lack of PSA-NCAM expression in the
GAD67-EGFP expressing puncta (Fig. 2).
Chronic stress increases dendritic arborization but does
not change spine density in GAD67-EGFP expressing
interneurons in the mPFC
Sholl analysis revealed increased dendritic arborization in
GAD67-EGFP expressing neurons in the mPFC of stressed
mice (Fig. 3a, b). These differences were statistically sig-
nificant in five of the 20-lm length segments of distance
from the soma that were analyzed (Fig. 3b): 60–80 lm
segment (t11 = -2.33, p = 0.04), 80–100 lm segment
(t11 = -3.11, p = 0.011), 100–120 lm segment (t11 =
-3.24, p = 0.0088), 120–140 lm segment (t11 = -2.44,
p = 0.035), 140–160 lm segment (t11 = -3.24;
p = 0.0089).
For the spine density study, selected dendrites were
divided into three segments of 50-lm length of distance
from the soma, and the number of total spines was counted
(insets in Fig. 3a). We did not find statistically significant
differences in dendritic spine density between control and
stressed groups neither in any of the three 50-lm length
segments (t11 = -0.74; 1.05; 0.67, p = 0.47; 0.31; 0.52
each segment, respectively; Fig. 3c), or when the whole
dendrite length (150 lm) was taken into account
(t11 = 0.75, p = 0.46).
Chronic stress reduces the number of GAD67
and GAD67-EGFP expressing neurons in the mPFC
but not the number of those expressing PSA-NCAM
In order to compare the number of neuronal somata
expressing PSA-NCAM, GAD67 or GAD67-EGFP in the
mPFC of control versus stressed mice, somata expressing
these molecules were quantified in all regions and layers of
the mPFC. Results indicate that GAD67 and GAD67-EGFP
Fig. 2 Somata expressing PSA-NCAM do not show colocalization
with GAD67-EGFP expressing somata (a). PSA-NCAM expressing
puncta in mPFC layer II do not show GAD67-EGFP expression (b).
Scale bar 5 lm for a and 10 lm for b. Confocal images are 2D
projections of eight consecutive confocal planes located 1 lm apart
(a) and four consecutive confocal planes located 0.5 lm apart
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expressing somata were significantly reduced in the mPFC
of the stressed individuals (t11 = 3.17, p = 0.0089;
t11 = 2.265, p = 0.045, respectively). The number of
PSA-NCAM expressing somata in the mPFC of stressed
mice did not differ significantly from those of the control
mice (t11 = -0.54, p = 0.6; Fig. 4).
Analysis of pyknotic nuclei and the Bax/Bcl2 ratio
indicates the absence of apoptosis in the mPFC
after chronic stress
The observation of DAPI stained sections revealed a
complete absence of pyknotic nuclei in all the regions of
the mPFC. In accordance with this result, we also failed
to detect changes in the Bax/Bcl2 genes ratio, which
represents a critical balance of regulatory pro-apoptotic
and anti-apoptotic proteins in normal living cells: The
increase in Bax/Bcl2 ratio leads to the release of Cyto-
chrome c from the mitochondria, a decisive event in the
apoptotic pathway. As measured by qRT-PCR, the fold-
change in stressed mice with respect to control of Bax
and Bcl2 gene expression showed no significant changes
with values of 1.3 and 1.4, respectively (Table 3). A
non-significant fold-change of 0.92 (t11 = 1.11,
p = 0.29) was achieved for the Bax/Bcl2 ratio when
stress mice were compared to control.
Fig. 3 a Sholl analysis of GAD67-EGFP expressing interneurons,
showing the number of intersections per 20 lm dendritic radial unit
distance from the soma. Insets in A1 and A2 show high magnification
views of dendritic spines of GAD67-EGFP expressing interneurons.
b 2D reconstructions of GFP-expressing interneurons in the mPFC of
control (b1) and chronically stressed animals (b2). e–g Confocal
microscopic analysis of dendritic spine number in GAD67-EGFP
expressing interneurons from the mPFC. Histograms of the differ-
ences in the total density of dendritic spines (e) and the dendritic spine
density in segments at different distances from the soma (f). Spines
were counted in three 50-lm length segments located 0–50, 50–100
and 100–150 lm from the interneuron soma, respectively. Unpaired
Student t test showed no statistically significant differences in any of
the segments analyzed. g Compositions, using fragments of different
confocal planes, of spinous dendrites of GAD67-EGFP expressing
interneurons in the mPFC of control (g1) and stressed animals (g2).
Scale bar 10 lm for a, b,d; 2 lm for insets in a; 5 lm for g. Confocal
images are 2D projections of eight (a, b) and 20 (d), consecutive
confocal planes located 1 lm apart; images in g are 2D projections of
25 confocal planes located 0.2 lm apart
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NCAM, SYN and GABAAa1 gene expression
in the mPFC is increased after chronic stress
In order to know whether chronic stress induces changes in
the expression level of several genes related to neuronal
plasticity and inhibitory neurotransmission, we performed
qRT-PCR of the encoding transcripts (see Table 2) in the
whole mPFC, using as a control the TBP gene. qRT-PCR
analysis revealed a significant mild increase in mRNA
expression (fold change = 1.19; t10 = -2.36, p = 0.039)
of NCAM but no changes were observed in the expression
of the polysialyltransferase genes (ST8SiaII and ST8SiaIV).
In the same direction, the mRNA of the synaptic protein
synaptophysin was significantly increased in the mPFC of
the stressed mice showing an increase of 1.92 fold change
when compared to control group (t10 = -2.53, p = 0.027).
The third overexpressed gene was the GABAAa1 receptor
(GABAAa1), with a 2.03 fold increase when compared to
non stressed individuals (t10 = -2.34, p = 0.04). No sig-
nificant changes were detected neither in the other subunits
of this receptor (a2, a3, a4 and c2) nor in the genes of the
glutamic acid decarboxylase (GAD65 and GAD67) or the
GABA vesicular transporter (GAT1). The rest of the mol-
ecules related to inhibitory neurotransmission, reelin
Fig. 4 Somata expressing PSA-
NCAM, GAD67 and GAD67-
EGFP in the mPFC. Histograms
showing the differences in the
total number of cells expressing
PSA-NCAM (a), GAD67 (c) or
GAD67-EGFP (e) in their
somata. Asterisks indicate
statistically significant
differences (*p \ 0.05) and
values represent
mean ± standard error of the
mean. PSA-NCAM expressing
somata in control (b1) and
stressed (b2) individuals,
GAD67 expressing somata in
control (d1) and stressed (d2)
individuals and GAD67-EGFP
expressing somata in control
(f1) and stressed individuals
(f2). Scale bar 50 lm. Confocal
images are 2D projections of 30
consecutive confocal planes
located 0.2 lm apart
Table 3 qRT-PCR results for tested genes in stress mice vs. control
Medial prefrontal cortex
D stress/control p value
ST8SiaII 0.75 0.32
ST8SiaIV 1.02 0.68
NCAM 1.19 0.039
GAD67 1.55 0.13
GAD65 1.57 0.1
Synaptophysin 1.92 0.027
GAT1 1.5 0.19
RELN 1.27 0.62
CB1 1.39 0.47
NMDAR1 1.35 0.82
GABAAa1 2.03 0.04
GABAAa2 1.87 0.24
GABAAa3 2.01 0.14
GABAAa4 1.81 0.25
GABAAc2 1.56 0.26
BAX 1.3 0.32
BCL2 1.4 0.25
D, change in gene relative to normalize
Information in bold represents significant changes
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(RELN), cannabinoid receptor 1 (CB1) and N-methyl-D-
aspartic acid receptor 1 (NMDAR1), did not show any
statistical change (Fig. 5; Table 3).
Discussion
The present results show for the first time that interneurons
in the mPFC of adult mice undergo dendritic remodeling
after chronic stress. This remodeling is accompanied by
significant changes in the number of neurons expressing
GAD67 and in the expression of different molecules rela-
ted to inhibitory neurotransmission and neuronal plasticity.
Apparently, the decrease in GAD67 expressing neurons is
not due to apoptosis but due to changes in the expression of
this GABA synthesizing enzyme. Therefore, our study
supports the idea that inhibitory networks in the mPFC are
also targets of chronic stress and that their alteration may
also contribute to the behavioral and cognitive impairments
induced by this aversive experience.
Chronic stress induces dendritic hypertrophy
in a subpopulation of prefrontocortical interneurons
We have observed a significant increase in the dendritic
arborization of mPFC interneurons and this is, to our
knowledge, the first report describing dendritic remodeling
in inhibitory neurons after chronic stress in this cortical
region. A chronic stress paradigm similar to that used in
our study induces dendritic atrophy and reductions in spine
density in pyramidal neurons of rats (Radley et al. 2004).
However, we have not found differences in spine density in
the subpopulation of interneurons studied in the present
report. Similar results have been found by our group when
studying the effects of chronic stress on spine density in the
amygdala of GIN mice (Gilabert-Juan et al. 2011).
The atrophy of pyramidal neurons has been interpreted
as a structural weakening of excitatory neurotransmission
in the mPFC, which may represent an adaptive cellular
substrate for responding to the increase in excitatory neu-
rotransmission elicited during the first phases of stress
(Lowy et al. 1995). It is tempting to interpret the hyper-
trophy of the dendrites of mPFC interneurons as another
attempt of mPFC circuitry to minimize this overexcitation.
An increased dendritic surface may favor the formation of
synaptic contacts on mPFC interneurons. However, we do
not know yet whether new synapses are established on this
expanded dendritic surface and, if so, whether they are
excitatory or inhibitory. Solving these questions is essential
to understand what is the role of the stress-induced inter-
neuronal remodeling. It is also very important to determine
the sequence of the events that lead to the scenario that we
observe after 21 days of stress: Is the interneuronal
hypertrophy subsequent to the decrease in inhibitory neu-
rotransmission suggested by the reduction in the number of
GAD67 and GAD67-GFP expressing somata or viceversa?
Are these two independent phenomena? Do changes in
interneuron structure in the mPFC occur before, simulta-
neously or after the changes described in pyramidal neuron
structure? Although, obviously, further experiments ana-
lyzing different time points along the chronic stress are
necessary to elucidate these questions, it is interesting to
note that a recent study by Keck et al. (2011) suggests that
structural changes in inhibitory neurons may precede
structural changes in excitatory circuitry in the visual
cortex following sensory deprivation.
The effects of chronic stress in the mPFC interneurons
are opposite to those found in the basolateral amygdala
(Gilabert-Juan et al. 2011), in fact this aversive experience
also induces opposite effects on the structure of principal
neurons in these two regions (Radley et al. 2004; Vyas
et al. 2002). The dendritic growth of principal neurons and
the atrophy of interneurons in the basolateral amygdala
have been interpreted as a structural strengthening of
excitatory neurotransmission, which may represent a cel-
lular substrate for enhanced anxiety (Gilabert-Juan et al.
2011; Roozendaal et al. 2009).
Our analysis of the phenotype of EGFP-expressing
neurons in the mPFC of GIN mice reveals that they belong
exclusively to those expressing somatostatin. According to
a recent report (Xu et al. 2010), the interneurons analyzed
structurally in our study cannot be chandelier or basket
cells, which always express parvalbumin. Since most of the
neurons in the mPFC of GIN mice are located in layers II,
III and upper V, and their axons arborize profusely in
superficial layers, we are confident that most of them have
to be Martinotti cells, as it has previously suggested in the
somatosensory cortex of this strain of transgenic mice (Ma
et al. 2006). Martinotti cells can also express calbindin and
Fig. 5 qRT-PCR mRNA fold change in gene expression showed as
stressed mice group versus control. All genes expression was
normalize using TATA binding protein as a housekeeping gene
Brain Struct Funct
123
calretinin in addition to somatostatin and they never
express NPY or parvalbumin (Xu et al. 2010). Martinotti
cells are interneurons whose axons mainly target the apical
dendritic tree of pyramidal neurons (Markram et al. 2004)
and, interestingly, this apical region is the one that shows
the dendritic retraction after chronic stress (Radley et al.
2004). Consequently, the dendritic hypertrophy that we
observe in these interneurons may be related to the
shrinkage of the apical region of pyramidal neurons.
However, studies directed to evaluate structural remodeling
in the axonal projection of EGFP-expressing interneurons
in superficial layers are needed to understand their rela-
tionship to the dendritic atrophy of principal neurons.
Chronic stress alters the expression of molecules related
to synapses and inhibitory neurotransmission
and the number of GAD67 expressing cells
in the medial prefrontal cortex
The changes we have observed in the structure of mPFC
interneurons, together with those described before in the
structure of pyramidal neurons, should be reflected in
alterations in the number of synapses or their reorganiza-
tion. Although a previous report has failed to find changes
in the levels of synaptophysin, a protein linked to synaptic
remodeling (Greengard et al. 1993) and considered a reli-
able index of synaptic density (Masliah et al. 1990), in the
PFC after chronic stress (Carvalho-Netto et al. 2011), we
have found significant increased expression of the SYN
gene in the total mPFC. This difference may be due to the
fact that Carvalho-Netto et al. (2011) studied the whole
PFC while we only focused in its medial region. It has to be
noted that synaptophysin is expressed both in excitatory
and inhibitory synapses and, consequently, detailed studies
on the synaptic input of pyramidal and inhibitory neurons
must be performed to shed light on this intricate matter.
Our present results showing a decrease in the number of
GAD67 and GAD67-EGFP expressing somata strongly
suggest a downregulation in the expression of this GABA
synthesizing enzyme. A previous report has described
increases of GAD65 or GAD67 mRNAs in the hippo-
campus after chronic immobilization stress (Bowers et al.
1998), but we have not found differences in the expression
of these mRNAs in the present study. It is possible that
changes in mRNA expression occur before 21 days, since
the study of Bowers et al., used a 15 days paradigm. On the
other hand, previous studies found decreased GABA levels
measured with HPLC in the PFC after 3 weeks of chronic
mild stress (Shalaby and Kamal 2009) and a decrease in the
number of parvalbumin cells in the hippocampus of tree
shrews (Czeh et al. 2005). Another possible explanation for
the decrease in GAD67 expressing interneurons found in
our study may be cell death. In fact, a previous study found
that the number of apoptotic cells was increased in the
cerebral cortex and the hilus of adult tree shrews after
chronic psychosocial stress (Lucassen et al. 2001) and this
has been suggested as an explanation for the loss of hip-
pocampal parvalbumin expressing cells (Czeh et al. 2005).
However, we find this possibility unlikely, unless it
occurred sooner during the stress procedure, since we have
not found evidences of apoptosis or of degenerated inter-
neurons in our material.
The analysis of the molecules related to inhibitory
neurotransmission by qRT-PCR has only found a signifi-
cant increase in the expression of the GABAAa1 receptor.
The function of this receptor appears to be necessary to
mediate the effects of chronic stress in the structural
remodeling of principal neurons, at least in the hippo-
campus, because treatment with specific agonists prevents
dendritic atrophy in CA3 pyramidal neurons (Magarinos
et al. 1999). It may be possible that the increase in GABAA
receptor expression constitutes an adaptive response
directed to augment the function of these receptors and to
counteract deleterious effects of stress on mPFC circuitry.
This response may also counteract the decreased binding to
GABAA receptors described after chronic stress (Gruen
et al. 1995).
Although previous reports have described changes in
PSA-NCAM expression after chronic stress in the hippo-
campus and the amygdala (Cordero et al. 2005; Pham et al.
2003; Sandi et al. 2001), the present results suggest that
this molecule is not directly implicated in the structural
changes we have described in the mPFC. First, the GAD67-
EGFP expressing interneurons in which the structural
features have been analyzed (both in control and in
chronically stressed mice) do not show PSA-NCAM
expression in their somata, neurites or in the puncta located
in their projection fields in layers I and II. Second, no
changes in the number of PSA-NCAM expressing cells or
in the expression of the mRNA of polysialyltransferases
have been observed after chronic stress. It is, however,
possible that changes in PSA-NCAM expression in the
mPFC occur before 21 days of chronic stress in interneu-
ronal populations different from the one studied in the
present report.
Our study has found an increase in the expression of
NCAM mRNA in the mPFC after chronic stress. A similar
study did not find changes in this parameter in the PFC
using in situ hybridization, although it described a reduc-
tion in the hippocampus (Venero et al. 2002), a region
where decreases in NCAM protein expression have also
been reported after chronic stress (Sandi et al. 2001).
However, it has to be taken into account that these mea-
sures were obtained in the whole PFC and not only in the
mPFC. The increase in NCAM expression after chronic
stress may lead to increased cell adhesion and can influence
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the different intracellular signaling cascades mediated by
this protein (Maness and Schachner 2007). This increase in
NCAM expression may have a neuroprotective role against
the effects of stress, since reduced levels of this protein
have been found to increase the vulnerability to behavioral
alterations induced by this aversive experience: NCAM
heterozygous mice (Jurgenson et al. 2012) and conditional
NCAM-CAMKII mice (Bisaz and Sandi 2012) display
increased immobility in the tail suspension test.
Implications of mPFC plasticity in anxiety
and mood disorders
Animal models involving chronic stress produce brain
changes that are relevant to human psychiatric conditions
such as anxiety and depression (McEwen 2000) and there is a
clear link between prefrontal cortex dysfunction and mood
disorders such as major depression (Brody et al. 2001) or
posttraumatic stress disorder (Bremner 2005). Conse-
quently, the present results may increase our understanding
of the molecular and structural plasticity associated to the
development of anxiety and mood disorders, especially those
involving prefrontocortical inhibitory circuits. In fact, sev-
eral lines of evidence indicate the involvement of the
GABAergic system in the pathophysiology of major
depression (Krystal et al. 2002; Sanacora et al. 1999). Neu-
roimaging studies have reported reductions in GABA levels
in the prefrontal cortex (Hasler et al. 2007; Sanacora et al.
1999), reduced GABA concentrations were also demon-
strated in the plasma and cerebrospinal fluid in depression
(Brambilla et al. 2003) and GAD-67 protein expression was
significantly reduced in depressed subjects (Karolewicz et al.
2010). Moreover, similar to what we have found in our
chronically stressed mice, post-mortem morphometric
analyses in major depression patients have found reductions
in the density and size of GABAergic interneurons immu-
noreactive for calbindin (Rajkowska et al. 2007) and calre-
tinin (Oh et al. 2012) in the PFC.
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Available online 4 February 2012Several lines of evidence indicate that alterations in the structure of neural circuits and
inhibitory neurotransmission underlie the physiopathogenesis of schizophrenia. Most of the
studies on these parameters have been focused on cortical regions and, despite the crucial
role of the amygdala in this psychiatric disorder, there is less information on this region. In
order to expand this knowledge, we have studied the expression of molecules related to
inhibitory neurotransmission and structural plasticity in rats subjected to post-weaning isola-
tion rearing, an animal model that reproduces several core symptoms of schizophrenia. We
have analyzed, using qRT-PCR and immunohistochemistry, the expression of synaptophysin,
GAD65, GAD67, the neural cell adhesionmolecule (NCAM), its polysialylated form (PSA-NCAM)
and its synthesizing enzymes (St8siaII and St8SiaIV). Isolation-reared rats showed significant
increases in the expression of GAD67 protein in the centromedial, medial and basolateral
amygdaloid nuclei, but no significant changes in GAD65 or synaptophysin expression were
found in these regions. The expression of PSA-NCAM and NCAM was significantly increased
in the basolateral and medial nuclei respectively. Our results indicate that isolation-rearing
influences positively inhibitory neurotransmission and neuronal structural plasticity in the
amygdala, probably through PSA-NCAM. These findings are in contrast to reports describing
decreased expression of molecules related to inhibitory neurotransmission in the amygdala
of schizophrenic patients. Consequently, although the social isolation rearing model can
reproduce some of the behavioral traits of schizophrenics it may fail to reproduce some of
the neurobiological features of this disorder, particularly in the amygdala.
© 2012 Elsevier B.V. All rights reserved.Keywords:
Schizophrenia
Animal model
Inhibitory neurotransmission
Interneuron1. Introduction
Schizophrenia is a complex disease, affecting approximately 1%
of the population worldwide. The heritability of this disease, Cell Biology Dpt., Univer
r B.V. All rights reserved.is around 80% (Owen, 2005), highlighting the importance of
altered genetic pathways in their development. Current patho-
physiological theories of schizophrenia are pointing to the
GABAergic system as responsible for some of the alterations insitat de València, Dr. Moliner, 50, Burjassot, 46100, Spain. Fax: +34
130 B R A I N R E S E A R C H 1 4 4 8 ( 2 0 1 2 ) 1 2 9 – 1 3 6schizophrenic brains, because of its implication in the regula-
tion of other neurotransmitter systems, such as dopaminergic
or serotoninergic, and its tight relationship with the excitatory
transmission (Benes and Berretta, 2001). GABA is the principal
inhibitory neurotransmitter in the central nervous system
(CNS) and genes implicated in itsmetabolism have been associ-
ated with schizophrenia in different human populations
(Straub et al., 2007; Zai et al., 2009) and in animal models of
this psychiatric disorder (Peleg-Raibstein et al., 2008). Almost
all of these studies have found important alterations in the iso-
enzymes responsible for GABA synthesis (GAD65 or GAD67) and
in their coding genes, showing that alterations in the synthesis
of GABA may be one of the crucial facts in schizophrenia.
In addition to these changes in inhibitory neurotransmis-
sion, structural changes have also been found in the brains of
schizophrenic patients, as well as in animal models of this
disorder (Phillips et al., 2003). This structural remodeling
involves changes in synaptic density, which are frequently esti-
mated analyzing the expression of synaptophysin, a synaptic
vesiclemembraneprotein,whose expression is linked to synap-
tic remodeling (Eastwood and Harrison, 2001; Greengard et
al., 1993). One of the mechanisms involved in this structural
plasticity is the addition of polysialic (PSA) acid to the Neural
Cell Adhesion Molecule (NCAM): This process, mediated by the
two polysialyltransferases (St8SiaII and St8SiaIV), facilitates
the formation of new synapses, the remodeling of neurites
(see Bonfanti, 2006; Rutishauser, 2008 for review), or the partial
isolation of neuronal elements (Gomez-Climent et al., 2011),
because, when polysialylated, NCAM becomes anti-adhesive.
Both NCAM and ST8SIAII genes have been associated with
schizophrenia and alterations in the expression of NCAM and
PSA-NCAM have been found in postmortem brain studies of
this disorder (Brennaman and Maness, 2010; Sullivan et al.,
2007; Tao et al., 2007).
Most of these data on the expression of molecules related
to inhibitory neurotransmission or structural plasticity have
been obtained from the prefrontal cortex, the nucleus accum-
bens and the hippocampus, regions specially affected in schizo-
phrenia. However, despite the fact that the amygdala is also
severely affected in schizophrenic patients, this knowledge is
still scarcer in this region. The amygdaloid complex plays a
critical role in the recognition and the response to emotional
stimuli, including fear and anxiety (Adolphs et al., 1995; Cahill
and McGaugh, 1998; Davis et al., 1994; LeDoux, 2000), which
are frequently abnormal in schizophrenic patients. Recent
brain imaging studies have shown that abnormalities in limbic
lobe regions including the amygdala may be responsible of the
inadequate affective responses in schizophrenics (Phillips et
al., 2003). Several studies have reported changes in the volume
of the amygdala in psychiatric patients, which probably reflect
structural changes in amygdaloid neurons (reviewed in
Drevets et al., 2008; Sheline et al., 1998; Tebartz van Elst et al.,
2000). In light of these set of evidence pointing to the amygdala,
wehave decided to study the expression ofmolecules related to
structural plasticity and inhibitory neurotransmission using an
animalmodel, which reproduces some of the core symptoms of
schizophrenia.
The post-weaning social isolation-paradigm offers a well
established and characterized animal model to study schizo-
phrenic symptoms in a rodent. Some of the behavioral andneurochemical changes induced by the isolation-rearing are
disrupted prepulse inhibition (Geyer et al., 1993), reduced ex-
pression of AMPA glutamate receptors in hippocampus
(Sestito et al., 2011), impaired spatial cognition with affected
prefrontal cortical synaptic plasticity (Quan et al., 2010), im-
paired novel object recognition (McLean et al., 2010), increased
aggression (Ferdman et al., 2007) and reduced prefrontal cortex
volume (Day-Wilson et al., 2006). Similar environmental inter-
ventions during early-life in humans may contribute to the
development of common psychiatric disorders, such as depres-
sion and schizophrenia in genetically predisposed individuals
(see Fone and Porkess, 2008 for review).
The main objective of this study is to determine specific
changes in the amygdaloid expression of different molecules
involved in structural plasticity and inhibitory neurotrans-
mission. For this purpose we have analyzed the expression
of GAD67, GAD65, synaptophysin, NCAM and PSA-NCAM by
means of immunohistochemistry and optical densitometry
in the centromedial (CeM), medial (Me) and basolateral
(BLa) amygdala. We have also studied the expression of
mRNAs for GAD67, GAD65, synaptophysin, NCAM and the
polysialyltransferases (St8SiaII and St8SiaIV) using quantita-
tive real-time PCR (qRT-PCR) of total amygdala.2. Results
2.1. Immunohistochemical analysis reveals that the
expression of GAD67, but not of GAD65 or synaptophysin, is
altered in the amygdala of isolation-reared rats
No changes were observed in the expression of GAD65 in any
nucleus of amygdala when comparing social versus isolation-
reared rats. By contrast, the expression of GAD67 was signifi-
cantly increased in all the three amygdaloid nuclei of the isola-
tion reared rats respect to the socially housed animals: Me, CeM
and BLa (t9=−2.822, p=0.02; t9=−3.572 p=0.006 and t9=−2.835
p=0.0196 respectively; Figs. 1 and 2). The expression of synapto-
physin, which is a general marker of synapses (Greengard et al.,
1993), showed no differences between the 2 groups of study in
the three nuclei of the amygdala analyzed.
2.2. Immunohistochemical analysis reveals increases in
the expression of PSA-NCAM and NCAM in different
amygdaloid nuclei of the isolation-reared rats
An increase in PSA-NCAM expression was observed in all the 3
nuclei analyzed in the amygdala of isolated rats, being only
significant for the BLa nucleus (t9=−2.775, p=0.0216). NCAM
expression was significantly increased in the Me nucleus (t9=
−3.14, p=0.0119) of the isolatedanimals anddidnot showsignif-
icant changes in the other two nuclei (Figs. 1 and 2).
2.3. qRT-PCR analysis does not reveal any significant
change in the expression of the studied genes in the amygdala
of isolation-reared rats
No significant changes were found in the expression of the
genes analyzed in the total amygdala when comparing the
socially housed rats with the isolation-reared rats. The mRNA
Fig. 1 – Neuropil immunoreactivity of GAD67, GAD65, NCAM, PSA-NCAM and SYN in the amygdala. Histogram bars show
the gray level measured in amygdaloid nuclei (Me, CeM, BLa) of control (white bar) and isolated-rearing (black bar) groups. Data
are the mean±S.E.M. from 6 control rats and 5 isolated rats in each group. *p<0.05 vs the control group.
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around 1-fold in the isolated rats and similar results were
obtainedwith synaptophysin gene. ST8SIAII and ST8SIAIV expres-
sions were reduced (−1.38 and −2.43 fold respectively) in these
animals (Table 2; Fig. 3).3. Discussion
Early-life adverse eventsmarkedly influence the development
of the nervous system and may facilitate, in genetically pre-
disposed individuals, the development of psychiatric disorders
such as schizophrenia ormajor depression. Exposing rodents to
postweaning social isolation affects brain development and
leads to behavioral, morphological and neurochemical alter-
ations during adulthood, which resemble core symptoms of
schizophrenic patients. The behavioral alterations include
neophobia, disrupted prepulse inhibition (Geyer et al., 1993),
impairments in sensorimotor gating, spatial cognition (Quanet al., 2010) and novel object recognition (McLean et al., 2010).
Rats reared in social isolation also show reduced prefrontal cor-
tex volume (Day-Wilson et al., 2006). At the molecular level,
these animals show reduced expression of AMPA glutamate
receptors in the hippocampus (Sestito et al., 2011) and alter-
ations in serotoninergic and dopaminergic systems. However,
despite the fact that both brain imaging and postmortem
studies have suggested a central role of the amygdala in the
pathophysiology of schizophrenia (Benes, 2010; Phillips et al.,
2003), most of the studies conducted in post-weaning socially-
isolated rodents have been focused in cortical regions and
very few of them have analyzed the amygdala.
This is particularly puzzling, because rodents reared in social
isolation show alterations in behaviors in which the amygdala
plays an important role, indicating that this limbic region
must be affected in this model. These animals show increased
aggression (Ferdman et al., 2007; Vale and Montgomery, 1997;
Valzelli, 1973), deficits in contextual fear conditioning (Weiss
et al., 2004) and appear more emotional than rodents reared in
groups (see Fone and Porkess, 2008 for review).
Fig. 2 – Panoramic and high magnification microphotographs showing immunohistochemistry for GAD67 (A, A′, B and B′),
GAD65 (C, C′, D and D′), NCAM (E, E′, F and F′), PSA-NCAM (G, G′, H and H′) and SYN (I, I′, J and J′) in the amygdala of control and
isolated rats. Scale bar: 500 μM for A–J and 50 μM for A′–J′.
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related to synaptic transmission in the amygdala of isolation-
reared rodents. Despite of the behavioral alterations showed
by these animals as described above, all of them have reported
only minor changes. Our study has found that the expression
of GAD67, but not GAD65, protein was increased in different
amygdaloid nuclei of isolation-reared rats. By contrast, no
differences were found in mRNA expression, which may be
due to the masking effect of total GAD67 mRNA when using
whole amygdala extracts. Our findings are in agreement with
those of a recent study, which did not find differences in
GAD65 protein expression in the amygdala of isolation-reared
Sprague–Dawley rats (Lim et al., 2011). These authors did not
find differences in amygdaloid GABA(B)R1 expression either.Unfortunately, there are no more previous studies exploring
the expression of molecules related to inhibitory neurotrans-
mission in the amygdala of isolation-reared rodents. Our results
indicating an increase in GAD67 expression are in contrast with
those reported in the amygdala of human schizophrenic
patients. These postmortem studies showed reduced GAD
activity (Bird et al., 1977), GABA concentration (Spokes et al.,
1980) and GAD67 expression (Varea et al., 2012), which are con-
sistent with an increased activation of the amygdala in schizo-
phrenia. Consequently, we should be cautious when using
isolation-reared rats as an animal model of schizophrenia, be-
cause while some of its features may correspond to those
observed in humanpatients, some of themmay be substantially
different.
Table 1 – Sequences of gene specific primers and
associated amplicon lengths for qRT-PCR.
Target
gene
Primers Sequence (5′→3′) Amplicon
size a
ST8SiaII Forward GGCAACTCAGGAGTCTTGCT 123
Reverse GTCAGTCTTGAGGCCCACAT
ST8SiaIV Forward CCTTCATGGTCAAAGGAGGA 125
Reverse CCAGTAACCTCTGACCGCAT
NCAM Forward AACGGACTCCAAACCATGAC 123
Reverse CTGGCTTTGCTTCTGACTCC
GAD67 Forward CTGGAGCTGGCTGAATACCT 120
Reverse TCGGAGGCTTTGTGGTATGT
GAD65 Forward CTGCTTCTGGTTTGTACCTCCT 122
Reverse CCATTGTGGTCCCATACTCC
SYN Forward CTATGGGCAGCAAGGCTATG 120
Reverse CAGGCCTTCTCTTGAGCTCTT
Ywhaz Forward TTGAGCAGAAGACGGAAGGT 136
Reverse GAAGCATTGGGGATCAAGAA
a Amplicon length in base pairs.
Fig. 3 – qRT-PCR mRNA fold change data shown as
isolated-rearing group versus control group gene expression.
All gene expression was normalized using Ywhaz as a
control gene.
133B R A I N R E S E A R C H 1 4 4 8 ( 2 0 1 2 ) 1 2 9 – 1 3 6Also in agreement with Lim et al. (2011) we have failed to
find differences in the expression of synaptophysin in the
amygdala of isolation-reared animals. These results are also
consistent with previous studies describing no differences in
the number of synapses in the medial amygdala (Ichikawa et
al., 1993).
The differences in PSA-NCAM expression observed in our
study may be related to structural changes in neurons, given
the anti-adhesive properties of this molecule (Rutishauser,
2008; Sandi, 2004). However, this structural plasticity should
be limited initially to interneurons, because, as it has been
demonstrated for many PSA-NCAM expressing structures in
the cerebral cortex (excluding those of immature neurons)
(Gomez-Climent et al., 2011; Nacher et al., 2002; Varea et al.,
2005), many PSA-NCAM expressing neurons in the amygdala
express markers of interneurons and lack expression of mole-
cules exclusively found in principal neurons (Gilabert-Juan et
al., 2011). Consequently, changes in PSA-NCAM expression
should primarily affect the structure of interneurons, rather
than that of principal neurons. In this line, using a transgenic
mice strain expressing GFPmainly in somatostatin expressing
interneurons (Oliva et al., 2000), we have recently reported
that PSA-NCAM expressing cortical interneurons have reduced
synaptic input and decreased dendritic arborization and spine
density when compared with neighboring interneurons lacking
PSA-NCAM (Gomez-Climent et al., 2011). It is possible then,Table 2 – qRT-PCR results for tested genes in isolated rats
vs. control.
Amygdala
Δ p-value
Gad67 1.03 0.877
Gad65 1.02 0.915
NCAM −1.25 0.375
St8siaII −1.38 0.437
St8siaIV −2.43 0.292
Synaptophysin −1.11 0.582
Δ, change in gene relative to normalize.that the increases in PSA-NCAM expression observed in the
present study affect the connectivity of certain amygdaloid in-
terneurons, leaving less plasma membrane extension free for
the establishment of synaptic contacts.Whether these changes
in PSA-NCAM expression are related to the increase in GAD67
expression still remains to be explored. Another non-
excluding possibility is that, given its anti-adhesive properties,
the increase in PSA-NCAM expression may facilitate the struc-
tural remodeling of certain interneurons in response to
different stimuli.
It is interesting to note that the increase in PSA-NCAM
expression is only significant in the basolateral amygdala, a
region considered critical in the pathophysiology of schizophre-
nia (Benes, 2010). This increase in PSA-NCAM expression may
be due to increase in polysialylation of pre-existing NCAMmol-
ecules, because we found an increment of this protein only in
the medial amygdala of the isolation-reared rats. However, we
have not detected parallel increments in any of the two NCAM
polysialyltransferases, which may mean that the increased
polysialylation of NCAM in the basolateral amygdala has
occurred at an earlier age.
Previous studies have shown that an enhanced dopami-
nergic activity exists in the amygdala of isolation-reared
rodents. This procedure increases basal dopamine turnover
(Heidbreder et al., 2000), dopaminergic presynaptic function
(Lapiz et al., 2003) and D2 receptor binding in the amygdala.
It is possible that the increases that we observed in GAD67
and PSA-NCAM expression respond to this enhanced dopami-
nergic activity through D2 receptors, because, at least in the
prefrontal cortex, chronic treatment with a D2 receptor ago-
nist produces the same effects (Castillo-Gomez et al., 2008).
In summary, our results indicate that discrete but signifi-
cant changes occur in the amygdala of isolation-reared rats,
involving molecules related to structural plasticity and inhib-
itory neurotransmission. However, the direction of these differ-
ences is not similar to that observed in schizophrenic patients.
Consequently, although this paradigm has been confirmed as
a suitable model to study schizophrenia, because it reproduces
some of its core defects (Fone and Porkess, 2008), it also may
present some differences, which should be taken into account
and explored further when establishing comparisons.
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4.1. Animals
Eight pregnant Lister Hooded rats were purchased from Jackson
laboratories (Bar Harbor, Maine, USA) and bred in our animal
facility. Pregnant rats were housed individually in a controlled
temperature room (25±1 °C) and on a 12-h light/dark cycle
with food and water available ad libitum. 27 male rats were
born from the pregnant rats andwere used for the experiments.
All efforts were made to minimize the number and suffering of
animals used. All animal experimentation was conducted in
accordance with the Directive 2010/63/EU of the European
Parliament and of the Council of 22 September 2010 on the
protection of animals used for scientific purposes and was
approved by the Committee on Bioethics of the Universitat de
València.
4.2. Social isolation-rearing
Newborn rats remained with their mothers until weaning
(21 days); at this moment, male rats were randomly divided
into two groups: social and isolated group. Socially housed
rats (n=15), used as controls, were housed 3 per cage
(215×465×145 mm) and isolated rats (n=12) were housed in
individual cages (220×220×145mm) and reared in isolation in-
dividually. All rats were housed in the same room, and sharing
the same light, temperature and humidity. Rats reared in isola-
tion could hear and smell the other rats, but were unable to see
or have physical contact with them. All animals were handled
once a week by the same person, who replaced the bedding of
the cage and added food and water. Rats were reared in these
conditions during 8 weeks.
4.3. Quantitative retrotranscription-polymerase chain
reaction
The rats used for qRT-PCRwere sacrificed by decapitation using
a guillotine. After that, brains were removed from the skull and
the whole Amygdala of each brain of 9 control and 7 isolated
rats were extracted. Total mRNA was extracted using TriPure
reagent (Roche Applied Science, Indianapolis, IN) following
manufacturer's instructions. The concentration and purity of
total RNA were determined by Eppendorf BioPhotometer plus
(Eppendorf AG, Hamburg, Germany). cDNA synthesis was
performed using the Expand reverse transcriptase (Roche
Applied Science).
Specific primers to rat GAD67, GAD65, NCAM, ST8SIAII,
ST8SIAIV and SYN genes (Table 1) were designed from public
sequences, which were obtained from Ensembl Genome
Browser data base (http://www.ensembl.org/) using Primer-
Blast free software (http://www.ncbi.nlm.nih.gov/tools/
primer-blast/). Primers were designed between exons to avoid
DNA contamination, when possible. The primer sequence for
the reference gene (ywhaz) was obtained from Bonefeld et al.
(2008). Primers were tested for nonspecific products and correct
amplicon size by electrophoresis in 1.5% EtBr agarose gel. qPCR
was carried out in triplicates with the ABI PRISM 7700 Sequence
Detector (Applied Biosystems) using SYBR Green PCR master
mix (Applied Biosystems), primers at a concentration of 240 nM,and 4 μl of cDNA (25 ng/μl). Following a 95 °C denaturation for
10min, the reactions were cycled 40 times with a 95 °C denatur-
ation for 15 s and a 60 °C annealing step for 1min. After this, a
melt curve was performed to assess the specificity of primers.
Relative quantification was performed using the compara-
tive threshold (Ct) method according to the 2−ΔΔCt method
(Pfaffl, 2001). Changes in gene expression were reported as
fold changes relative to controls. An unpaired t-test was
performed to analyze the statistical significance of results.
4.4. Immunohistochemistry
Six control rats and five isolated rats were perfused transcar-
diallywith a 4%paraformaldehyde solution in phosphate buffer
(PB, 0.1 M, pH 7.4). Brains were removed from the cranium and
the hemispheres were separated. The right hemisphere was
cryoprotected ina 30%sucrose solution in PB and cut in a sliding
microtomeat 50 μm.These sectionswere destined for immuno-
histochemical analyses. The contralateral hemisphere was
stored.
The immunohistochemistry protocol was performed as
follows: Briefly, floating sections were incubated for 1 min in
an antigen unmasking solution (0.01 M citrate buffer, pH 6 at
100 °C). After cooling down the sections to room temperature,
they were incubated with 3% H2O2 in phosphate buffered
saline (PBS) for 10min to block endogenous peroxidase activity.
After this, sectionswere treated for 1 hwith 10%normal donkey
serum (NDS) (Jackson ImmunoResearch Laboratories) in
PBSwith 0.2%Triton-X-100 (Sigma-Aldrich) and theywere incu-
bated overnight at room temperature with one of these anti-
bodies: anti-PSA-NCAM (AbCys, 1:700), anti-NCAM (DSHB,
1:500), anti-GAD65 (Millipore, 1:500), anti-GAD67 (Chemicon,
1:500), anti-synaptophysin (Sigma, 1:200) with PBS containing
0.2% Triton-X-100 and 3% NDS. The second day, sections were
incubated for 1 h with either donkey anti-mouse IgM or IgG
biotinylated antibodies (1:200; Jackson ImmunoResearch Labo-
ratories) in PBS with 0.2% Triton-X-100 and 5% NDS. Then,
sections were incubated in an avidin–biotin–peroxidase
complex (Vector Laboratories) for 30 min in PBS. Color develop-
ment was achieved by incubating with 3,3-diaminobenzidine
tetrahydrochloride (Sigma-Aldrich) and 0.033% hydrogen
peroxide in PB for 4 min. Finally, sections were mounted on
slides, dried for one day at room temperature, dehydrated
with ascending alcohols and rinsed in xylene. After this,
sections were coverslipped using Eukitt mounting medium.
All the studied sections passed through all procedures
simultaneously in order to minimize any difference from
immunohistochemical staining itself. To avoid any bias in the
analysis, all slides were coded prior to analysis and the codes
were not broken until the experiment was finished. All the
sections were analyzed by the same researcher.
4.5. Quantification of neuropil immunoreactivity
From each immunostaining (PSA-NCAM, SYN, GAD65, GAD67
andNCAM), three sectionsper animal containing the 3 amygda-
loid nuclei analyzed (CeM, BLa andMe) were selected randomly
from the following coordinate interval: Bregma −1.80 to
2.80 mm (Paxinos and Watson, 1986), in order to measure
immunoreactivity as previously described (Varea et al., 2007).
135B R A I N R E S E A R C H 1 4 4 8 ( 2 0 1 2 ) 1 2 9 – 1 3 6Sections of each immunostaining were examined in one single
session with an Olympus CX41 microscope under bright-field
illumination, homogeneously lighted and digitalized using a
CCD camera. Photographs to the different regions were taken
at 20× magnification. Gray levels were converted to optical
densities (OD) using Image J software (NIH). In order to normal-
ize the values, the gray levels obtained from photographs of the
corpus callosum in each section were subtracted from those
obtained in the different amygdaloid nuclei. Means were deter-
mined for each experimental group, using the number of
animals as the “n”, and data were analyzed by means of
unpaired Student's t-test.Acknowledgments
Spanish Ministry of Science and Innovation (MICINN-FEDER)
BFU2009-12284/BFI, MICINN-PIM2010ERN-00577/NEUCONNECT
in the frame of ERA-NET NEURON and the Stanley Medical
Research Institute supported JN. Javier Gilabert-Juan has a FPU
predoctoral fellowship from the Spanish Ministry of Education
(AP2008-00937).R E F E R E N C E S
Adolphs, R., Tranel, D., Damasio, H., Damasio, A.R., 1995. Fear and
the human amygdala. J. Neurosci. 15, 5879–5891.
Benes, F.M., 2010. Amygdalocortical circuitry in schizophrenia:
from circuits to molecules. Neuropsychopharmacology 35,
239–257.
Benes, F.M., Berretta, S., 2001. GABAergic interneurons: implications
for understanding schizophrenia and bipolar disorder.
Neuropsychopharmacology 25, 1–27.
Bird, E.D., Spokes, E.G., Barnes, J., MacKay, A.V., Iversen, L.L.,
Shepherd, M., 1977. Increased brain dopamine and reduced
glutamic acid decarboxylase and choline acetyl transferase
activity in schizophrenia and related psychoses. Lancet 2,
1157–1158.
Bonefeld, B.E., Elfving, B., Wegener, G., 2008. Reference genes for
normalization: a study of rat brain tissue. Synapse 62, 302–309.
Bonfanti, L., 2006. PSA-NCAM in mammalian structural plasticity
and neurogenesis. Prog. Neurobiol. 80, 129–164.
Brennaman, L.H., Maness, P.F., 2010. NCAM in neuropsychiatric and
neurodegenerative disorders. Adv. Exp. Med. Biol. 663, 299–317.
Cahill, L., McGaugh, J.L., 1998. Mechanisms of emotional arousal
and lasting declarative memory. Trends Neurosci. 21, 294–299.
Castillo-Gomez, E., Gomez-Climent, M.A., Varea, E., Guirado, R.,
Blasco-Ibanez, J.M., Crespo, C., Martinez-Guijarro, F.J., Nacher,
J., 2008. Dopamine acting through D2 receptors modulates the
expression of PSA-NCAM, a molecule related to neuronal
structural plasticity, in the medial prefrontal cortex of adult
rats. Exp. Neurol. 214, 97–111.
Davis, M., Rainnie, D., Cassell, M., 1994. Neurotransmission in the
rat amygdala related to fear and anxiety. Trends Neurosci. 17,
208–214.
Day-Wilson, K.M., Jones, D.N., Southam, E., Cilia, J., Totterdell, S.,
2006. Medial prefrontal cortex volume loss in rats with
isolation rearing-induced deficits in prepulse inhibition of
acoustic startle. Neuroscience 141, 1113–1121.
Drevets, W.C., Price, J.L., Furey, M.L., 2008. Brain structural and
functional abnormalities in mood disorders: implications for
neurocircuitry models of depression. Brain Struct. Funct. 213,
93–118.Eastwood, S.L., Harrison, P.J., 2001. Synaptic pathology in the
anterior cingulate cortex inschizophrenia and mood
disorders. A review and a Western blot study of
synaptophysin, GAP-43 and the complexins. Brain Res. Bull.
55, 569–578.
Ferdman, N., Murmu, R.P., Bock, J., Braun, K., Leshem, M., 2007.
Weaning age, social isolation, and gender, interact to
determine adult explorative and social behavior, and dendritic
and spine morphology in prefrontal cortex of rats. Behav. Brain
Res. 180, 174–182.
Fone, K.C., Porkess, M.V., 2008. Behavioural and neurochemical
effects of post-weaning social isolation in rodents-relevance to
developmental neuropsychiatric disorders. Neurosci. Biobehav.
Rev. 32, 1087–1102.
Geyer, M.A., Wilkinson, L.S., Humby, T., Robbins, T.W., 1993.
Isolation rearing of rats produces a deficit in prepulse
inhibition of acoustic startle similar to that in schizophrenia.
Biol. Psychiatry 34, 361–372.
Gilabert-Juan, J., Castillo-Gomez, E., Perez-Rando, M., Molto, M.D.,
Nacher, J., 2011. Chronic stress induces changes in the
structure of interneurons and in the expression of molecules
related to neuronal structural plasticity and inhibitory
neurotransmission in the amygdala of adult mice. Exp. Neurol.
232, 33–40.
Gomez-Climent, M.A., Guirado, R., Castillo-Gomez, E., Varea, E.,
Gutierrez-Mecinas, M., Gilabert-Juan, J., Garcia-Mompo, C.,
Vidueira, S., Sanchez-Mataredona, D., Hernandez, S.,
Blasco-Ibanez, J.M., Crespo, C., Rutishauser, U., Schachner, M.,
Nacher, J., 2011. The polysialylated form of the neural cell
adhesion molecule (PSA-NCAM) is expressed in a
subpopulation of mature cortical interneurons characterized
by reduced structural features and connectivity. Cereb. Cortex
21, 1028–1041.
Greengard, P., Valtorta, F., Czernik, A.J., Benfenati, F., 1993.
Synaptic vesicle phosphoproteins and regulation of synaptic
function. Science 259, 780–785.
Heidbreder, C.A., Weiss, I.C., Domeney, A.M., Pryce, C., Homberg,
J., Hedou, G., Feldon, J., Moran, M.C., Nelson, P., 2000.
Behavioral, neurochemical and endocrinological
characterization of the early social isolation syndrome.
Neuroscience 100, 749–768.
Ichikawa, M., Matsuoka, M., Mori, Y., 1993. Effect of differential
rearing on synapses and soma size in rat medial amygdaloid
nucleus. Synapse 13, 50–56.
Lapiz, M.D., Fulford, A., Muchimapura, S., Mason, R., Parker, T.,
Marsden, C.A., 2003. Influence of postweaning social isolation
in the rat on brain development, conditioned behavior, and
neurotransmission. Neurosci. Behav. Physiol. 33, 13–29.
LeDoux, J.E., 2000. Emotion circuits in the brain. Annu. Rev.
Neurosci. 23, 155–184.
Lim, A.L., Taylor, D.A., Malone, D.T., 2011. Isolation rearing in rats:
effect on expression of synaptic, myelin and GABA-related
immunoreactivity and its utility for drug screening via the
subchronic parenteral route. Brain Res. 1381, 52–65.
McLean, S., Grayson, B., Harris, M., Protheroe, C., Woolley, M.,
Neill, J., 2010. Isolation rearing impairs novel object recognition
and attentional set shifting performance in female rats. J.
Psychopharmacol. 24, 57–63.
Nacher, J., Blasco-Ibanez, J.M., McEwen, B.S., 2002. Non-granule
PSA-NCAM immunoreactive neurons in the rat hippocampus.
Brain Res. 930, 1–11.
Oliva, A.A., Jiang, M., Lam, T., Smith, K.L., Swann, J.W., 2000. Novel
hippocampal interneuronal subtypes identified using
transgenic mice that express green fluorescent protein in
GABAergic interneurons. J. Neurosci. 20, 3354–3368.
Owen, M.J., 2005. Genomic approaches to schizophrenia. Clin.
Ther. 27 (Suppl A), S2–S7.
Paxinos, G., Watson, C., 1986. The Rat Brain in Stereotaxic
Coordinates. Academic Press, London.
136 B R A I N R E S E A R C H 1 4 4 8 ( 2 0 1 2 ) 1 2 9 – 1 3 6Peleg-Raibstein, D., Knuesel, I., Feldon, J., 2008. Amphetamine
sensitization in rats as an animal model of schizophrenia.
Behav. Brain Res. 191, 190–201.
Pfaffl, M.W., 2001. A new mathematical model for relative
quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45.
Phillips, M.L., Drevets, W.C., Rauch, S.L., Lane, R., 2003.
Neurobiology of emotion perception II: implications for major
psychiatric disorders. Biol. Psychiatry 54, 515–528.
Quan, M.N., Tian, Y.T., Xu, K.H., Zhang, T., Yang, Z., 2010. Post
weaning social isolation influences spatial cognition, prefrontal
cortical synaptic plasticity and hippocampal potassium ion
channels in Wistar rats. Neuroscience 169, 214–222.
Rutishauser, U., 2008. Polysialic acid in the plasticity of the
developing and adult vertebrate nervous system. Nat. Rev.
Neurosci. 9, 26–35.
Sandi, C., 2004. Stress, cognitive impairment and cell adhesion
molecules. Nat. Rev. Neurosci. 5, 917–930.
Sestito, R.S., Trindade, L.B., de Souza, R.G., Kerbauy, L.N., Iyomasa,
M.M., Rosa, M.L., 2011. Effect of isolation rearing on the
expression of AMPA glutamate receptors in the hippocampal
formation. J. Psychopharmacol. 25 (12), 1720–1729.
Sheline, Y.I., Gado, M.H., Price, J.L., 1998. Amygdala core nuclei
volumes are decreased in recurrent major depression.
NeuroReport 9, 2023–2028.
Spokes, E.G., Garrett, N.J., Rossor, M.N., Iversen, L.L., 1980.
Distribution of GABA in post-mortem brain tissue from
control, psychotic and Huntington's chorea subjects. J. Neurol.
Sci. 48, 303–313.
Straub, R.E., Lipska, B.K., Egan, M.F., Goldberg, T.E., Callicott, J.H.,
Mayhew, M.B., Vakkalanka, R.K., Kolachana, B.S., Kleinman,
J.E., Weinberger, D.R., 2007. Allelic variation in GAD1 (GAD67) is
associated with schizophrenia and influences cortical function
and gene expression. Mol. Psychiatry 12, 854–869.
Sullivan, P.F., Keefe, R.S., Lange, L.A., Lange, E.M., Stroup, T.S.,
Lieberman, J., Maness, P.F., 2007. NCAM1 and neurocognition
in schizophrenia. Biol. Psychiatry 61, 902–910.Tao, R., Li, C., Zheng, Y., Qin, W., Zhang, J., Li, X., Xu, Y., Shi, Y.Y.,
Feng, G., He, L., 2007. Positive association between SIAT8B and
schizophrenia in the Chinese Han population. Schizophr. Res.
90, 108–114.
Tebartz van Elst, L., Woermann, F., Lemieux, L., Trimble, M.R.,
2000. Increased amygdala volumes in female and depressed
humans. A quantitative magnetic resonance imaging study.
Neurosci. Lett. 281, 103–106.
Vale, A.L., Montgomery, A.M., 1997. Social interaction: responses
to chlordiazepoxide and the loss of isolation-reared effects
with paired-housing. Psychopharmacology (Berl.) 133,
127–132.
Valzelli, L., 1973. The “isolation syndrome” in mice.
Psychopharmacologia 31, 305–320.
Varea, E., Nacher, J., Blasco-Ibanez, J.M., Gomez-Climent, M.A.,
Castillo-Gomez, E., Crespo, C., Martinez-Guijarro, F.J., 2005.
PSA-NCAM expression in the rat medial prefrontal cortex.
Neuroscience 136, 435–443.
Varea, E., Blasco-Ibanez, J.M., Gomez-Climent, M.A.,
Castillo-Gomez, E., Crespo, C., Martinez-Guijarro, F.J., Nacher,
J., 2007. Chronic fluoxetine treatment increases the expression
of PSA-NCAM in the medial prefrontal cortex.
Neuropsychopharmacology 32, 803–812.
Varea, E., Guirado, R., Gilabert-Juan, J., Martí, U., Castillo-Gomez,
E., Blasco-Ibáñez, J.M., Crespo, C., Nacher, J., 2012. Expression
of PSA-NCAM and synaptic proteins in the amygdala of
psychiatric disorder patients. J. Psychiatr. Res 46 (2), 189–197.
Weiss, I.C., Pryce, C.R., Jongen-Relo, A.L., Nanz-Bahr, N.I., Feldon,
J., 2004. Effect of social isolation on stress-related behavioural
and neuroendocrine state in the rat. Behav. Brain Res. 152,
279–295.
Zai, C.C., Tiwari, A.K., King, N., De Luca, V., Mueller, D.J., Shaikh, S.,
Wong, G.W., Meltzer, H.Y., Lieberman, J.A., Kennedy, J.L., 2009.
Association study of the gamma-aminobutyric acid type a
receptor gamma2 subunit gene with schizophrenia. Schizophr.
Res. 114, 33–38.
 
 
 
 
 
 
 
 
 
Article 4: A “double hit” murine model for schizohphrenia shows 
alterations in the structure and neurochemistry of the medial 
prefrontal cortex and the hippocampus 
 
 
 
 
 
 
 
 
  
 
 
Gilabert-Juan et al.    Double hit animal model for schizophrenia 
 
TITLE: A “DOUBLE HIT” MURINE MODEL FOR SCHIZOPHRENIA SHOWS 
ALTERATIONS IN THE STRUCTURE AND NEUROCHEMISTRY OF THE 
MEDIAL PREFRONTAL CORTEX AND THE HIPPOCAMPUS 
 
AUTHORS: Javier Gilabert-Juan1,2,3,4 , Maria Belles1, Ana Rosa Saez2, Hector 
Carceller1, Maria Dolores Moltó2,3,4, Juan Nacher1,3,4*. 
1. Neurobiology Unit and Program in Basic and Applied Neurosciences, Cell 
Biology Dpt., Universitat de València, Spain 
2.Genetics Dpt., Universitat de València, Spain 
3. CIBERSAM: Spanish National Network for Research in Mental Health  
4. Fundación Investigación Hospital Clínico de Valencia, INCLIVA, Spain 
*CORRESPONDING AUTHOR: 
Dr. Juan Nacher 
Neurobiology Unit  
Cell Biology Dpt.  
Universitat de València 
Dr. Moliner, 50 
Burjassot, 46100 
Spain 
Telf: 34 96 354 3241 
e-mail: nacher@uv.es 
 
NUMBER OF FIGURES AND TABLES: 7 figures, 4 supplemental figures and 1 
table. 
 
Gilabert-Juan et al.    Double hit animal model for schizophrenia 
 
ABSTRACT 
 Schizophrenia is a very complex psychiatric disorder in which both 
alterations in neurodevelopment and aversive experiences during adolescence 
seem to be important risk factors. Animal models reproducing these types of 
alterations mimic some of the symptoms found in patients, constituting a valid 
approach to study the etiopathology of this disorder and a good platform to test 
the validity of new therapeutic approaches. Among these models, the perinatal 
injection of NMDA receptor antagonists and the postweaning social isolation 
rearing are among the most widely used. Each of them has reproduced different 
behavioral, structural and neurochemical alterations resembling those found in 
schizophrenic patients. Our aim is to combine them in a “double hit” model, 
which should produce a wider spectrum of alterations. Lister Hooded rats have 
been subjected to a single injection of MK-801 at P7 and have been socially 
isolated from postweaning to adulthood. We have found that these animals 
present increased weight gain and volume reductions in their medial prefrontal 
cortex (mPFC) and hippocampus.  They also show an increased number of 
activated pyramidal cells and a decrease of parvalbumin expressing cells in the 
mPFC. The expression of the polysialylated form of the neural cell adhesion 
molecule (PSA-NCAM), a molecule related to neuronal structural plasticity and 
that of GAD67 are decreased in the mPFC. qRT-PCR analysis revealed that the 
mRNA of calbindin was decreased in the mPFC while,  that of calretinin was 
increased.  Alterations in the expression of the ERbB4 mRNA, a gene 
associated to schizophrenia, were also found in this region.  All these structural 
and neurochemical alterations, specially in cortical inhibitory circuits, are similar 
to those found in schizophrenic patients and are more numerous than those 
found in each of the single models.  Consequently, we consider that the present 
“double hit” model is a better tool to study the neurobiological basis of 
schizophrenia and to explore new pharmacological approaches to treat this 
disorder. 
 
 
KEYWORDS: Schizophrenia, animal model, inhibitory neurotransmission, adult 
neurogenesis interneuron. 
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INTRODUCTION 
 Schizophrenia is a highly complex, multifactorial disease, which results in 
dramatic changes in behavior, perception and cognition. These changes are 
paralleled by alterations in the structure, neurochemistry and physiology of 
certain cerebral regions, specially the prefrontal cortex (PFC) and the 
hippocampus, two regions critically involved in the etiopathology of this 
psychiatric disorder.  
Several structural studies have shown that patients with schizophrenia 
have lower volumes of PFC and hippocampus than normal control subjects (for 
review see (Levitt et al. 2010, Phillips et al. 2003). Another aspect of structural 
plasticity, which may be relevant to schizophrenia, given the involvement of the 
hippocampus in this disorder, is the apparent presence of alterations in adult 
neurogenesis in the dentate gyrus of schizophrenic patients (Reif et al. 2006). 
A closer view to the cerebral cortex of schizophrenic patients has also 
revealed alterations in neuronal circuitry, specially affecting the structure of 
neuronal inhibitory networks and their neurotransmission. In fact, current 
pathophysiological theories of schizophrenia are pointing to the GABAergic 
system as responsible for some of the alterations in schizophrenic brains 
(Benes and Berretta 2001, Lewis and Gonzalez-Burgos 2008). The inhibitory 
neurotransmitter GABA and some genes implicated in its metabolism have 
been associated with schizophrenia (Straub et al. 2007, Zai et al. 2009), 
specially the 67-kDa isoform of glutamic acid decarboxylase (GAD67) (See 
Akbarian and Huang 2006, Beneyto and Lewis 2011, Curley et al. 2011 for 
review). These alterations in inhibitory neurotransmission appear to affect 
particularly certain interneuronal populations, specially those expressing 
parvalbumin. Decreased density of neurons expressing the phenotypic markers 
of cortical GABAergic interneurons, parvalbumin and calbindin have been found 
in the PFC (Akbarian et al. 1995, Beasley et al. 2002, Chance et al. 2005, Sakai 
et al. 2008) and the hippocampus (Zhang and Reynolds 2002) in post-mortem 
studies of subjects with schizophrenia. Interestingly, a recent study suggests 
that these alterations in inhibitory circuitries may be mediated by neuregulin 1 
(Nrg1) and its receptor ErbB4, two important risk genes for schizophrenia, since 
their signaling controls the development and connectivity of these circuitries in 
the cerebral cortex (Fazzari et al. 2010). 
The structural alterations in cortical inhibitory neurons found in 
schizophrenia may be mediated by the polysialylated form of the neural cell 
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adhesion molecule (PSA-NCAM), which, through its antiadhesive properties, 
facilitates neuronal and synaptic remodeling (see Bonfanti 2006, Rutishauser 
2008 for review), or the partial isolation of neuronal elements (Gomez-Climent 
et al. 2011). The addition of PSA to NCAM is mediated by the two 
polysialyltransferases St8SiaII and St8SiaIV (see Hildebrandt et al. 2008 for 
review). PSA-NCAM is expressed in a subpopulation of interneurons, both in 
the PFC and the hippocampus of different mammalian species, including 
humans (Gilabert-Juan et al. 2012a, Gilabert-Juan et al. 2012b, Gomez-Climent 
et al. 2011, Mikkonen et al. 1998, Mikkonen et al. 1999, Nacher et al. 2002, 
Varea et al. 2005, Varea et al. 2007b), which have more reduced structural 
features than those lacking this molecule (Gomez-Climent et al. 2011). 
Interestingly, both NCAM and ST8SIAII genes have been associated with 
schizophrenia and alterations in the expression of NCAM and PSA-NCAM have 
been found in postmortem studies of this disorder, including some on the 
hippocampus and the PFC (Barbeau et al. 1995, Brennaman and Maness 2010, 
Gilabert-Juan et al. 2012b, Sullivan et al. 2007, Tao et al. 2007). 
To circumvent the intrinsic problems of studying human brains and to 
explore new experimental therapeutic approaches, several animal models of 
schizophrenia have been developed during the recent years. Obviously, none of 
these models mimics completely the disorder, but all of them can reproduce 
some of its core symptoms. Given the importance of altered neurodevelopment 
on the etiopathogenesis of schizophrenia, some of these models consist in 
experimental interventions during embryogenesis or early postnatal 
development. One of the most used of such models is the administration of 
NMDA receptor antagonists during the perinatal period, which produces certain 
cognitive and social impairments similar to those found in schizophrenia, 
(Abdul-Monim et al. 2006, Beninger et al. 2002, Hickey et al. 2012, Rung et al. 
2005). Perinatal NMDA glutamate receptor antagonist administration also 
reduces GABAergic neurotransmission and the number of parvalbumin 
expressing neurons in the PFC and the hippocampus in adulthood (Rotaru et al. 
2012). The existence of adverse experiences during early-life markedly 
influences the development of the nervous system and may facilitate, in 
genetically pre-disposed individuals, the development of psychiatric disorders 
such as schizophrenia. In this line, it is known that exposing rodents to 
postweaning social isolation affects brain development and leads to behavioral, 
morphological and neurochemical alterations during adulthood, which resemble 
core symptoms of schizophrenic patients (Fone and Porkess 2008, McLean et 
al. 2010, Simpson et al. 2010). These alterations include reduced cortical 
Gilabert-Juan et al.    Double hit animal model for schizophrenia 
 
volume (Day-Wilson et al. 2006), as well as deficits in the number of 
parvalbumin and calbindin interneurons in the hippocampus (Harte et al. 2007). 
During the recent years there has been an effort to combine some of the 
previous animal models of schizophrenia to better reproduce the disorder. A 
recent report has tested the hypothesis that a “double-hit” model combining MK-
801 administration during adulthood and postweaning social isolation rearing of 
Sprague-Dawley rats, produces greater behavioral and neurochemical effects 
than either insult alone, with limited results (Hickey et al. 2012). In the present 
study, we have developed a similar “double hit” model in Lister Hooded rats in 
order to find whether the combination of an earlier injection of MK-801 (P7), 
which may alter different neurodevelopmental processes, and a postweaning 
social isolation rearing reproduces some of the structural and molecular 
changes found in the mPFC and the hippocampus of schizophrenic patients, 
particularly in their inhibitory networks. We have analyzed the volume of these 
regions, the presence of alterations in the expression of the immediate early 
gene c-fos in their pyramidal neurons and have studied putative differences in 
the number of proliferating cells and of immature neurons in the hippocampal 
dentate gyrus. We have also analyzed changes in the number of parvalbumin 
expressing interneurons and the expression of different molecules involved in 
synaptic/structural plasticity and inhibitory neurotransmission, such as GAD67, 
synaptophysin, NCAM and PSA-NCAM by means of immunohistochemistry and 
optical densitometry. Finally, we have quantified and compared the expression 
of mRNAs for GAD67, synaptophysin, NCAM, parvalbumin, calretinin, calbindin, 
ErbB4, Nrg1 and the polysialyltransferases (St8SiaII and St8SiaIV) using 
quantitative real-time PCR (qRT-PCR). 
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EXPERIMENTAL PROCEDURES 
Animals 
Fifteen pregnant Lister Hooded rats were purchased from Jackson 
laboratories (Bar Harbor, Maine, USA) and bred in our animal facility. Pregnant 
rats were housed individually in a controlled temperature room (25º C) and on a 
12-h light/dark cycle with food and water available ad libitum. After a week, 60 
male rats were born from the pregnant rats and were used for the experiments. 
These animals were assigned randomly to the vehicle or the MK-801 groups. 
The weight of the rats was determined at postnatal day 7 (P7), P21 and after 
the 8 weeks of isolation (P77), right before their sacrifice. All animal 
experimentation was conducted in accordance with the Directive 2010/63/EU of 
the European Parliament and of the Council of 22 September 2010 on the 
protection of animals used for scientific purposes and was approved by the 
Committee on Bioethics of the Universitat de València. 
 
Isolation and MK-801 Acute Treatment 
P7 male rat pups were randomly assigned to 2 groups. 28 rats were 
intraperitoneally injected with a solution of the non-competitive antagonist of the 
N-methyl-d-aspartate (NMDA) receptor dizocilpine (MK-801, 1mg/Kg, Ascent 
Scientific, Princeton, USA) and 32 rats were injected with saline solution (0.9% 
NaCl). All rat pups remained with their mothers until weaning (21 days); at this 
postnatal day, rats were housed in groups or reared in isolation, thus forming 4 
new groups: Socially housed and vehicle injected (n=15), socially housed and 
MK-801 injected (n=12), isolated and vehicle injected (n=17) and finally isolated 
and MK-801 injected (n=16). Rats reared in group were housed 3 per cage (215 
× 465 × 145 mm), while isolated rats were housed in individual cages (220 × 
220 × 145 mm). All rats were housed in the same room, sharing the same 
controlled light, temperature and humidity. Rats reared in isolation could hear 
and smell other rats, but were unable to see or have physical contact with them. 
All animals were handled once a week by the same person, who replaced the 
bedding of the cage and added food and water. Rats were reared in these 
conditions during 8 weeks. 
 
Gene Expression 
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Thirty-two rats were used for qRT-PCR analysis and were sacrificed by 
decapitation using a guillotine. After this, their brains were removed from the 
skull and the whole medial prefrontal cortex (mPFC) and hippocampus of each 
brain were microdissected. Total mRNA was extracted using TriPure reagent 
(Roche Applied Science, Indianapolis, IN) following manufacturer’s instructions. 
The concentration and purity of total RNA was determined with an Eppendorf 
BioPhotometer plus (Eppendorf AG, Hamburg, Germany). cDNA synthesis was 
performed using the Expand Reverse Transcriptase (Roche Applied Science).  
qRT-PCR analyses were performed in triplicates. Specific primers for all 
genes (Table 1) at a concentration of 240 nM, and 4 µl of cDNA (50ng) were 
used. Primers were designed between exons to avoid DNA contamination, 
when possible. Ywhaz was used as a reference gene based on the study of 
Bonefeld et al. (2008). Primers were tested for nonspecific products and correct 
amplicon size by electrophoresis in 1.5% EtBr agarose gel. qPCR was carried 
out with the ABI PRISM 7700 Sequence Detector (Applied Biosystems) using 
SYBR Green PCR master mix (Applied Biosystems), following a 95ºC 
denaturation for 10 minutes, the reactions were cycled 40 times with a 95ºC 
denaturation for 15 seconds, and a 60ºC annealing step for 1 minute. After this, 
a melt curve was performed to assess the specificity of primers. 
Relative quantification was performed using the comparative threshold 
(Ct) method according to the 2-∆∆Ct method (Pfaffl 2001). Changes in gene 
expression were reported as fold changes relative to controls.  
 
Immunohistochemistry  
Twenty-eight rats were perfused transcardially with a 4% 
paraformaldehyde solution in phosphate buffer (PB, 0.1M, pH 7.4). Brains were 
removed from the cranium and the hemispheres were separated. The right 
hemisphere was cryoprotected in a 30% sucrose solution in PB (3-4 days) and 
cut frozen in a sliding microtome at 50 µm in coronal sections. These sections 
were destined for immunohistochemical analyses. The contralateral hemisphere 
was stored. 
The immunohistochemistry protocol was performed as follows: Briefly, 
floating sections were incubated for 1 min in an antigen unmasking solution 
(0.01 M citrate buffer, pH 6 at 100 °C). After cooling down the sections to room 
temperature, they were incubated with 3% H2O2 in phosphate buffered saline 
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(PBS) for 10 min to block endogenous peroxidase activity. After this, sections 
were treated for 1 h with 10% normal donkey serum (NDS) (Jackson 
ImmunoResearch Laboratories) in PBS with 0.2% Triton-X-100 (Sigma-Aldrich) 
and they were incubated overnight at room temperature with the primary 
antibody in each case; anti-PSA-NCAM (AbCys, 1:700), anti-NCAM (DSHB, 
1:500), anti-GAD67 (Chemicon, 1:500), anti-parvalbumin (SWANT, 1:2000), 
anti-Ki67 (Abcam, 1:500) and anti-DCX (Abcam, 1:1000) with PBS containing 
0.2% Triton-X-100 and 3% NDS. The second day, sections were incubated for 1 
hour with either donkey anti-mouse IgM or IgG, and donkey anti-rabbit IgG 
biotinylated antibodies (1:200; Jackson ImmunoResearch Laboratories) in PBS 
with 0.2% Triton-X-100 and 5% NDS. Then, sections were incubated in an 
avidin-biotin-peroxidase complex (Vector Laboratories) for 30 min in PBS. Color 
development was achieved by incubating with 3,3-diaminobenzidine 
tetrahydrochloride (Sigma-Aldrich) and 0.033% hydrogen peroxide in PB for 4 
min. Finally, sections were mounted on slides, dried for one day at room 
temperature, dehydrated with ascending alcohols and rinsed in xylene. After 
that, sections were coverslipped using Eukkit mounting medium. All the slides 
containing sections destined to quantitative analysis were coded and their code 
was not broken until the analyses were finished. 
 
Quantification of Neuropil Immunoreactivity 
From the immunostainings of PSA-NCAM, GAD67 and NCAM, the 5 
layers of the mPFC and the lucidum, radiatum and oriens layers of the 
hippocampus were selected in order to measure immunoreactivity as previously 
described (Varea et al. 2007a). Sections of each immunostaining were 
examined in one single session with an Olympus CX41 microscope under 
bright-field illumination, homogeneously lighted and digitalized using a CCD 
camera. Five photographs of the different areas and layers were taken for each 
animal at 20X magnification. Grey levels were converted to optical densities 
(OD) using Image J software (NIH).  In order to normalize the values, the gray 
levels obtained from photographs of the corpus callosum in each section were 
subtracted from those obtained in the different layers. Means were determined 
for each experimental group, using the number of animals as the “n”. 
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Estimation of the total number of PV+ cells in mPFC and hippocampus 
and of Ki67+ and DCX+ cells in the dentate gyrus 
The total number of neurons expressing parvalbumin (PV) protein in their 
somata was estimated in the different regions of the mPFC and in the 
hippocampus as described before (Varea et al. 2007a); the same procedure 
was used for Ki67 and doublecortin (DCX) expressing cells in the dentate gyrus 
of the hippocampus. Briefly, sections were selected by a 1:10 fractionator 
sampling covering the whole rostral to caudal extension of the different regions 
of interest studied and on each section all labeled cells within the region were 
counted. Cell somata were identified and counted with a 40X objective using an 
Olympus CX41 microscope. 
 
 
Quantification of the activation of CaMKII expressing pyramidal neurons 
in the mPFC  
In order to estimate the proportion of activated pyramidal cells in the 
mPFC and hippocampus, we performed a double fluorescence 
immunohistochemistry in one in ten subseries of brain sections from each 
animal. The protocol used was similar to that described above, omitting the 
endogenous peroxidase block. Sections were incubated overnight at room 
temperature in polyclonal rabbit IgG against c-Fos (1:20, Santa Cruz 
Biotechnology Inc.) and mouse IgGs1 against CaMKII (1:500, Abcam) primary 
antibodies. Then they were incubated for 1 hour in Dylight 649 conjugated 
secondary antibody against rabbit IgG (Jackson ImmunoResearch,1:200) and 
Dylight 488 conjugated secondary antibody against mouse IgGs1 (Jackson 
ImmunoResearch, 1:200). Fifty CAMKII expressing pyramidal neurons per 
animal/region were randomly selected from each animal. Then, the percentage 
of c-Fos co-expressing cells was determined.  
 
Volumetry 
In order to estimate the volumes of the regions studied, one in ten 
subseries of fixed brains was stained with cresyl violet, mounted and 
coverslipped with Eukitt. Volumetries of the different mPFC regions (prelimbic, 
infralimbic, cingulate 1 and 2) and the total hippocampus were performed by 
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means of Volumest plugin in the Image J Software (NIH). First, pictures of all 
slices were acquired with an Olympus CX41 microscope under bright-field 
illumination, homogeneously lighted and digitalized using a CCD camera. After 
that, the measures of the areas were estimated in pictures containing: prelimbic 
cortex in Bregma 4.70mm to 2.20mm; infralimbic cortex in Bregma 3.20mm to 
2.20mm; cingulated 1 cortex in Bregma 3.70mm to -1.40mm; cingulate 2 cortex  
in Bregma 1.70mm to -1.40mm and hippocampus in Bregma -1.80mm to -
6.80mm. The volumes were estimated for the right hemisphere using the 
Cavalieri’s principle (Gundersen and Jensen, 1987), outlining the region of 
interest digitally and combining the cut section (50μm) and the section 
increment (10 μm), to compute volumes automatically.  
 
Data analysis 
For body weight analysis, body weight differences at P21 were subjected 
to t-test analysis, and at P77, the differences were assessed by means of 2-way 
analyses of variance (ANOVA). All the data from the volumetries, counts, gene 
expression or densitometries were analyzed separately in each layer studied in 
the mPFC or the hippocampus, using 2-way ANOVA considering treatment 
(vehicle vs. MK-801) and housing (social vs. isolated) such as between-subjects 
factors. When appropriate, tests of simple main effects and pair-wise 
comparisons were performed. An alpha level of 0.05 was used for all statistical 
tests and all tests were conducted using Statview software.  
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RESULTS 
Body weight is affected by MK-801 treatment and by postweaning 
isolation rearing 
Body weight changes were measured at P7 (the day of MK-801 
treatment), P21 (the weaning day) and at the end of the experiment (P77). 
There were no differences in weight between the two groups (MK-801 or 
Vehicle solution) of rat pups injected in P7. The t-test at P21 day showed less 
weight in individuals treated with MK-801 than those injected with the vehicle 
solution (0.9% NaCl) t = 11.01, p = 0.0016. In contrast, the 2-way ANOVA 
performed at P77 showed an increased weight gain in rats reared in isolation 
compared to those reared in group, indicating an effect of the housing F (1,55) 
= 5.36,  p = 0.024 (Supplemental figure 1). 
 
Volume reduction of mPFC and hippocampus 
 The volume measures showed a significant reduction of the prelimbic 
region caused by the housing F (1, 21) = 4.96, p = 0.037 and the treatment F (1, 
21) = 7.22, p = 0.014. Similarly, the infralimbic region was significantly reduced 
by the housing F (1, 21) = 4.52, p = 0.045 and the treatment F (1, 21) = 5.5, p = 
0.029. No significant changes in volume were detected in the cingulate cortices. 
However, when the total mPFC was taken into account, significant reductions 
were found again, caused by the housing F (1, 21) = 4.48, p = 0.046 and the 
treatment F (1, 21) = 6.91, p = 0.016 (Figure 1).  
 The hippocampal volume was also reduced, although this reduction was 
only caused by the treatment F (1, 21) = 11.36, p = 0.0029 (Figure 1). 
 
c-Fos expression reveals an increase in the proportion of activated 
excitatory neurons in the  infralimbic cortex 
In order to know the proportion of principal neurons activated in the 
different groups of rats, we have estimated the percentage of cells coexpressing 
CaMKII (a marker of excitatory neurons) and c-Fos in the different regions of 
the mPFC. We observed a significant increase in the percentage of activated 
cells in the infralimbic region due to the housing F (1, 21) = 11.18, p = 0.0031, 
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but no changes were found in the rest of the mPFC regions or when the whole 
mPFC was taken into account (Figure 2).  
 
The total number of parvalbumin expressing somata is decreased in the 
infralimbic cortex   
 The total number of parvalbumin (PV) expressing somata was estimated 
in the four regions of the mPFC and the CA1, CA3 and dentate gyrus regions of 
the hippocampus. In the mPFC regions, there was a decrease in the number of 
PV expressing cells in the infralimbic cortex caused by the treatment F (1, 20) = 
5.7, p = 0.027, and an interaction housing x treatment F (1, 20) = 17.17, p = 
0.0005. Follow up tests showed decreased number of PV expressing cells in 
Iso-Veh, Soc-MK-801, Iso-MK-801 groups respect to Soc-Veh group (p = 
0.0015; 0.0004; 0.03 respectively) and an increase of cells in Iso-MK-801 group 
respect to Soc-MK-801 (p = 0.044). Trends towards a decrease in the number 
of PV immunoreactive cells were observed in the other three studied mPFC 
regions and when considering the mPFC as a whole (Figure 3).  
 Regarding the hippocampal measures, no significant changes were 
observed when analyzing the CA1 and CA3 regions or the dentate gyrus of the 
hippocampus or when analyzing this structure as a whole (Supplemental figure 
2). 
 
The expression of PSA-NCAM and GAD67 is decreased in deep layers of 
the mPFC and that of PSA-NCAM is decreased in the stratum lucidum of 
the hippocampus.   
 To study the alterations in the expression of GAD67, PSA-NCAM and 
NCAM in the mPFC and hippocampus, we have performed a comparison of the 
immunoreactivity in the neuropil of each layer of these brain regions. Our results 
showed a significant decrease of GAD67 expression in layers V and VI of the 
mPFC induced by the treatment (F (1, 21) = 4.56, p = 0.045; F (1, 21) = 4.80, p 
= 0.039 respectively). A similar decrease in PSA-NCAM expression was found 
in these two deep layers (V and VI), but induced by the housing (F (1, 20) = 
6.06, p = 0.023; F (1, 21) = 8.41, p = 0.0088 respectively). No significant 
changes in GAD67 or PSA-NCAM expression were found in the rest of layers of 
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the mPFC. No changes in the expression of NCAM were found in any layer of 
the mPFC (Figure 4).  
In the hippocampus, PSA-NCAM expression was altered in the stratum 
lucidum induced by housing x treatment interaction (F (1, 23) = 4.54, p = 0.044). 
Follow up tests revealed a decreased PSA-NCAM expression in the Soc-MK-
801group compared to the Soc-Veh group (p = 0.026). The expression of 
GAD67 and NCAM did not change in any region of the hippocampus (Figure 5). 
 
Altered expression of calbindin, calretinin and ErbB4 genes in the mPFC  
 In order to study the expression of different genes related to inhibitory 
synapses, plasticity and cell signaling, we performed quantitative RT-PCR of 
some transcripts (table 1) in the whole mPFC and hippocampus, using as a 
control gene the Ywhaz mRNA. The qRT-PCR analysis on the mPFC revealed 
a significant increase in the mRNA of the calcium binding protein calbindin (CB) 
in isolated animals when compared to socially reared animals. Two-way 
ANOVA analysis revealed significant effects of housing (F (1, 27) = 8.66, p = 
0.006). By contrast, the expression of the gene of the calcium binding protein 
calretinin (CR) was significantly reduced in animals treated with MK-801 when 
compared with those injected with vehicle (F (1, 27) = 6.13, p = 0.019), showing 
an effect of the treatment. For the ErbB4 receptor gene, there was a significant 
housing x treatment interaction (F (1, 27) = 4.97, p = 0.034). Follow up tests of 
simple main effects revealed that Iso-Veh animals had lower mRNA expression 
than Soc-Veh and Iso-MK-801 animals (p = 0.02; p = 0.041 respectively). There 
was no significant effect of housing or treatment in the rest of the genes studied, 
neither in the mPFC nor in the hippocampus (Figure 6 & supplemental figure 3). 
 
Increased number of immature neurons in the hippocampus 
 The total number of doublecortin (DCX) and Ki67 expressing cells was 
estimated in the granule cell layer of the hippocampus of the 4 groups studied. 
DCX is considered a solid marker of immature neurons in this region (Brown et 
al. 2003) and Ki67 expression is present in proliferative cells (Kee et al. 2002). 
The total number of DCX expressing cells was significantly increased in isolated 
individuals when compared to those reared in groups (F (1, 22) = 5.6, p = 
0.027). No significant changes were found in the total number of Ki67 
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expressing cells. Nevertheless, the correlation between the numbers of DCX 
and Ki67 expressing cells was high (R = 0.52, p = 0.0084) (Figure 7). 
 
Absence of alterations in apoptotic markers in the adult mPFC and 
hippocampus 
 In order to determine the expression of apoptotic markers in the two 
studied areas we performed a qRT-PCR of the proapoptotic gene Bax and the 
antiapoptotic gene Bcl2. The Bax/Bcl2 genes ratio represents a critical balance 
of regulatory pro-apoptotic and anti-apoptotic proteins in normal living cells, 
being an increase in Bax/Bcl2 ratio a trigger for the apoptotic pathway. There 
were no significant alterations in the fold change of Bax or Bcl2 expression in 
the mPFC or in the hippocampus. When the Bax/Bcl2 ratio was analyzed, there 
were no changes in the different groups in any of the two brain region studied 
(Supplemental figure 4).
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DISCUSSION 
In the present study we report alterations in the volume and different 
parameters related to structural plasticity and inhibitory neurotransmission in a 
“double hit” model of schizophrenia in Lister Hooded rats, which combines a 
perinatal injection of the NMDA receptor antagonist MK-801 and a postweaning 
social isolation rearing. The combined model shows a wider spectrum of 
schizophrenia-like symptoms than each model by itself. The postweaning 
isolation rearing contributes to the increased body weight during adulthood, the 
increase in the activation of mPFC pyramidal neurons, the decrease in the 
expression PSA-NCAM and the increase in the expression of Calbindin in this 
neocortical region, as well as the increase in the number of immature neurons 
in the dentate gyrus. On the other hand, the perinatal NMDA antagonist 
treatment contributes to the decrease in hippocampal volume and to the 
decreases in the expression of GAD67 and Calretinin in the mPFC. The 
interaction of the two interventions contributes to the decrease in the volume 
and the number of parvalbumin expressing cells in the mPFC, as well as to the 
decrease in PSA-NCAM expression in the hippocampal stratum lucidum. In the 
following paragraphs we discuss these data, comparing them with previous 
results obtained independently in each treatment and with data obtained from 
postmortem studies on schizophrenic patients. 
The present results show an increased weight gain in rats reared in 
isolation compared to those reared in groups, indicating an effect of the 
housing. These results are in agreement with previous studies, which reported 
similar changes in female Sprague Dawley rats (Hermes et al. 2011, Ness et al. 
1995). Although we have not found changes in body weight in adulthood 
induced by the perinatal MK-801 injection, treated rats showed less weight 
when weighed at P21. This is in accordance with other reports using different 
perinatal MK-801 treatments, which have consistently found transient lower 
body weights that normalized in adolescence or in adulthood (Stefani and 
Moghaddam 2005, Su et al. 2011).  The previous studies using dual animal 
models of schizophrenia combining postweaning social isolation rearing and 
acute MK-801 treatment did not explore changes in body weight (Ashby et al. 
2010, Hickey et al. 2012). 
In regard to volumetric changes, our results are in agreement with 
previous reports describing a decrease in mPFC volume in Lister Hooded rats 
reared in isolation  (Day-Wilson et al. 2006, Schubert et al. 2009). Our study 
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expands these previous findings, showing that the volume changes in the 
mPFC appear to be due to reductions in the prelimbic and infralimbic cortices, 
but not in the cingulate cortices. Moreover, we have found that these volumetric 
changes are caused both by the social isolation rearing and by the perinatal 
MK-801 treatment. Another interesting result of the present study is that the 
hippocampal volume was also reduced in the “double hit” model, although this 
effect was only caused by the MK-801 injection. These volumetric reductions in 
the “double hit” model are extremely important, because they are very similar to 
those found consistently in schizophrenia: Reductions in the volume of the PFC 
and hippocampus have been found in these patients, even in first episodes, 
suggesting a marked progression at the initial stage of the disease (Levitt et al. 
2010, Yoshida et al. 2011).  
The volume reductions found in the hippocampus and the mPFC in our 
study may well be correlated with structural changes in the neuropil. In fact, 
reduced dendritic length has been reported in pyramidal neurons of the PFC 
and hippocampus, and decreased spine density was found in hippocampal 
pyramidal neurons in rats reared in social isolation (Silva-Gomez et al. 2003). 
Moreover, similar changes in dendritic atrophy and spine density reduction have 
been found in the PFC of schizophrenia patients (Black et al. 2004, Broadbelt et 
al. 2002, Glantz and Lewis 2000) and diminished spine density has been 
observed in the subicular pyramidal neurons (Rosoklija et al. 2000). The 
presence of reduced neuronal and glial size and reduced glial cell density in the 
PFC and the hippocampus of schizophrenic patients (Benes et al. 1991, 
Rajkowska et al. 1998, Stark et al. 2004, Schmitt et al. 2009) may also be 
responsible for the volume reductions found in these cortical regions. 
Another aspect of structural plasticity, which may be relevant to the 
hippocampus, is the presence of alterations in adult neurogenesis. Although 
these alterations are far from explaining the etiology of schizophrenia, they may 
contribute to the hippocampal aspects of this disorder (Kempermann 2011). A 
study in adult human postmortem tissue has found reduced amounts of 
proliferating cells in the hippocampus of schizophrenic patients (Reif et al. 
2006). This is in contrast with our results in the “double hit” model, showing an 
increase of immature granule neurons (due to social isolation rearing) and no 
changes in the number of proliferating cells. These results may appear to be in 
conflict with those found in schizophrenic patients. However, it has to be noted 
that a significantly higher incidence of granule cells with basal dendrites has 
been found in these brains (Lauer et al. 2003) and that the presence of basal 
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dendrites has been described as a characteristic of immature granule cells, at 
least in rodents (Nacher et al. 2001, Shapiro et al. 2005). 
Several lines of evidence point to alterations in inhibitory circuits as one 
of the main factors to explain the neurobiological basis of schizophrenia  (Benes 
and Berretta 2001, Lewis et al. 2005). In this regard, the 67-kDa isoform of 
glutamic acid decarboxylase (GAD67), one of the enzymes responsible of 
GABA synthesis, is one of the most affected molecules (See Curley et al. 2011, 
Akbarian and Huang 2006, Beneyto and Lewis 2011 for review). Reduced 
expression of the GAD67 mRNA in the PFC (Akbarian et al. 1995, Guidotti et al. 
2000, Hashimoto et al. 2008, Torrey et al. 2005) and the hippocampus 
(Thompson Ray et al. 2011) is one of the most consistent findings in 
postmortem studies of individuals with schizophrenia. Similar decreases in 
GAD67 protein expression in the PFC and the hippocampus of schizophrenics 
have been found (Torrey et al. 2005), including those reported recently by our 
group (Gilabert-Juan et al. 2012b). The present results are partially in 
accordance with the findings in schizophrenic brains, showing a significant 
decrease of GAD67 protein expression in layers V and VI of the mPFC, 
although no changes were detected in the hippocampus. No differences in the 
expression of GAD67 mRNA were detected in our study, suggesting the 
presence of posttranscriptional alterations or the presence of downregulations 
of mRNA expression prior to the age at which our animals were sacrificed. The 
alterations in mPFC GAD67 protein expression were present in the “double hit” 
model, although they were induced only by MK-801 perinatal injection.   
Interestingly, previous reports using perinatal treatments with NMDA receptor 
antagonists have failed to find significant differences in GAD67 expression 
(Facchinetti et al. 1993). It is possible that this discrepancy with our results may 
be due to differences in the strain (Wistar) or the dosis/duration of the treatment 
(chronic treatment for 22 days) used by Facchinetti et al. (1993).  
Our results are in agreement with those reported recently by Hickey et al. 
(2012) using a similar “double hit” model combining social isolation rearing and 
MK-801 treatment, which describe increases in the activity of the GABA 
transporter (GAT1) and the expression of the GABAA receptor, both in the PFC 
and the hippocampus. Their results also suggest a reduction in inhibitory 
neurotransmission, together with a compensatory response of GABA receptors 
to the decreased GABA availability. However, one should be cautious when 
comparing the two models, because Hickey and collaborators injected MK-801 
at P56 (after the isolation paradigm) and twice daily for 7 days. 
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In addition to these changes in GAD67 expression, recent findings 
indicate that schizophrenia is associated with different alterations in certain 
interneuronal subpopulations, specially parvalbumin expressing cells, which 
may have an important impact on the physiology of pyramidal cells (see Lewis 
et al. 2012 for review). The number of parvalbumin expressing interneurons 
does not appear to be reduced in schizophrenic patients, at least in the PFC, 
but they exhibit reduced expression of parvalbumin mRNA and lower density of 
parvalbumin expressing puncta in certain layers, among other abnormalities at 
the presynaptic and postsynaptic level (see Beneyto and Lewis 2011 for 
review). Our “double hit” model also shows alterations in parvalbumin 
expressing cells in the mPFC. The number of these interneurons is reduced 
significantly in the infralimbic cortex, although trends toward decreases were 
also found in the rest of regions studied. This effect was due to MK-801 
treatment  and it is in accordance with previous reports describing similar 
reductions after acute perinatal treatment with MK-801 (Coleman et al. 2009, 
Wang et al. 2008). It is probable that this reduction in the number of 
parvalbumin expressing cells is due to the extensive cell death caused by the 
perinatal NMDA antagonist administration during perinatal development (see 
Lim et al. 2012 for review); we have not found evidence of cell death at the time 
of sacrifice. Although we have not found alterations in the expression of 
parvalbumin mRNA in the present study, we have observed differential changes 
in calbindin and calretinin expression, which certainly make necessary future 
experiments to evaluate more closely the subpopulations of interneurons 
expressing these calcium binding proteins. Although apparently the calretinin 
subpopulation is not affected in schizophrenic patients, the calbindin 
subpopulation may be altered (see Lewis and Hashimoto 2007 for review). 
Our study on the expression of c-Fos in the mPFC also gives support to 
the idea that prefrontocortical inhibition is decreased in the “double hit” model 
and, consequently, this may lead to an excessive activation of excitatory 
neurotransmission, since we have found an increase in the expression of this 
marker of cell activity in the nuclei of pyramidal neurons. Interestingly, the 
increase in c-Fos expression is found in the same region, the prelimbic cortex, 
where a significant reduction in parvalbumin expressing interneurons has been 
observed. 
Although our results show an interaction, which prevents the observation 
of changes in ErbB4 mRNA in the “double hit” model, we still find very 
interesting that social isolation alone is capable of decreasing its expression. 
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This is the first report describing this decrease in this schizophrenia model. A 
previous report found decreased ErbB4 and p-ErbB4 expression in the adult 
mPFC after perinatal treatment with an NMDA receptor antagonist 
(phencyclidine) (du Bois et al. 2012). However, it has to be noted that in this 
model the animals received three injections of the NMDA receptor antagonist, 
on postnatal days 7, 9 and 11, while only one injection was used in our model. 
ErbB4 and its ligand Nrg1 are important risk genes for schizophrenia 
(Buonanno 2010, Norton et al. 2006) and their signaling controls the 
development of inhibitory cortical networks, regulating the connectivity of certain 
interneuronal populations, particularly parvalbumin expressing basket and 
chandelier cells (Fazzari et al. 2010). Consequently, alterations in ErbB4 during 
postnatal development and adolescence, such as those induced by post-
weaning social isolation rearing, must interfere with the final establishment of 
cortical connectivity, specially that involving inhibitory neurons.  
In connection with the changes induced by the “double hit” model 
discussed above regarding inhibitory circuits, we find very interesting our result 
indicating a similar decrease in PSA-NCAM expression and GAD67 in the deep 
layers (V and VI) of the mPFC. This provides a putative link between changes in 
inhibitory neurotransmission and structural plasticity. In this regard, previous 
work in our laboratory has found that a subpopulation of interneurons in the 
mPFC of adult humans and rodents expresses PSA-NCAM (Gomez-Climent et 
al. 2011, Varea et al. 2005, Varea et al. 2007b) and that these inhibitory 
neurons display reduced dendritic arborization and spine density when 
compared with interneurons lacking this molecule (Gomez-Climent et al. 2011). 
Parallel alterations in the expression of GAD67, synaptophysin and PSA-NCAM 
have been observed in the mPFC in rats with pharmacological manipulations of 
dopamine D2 receptors and these changes are blocked when PSA is depleted 
from the mPFC (Castillo-Gomez et al. 2008, Castillo-Gomez et al. 2011). 
Changes in PSA-NCAM expression also occur in parallel to the stress-induced 
dendritic remodeling of interneurons, at least in the amygdala (Gilabert-Juan et 
al. 2011). Moreover, the reductions in PSA-NCAM and GAD67 expression 
observed in the “double hit” model are similar to those we have found in the 
mPFC of schizophrenic patients (Gilabert-Juan et al. 2012b). We have not 
found any change in the expression of NCAM or the polysialyltransferases, 
suggesting that this cell adhesion molecule is apparently unaffected in this 
model and that changes in the expression of the enzymes responsible for the 
addition of PSA to NCAM may have occurred previously to sacrifice or that the 
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reduction of PSA-NCAM is due to other factors, such as an enhancement of its 
removal from the plasma membrane. 
We have not performed behavioral analysis in the present study, but a 
similar “double hit” model shows alterations in locomotor activity, which may be 
the result of decreased inhibitory neurotransmission (Hickey et al. 2012). Future 
experiments should explore whether other behavioral alterations resembling 
some of those observed in schizophrenia, which have been described 
independently in the perinatal MK-801 injections and in the social isolation 
rearing models, persist in the “double hit” model. Such alterations include 
impaired social interactions, deficits in sensory motor gating, hyperactivity in a 
novel environment, as well as impaired cognitive flexibility, reversal learning, 
and novel object discrimination (for review see Fone and Porkess 2008, Lim et 
al. 2012). 
Although many of the parameters analyzed in our study appear to act 
through independent mechanisms, we find that, using their combination, this 
“double hit” model can be a very valuable experimental tool to mimic a wider 
spectrum of specific symptoms and alterations of schizophrenia, specially those 
affecting inhibitory neurotransmission, and to serve as a testing platform for 
novel treatments directed to this devastating disorder.  
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FIGURE LEGENDS 
Figure 1. Stereological estimates of mPFC and hippocampal volumes. 
Histograms show the estimated volumes of the prelimbic, infralimbic, cingulate 
1 and cingulate 2 cortices, as well as those of the whole mPFC and 
hippocampus in Soc-Veh, Iso-Veh, Soc-MK-801 and Iso-MK-801groups. Values 
represent mean±S.E.M. # p < 0.05 by housing.   * p < 0.05 by treatment. ** p < 
0.01 by treatment. 
 
Figure 2. Histograms showing the percentages of CaMKII expressing pyramidal 
neuron somata colocalizing c-fos in their nuclei in the prelimbic, infralimbic, 
cingulate 1, cingulate 2 cortices and in the whole mPFC. # p < 0.05 by housing. 
Images show cells expressing CaMKII (green) in their soma and c-fos (blue) in 
their nucleus in the infralimbic region of the mPFC. Scale bar: 10 μm. 
 
Figure 3. Somata expressing parvalbumin protein in the mPFC. Histograms 
show the differences in the total number of cells expressing parvalbumin in their 
somata. Values represent mean±S.E.M. * p < 0.05 by treatment. ‡ p < 0.05 in 
the Iso-MK801group compared to the Iso-Veh group. Images show parvalbumin 
expressing somata in the four groups (Soc-Veh, Iso-Veh, Soc-MK-801 and Iso-
MK-801) in the infralimbic region. Scale bar: 200 μm. 
 
Figure 4. Neuropil immunoreactivity of GAD67, PSA-NCAM and NCAM in the 
mPFC. Histogram bars show the grey level measured in the five layers (I, II, III, 
V and VI) of Soc-Veh, Iso-Veh, Soc-MK-801 and Iso-MK-801 groups. Data are 
the mean±S.E.M. # p < 0.05 by housing, * p < 0.05 by treatment, ** p < 0.01 by 
treatment.  
 
 
Figure 5. Neuropil immunoreactivity of GAD67, PSA-NCAM and NCAM in the 
hippocampus. Histogram bars show the grey level measured in the three 
regions (radiatum, oriens and lucidum) of Soc-Veh, Iso-Veh, Soc-MK-801 and 
Iso-MK-801 groups. Data are the mean±S.E.M. ‡ p < 0.05 in the Soc-
MK801group compared to the Soc-Veh group. 
 
Figure 6. Relative gene expression. qRT-PCR mRNA fold change data for the 
four studied groups (Soc-Veh, Iso-Veh, Soc-MK801 and Iso-MK-801) in the 
mPFC for the genes St8siaII, St8siaIV, Gad67, NCAM, SYN, parvalbumin, 
calbindin,calretinin, CaMKII, ErbB4 and Nrg1. The expression of all studied 
genes was normalized using Ywhaz as a control gene. # # p < 0.01 by housing, 
* p < 0.05 by treatment. ‡ p < 0.05 by single group effect.  
 
Figure 7. DCX and Ki67 expression in the hippocampus. Histograms show the 
differences in the total number of cells expressing DCX and Ki67 in their somata 
and nuclei respectively. Values represent mean±S.E.M. # p < 0.05 by housing. 
The graph on the right side of the figure shows the correlation of the number of 
DCX expressing somata with Ki67 expressing nuclei in each individual. White 
circles represent Soc-Veh individuals, black circles represent Iso-Veh 
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individuals, white squares represent Soc-MK-801 individuals and black squares 
represent Iso-MK801 individuals (R = 0.52, p = 0.0084). 
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SUPPLEMENTAL FIGURE LEGENDS 
 
Supplemental figure 1. Histograms showing the weight of animals at 21 PND 
in the group injected with saline solution (Control) and the group injected with 
MK-801 (MK801). Values represent mean±S.E.M. ** p < 0.01. The final weight 
graph shows the histograms indicating the weight at the end of the experiment 
for each group (Soc-Veh, Iso-Veh, Soc-MK801 and Iso-MK-801). Values 
represent mean±S.E.M. # p < 0.05 by housing. 
 
Supplemental figure 2. Somata expressing parvalbumin protein in the 
hippocampus. Histograms show the differences in the total number of cells 
expressing parvalbumin in their somata. Values represent mean±S.E.M.  
 
Supplemental figure 3. Relative gene expression. qRT-PCR mRNA fold 
change data for the four studied groups (Soc-Veh, Iso-Veh, Soc-MK801 and 
Iso-MK-801) in the hippocampus for the genes St8siaII, St8siaIV, Gad67, 
NCAM, SYN, parvalbumin, calbindin, calretinin, CaMKII, ErbB4 and Nrg1. The 
expression of all studied genes was normalized using Ywhaz as a control gene. 
 
Supplemental figure 4. Expression of apoptosis-related genes. Histograms 
show the fold change of the proapoptotic gene Bax, the antiapoptotic gene Bcl2 
and the Bax/Bcl2 relationship in the mPFC and the hippocampus for each group 
(Soc-Veh, Iso-Veh, Soc-MK-801 and Iso-MK-801). 
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TABLES 
 
 
Table 1. Sequences of gene specific primers and associated amplicon lengths for 
qRT-PCR. 
Target gene  Primers  Sequence (5’ → 3’)  Amplicon size(1) 
ST8SiaII  Forward  GGCAACTCAGGAGTCTTGCT  123 
  Reverse  GTCAGTCTTGAGGCCCACAT   
ST8SiaIV  Forward  CCTTCATGGTCAAAGGAGGA  125 
  Reverse  CCAGTAACCTCTGACCGCAT   
GAD67  Forward  CTGGAGCTGGCTGAATACCT  120 
  Reverse  TCGGAGGCTTTGTGGTATGT   
NCAM  Forward  AACGGACTCCAAACCATGAC  123 
  Reverse  CTGGCTTTGCTTCTGACTCC   
SYN  Forward  CTATGGGCAGCAAGGCTATG  120 
  Reverse  CAGGCCTTCTCTTGAGCTCTT   
Pvalb  Forward  AAGAGTGCGGATGATGTGAAG  150 
  Reverse  AGCCATCAGCGTCTTTGTTT   
Calbindin  Forward  AGGGATGTGCTTCTGCTTGT  171 
  Reverse  CATCTGGCTACCTTCCCTTG   
Calretinin  Forward  GTGGTGGGTGGGTCACACGG  179 
  Reverse  GGAATTGCGGGGGTCAGTGGG   
CaMKII  Forward  ACCATCAACCCGTCCAAAC  152 
  Reverse  ATGGCTCCCTTCAGTTTCCT   
ErbB4  Forward  CAGTCGCCCAGGGTGCAACG  133 
  Reverse  GCGAACACTGTGGGGTCGGC   
Nrg1  Forward  GCTCCGGTGCGAAACCAGCT  133 
  Reverse  TCGAAGCTCTGACTTCCCTGGCT   
BAX  Forward  AAACTGGTGCTCAAGGCCCT  92 
  Reverse  AGCAGCCGCTCACGGAG   
BCL2  Forward  CCGGGAGAACAGGGTATGATAA  81 
  Reverse  CCCACTCGTAGCCCCTCTG   
Ywhaz  Forward  TTGAGCAGAAGACGGAAGGT  136 
  Reverse  GAAGCATTGGGGATCAAGAA   
(1) Amplicon length in base pairs. 
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Article 5: Alterations in the expression of PSA-NCAM and synaptic 
proteins in the dorsolateral prefrontal cortex of psychiatric disorder 
patients 
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Synaptic  and  plasticity  markers  are  altered  in  the  DLPFC  in  psychiatric  disorders.
There  is a  reduction  in  the  complexity  of  the  circuitry  for  all  these  disorders.
In  schizophrenic  patients  there  is a  reduction  in  the  plasticity  molecule  PSA-NCAM.
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a  b  s  t  r  a  c  t
Alterations  in the  structure  and  physiology  of the  prefrontal  cortex  (PFC)  have  been  found  in  different  psy-
chiatric  disorders  and  some  of  them  involve  inhibitory  networks,  especially  in  schizophrenia  and  major
depression.  Changes  in  the  structure  of these  networks  may  be mediated  by the polysialylated  neural
cell adhesion  molecule  (PSA-NCAM),  a molecule  related  to neuronal  structural  plasticity,  expressed  in
the PFC  exclusively  by  interneurons.  Different  studies  have  found  that  PSA-NCAM  expression  in  the  hip-
pocampus  and  the  amygdala  is  altered  in  schizophrenia,  major  depression  and animal  models  of  these
disorders,  in  parallel  to  changes  in  the expression  of  molecules  related  to inhibitory  neurotransmis-
sion  and  synaptic  plasticity.  We  have  analyzed  post-mortem  sections  of  the  dorsolateral  PFC from  the
Stanley  Neuropathology  Consortium,  which  includes  controls,  schizophrenia,  bipolar  and major  depres-
sion patients,  to  check  whether  similar  alterations  occur.  PSA-NCAM  was  found  in  neuronal  somata
and  neuropil  puncta,  many  of  which  corresponded  to interneurons.  PSA-NCAM  expression  was  only
reduced  signiﬁcantly  in  schizophrenic  patients,  in parallel  to a decrease  in glutamic  acid-decarboxylase-
67  (GAD67)  and to an  increased  expression  of  vesicular  glutamate  transporter  1  (VGLUT1)  in the  white
matter.  Depressed  patients  showed  signiﬁcant  decreases  in  synaptophysin  (SYN)  and VGLUT1  expres-
sion. Whereas  in  bipolar  patients,  decreases  in  VGLUT1  expression  have  also  been  found,  together  with  a
reduction of  GAD67.  These  results  indicate  that  the expression  of  synaptic  proteins  is  altered  in the  PFC
of patients  suffering  from  these  disorders  and  that, particularly  in schizophrenia,  abnormal  PSA-NCAM
ay  unand  GAD67  expression  m
. Introduction
Schizophrenia, bipolar disorder, and major depression are dev-
stating mental diseases, each with distinctive yet overlapping
haracteristics. Alterations in the structure and function of the
refrontal cortex (PFC) seem to be common features to all of
∗ Corresponding author at: Neurobiology Unit, Cell Biology Dpt., Universitat de
alència, Dr. Moliner, 50, Burjassot 46100, Spain. Tel.: +34 96 354 3241;
ax: +34 96 354 4372.
E-mail address: nacher@uv.es (J. Nácher).
1 Current address: Sigrid Jusélius Laboratory, University of Helsinki, Finland.
304-3940/$ – see front matter ©  2012 Elsevier Ireland Ltd. All rights reserved.
ttp://dx.doi.org/10.1016/j.neulet.2012.09.032derlie  the  alterations  observed  in inhibitory  neurotransmission.
© 2012 Elsevier Ireland Ltd. All rights reserved.
them. Interestingly, these disorders, specially schizophrenia and
major depression, as well as animal models mimicking some of
their symptoms, are also particularly characterized by abnormali-
ties involving prefrontocortical inhibitory networks. Schizophrenic
patients have impaired cognitive and executive functions associ-
ated with the PFC [19,28,41],  which correlate with a reduction
in the number of interneurons [3,21].  Moreover, other studies
have also revealed a reduction in the expression of the tran-
script for the 67-kDa isoform of glutamic acid decarboxylase
(GAD67) [1,12,39,40]. Several lines of evidence coming from both
animal and human studies also indicate the involvement of the
GABAergic system in the pathophysiology of major depression
[20,23,27,29].
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These alterations in the inhibitory neurotransmission of the PFC
ay be mediated by changes in the structure and connectivity
f interneurons. The polysialylated form of the neural cell adhe-
ion molecule (PSA-NCAM) is an extremely interesting candidate
o mediate these changes, because it is expressed in the PFC of
umans, speciﬁcally in inhibitory neurons [35]. These interneu-
ons have more reduced structural features and synaptic input than
hose lacking this molecule [16]. Moreover, changes in the levels of
SA-NCAM expression occur in parallel to the structural remod-
ling of interneurons in the mouse amygdala after chronic stress,
n animal model of depression [14]. In addition, manipulation of
erotoninergic [34] or dopaminergic [6] neurotransmission, two
onoamines critically involved in the etiology and treatment of
sychiatric disorders, induces alterations in PSA-NCAM expression
n the PFC. These changes are accompanied by alterations in the
xpression of proteins related to general and inhibitory neurotrans-
ission and may  indicate the presence of synaptic remodeling in
nhibitory networks. Finally, a recent report from our laboratory
sing the same brain collection of the present study, has found
lterations in the expression of PSA-NCAM, synaptophysin (SYN)
nd/or GAD67 in the amygdala of major depression, bipolar and
chizophrenic patients [37].
In order to know whether similar changes can be detected in the
FC using immunohistochemistry, we have analyzed the expres-
ion of PSA-NCAM and that of SYN, vesicular glutamate transporter
ype 1 (VGLUT1) and GAD67, markers of generic, excitatory and
nhibitory synapses respectively. We  have performed our analyses
n the dorsolateral PFC from post-mortem samples of the Stan-
ey Foundation Neuropathology Consortium, which includes tissue
rom control, schizophrenia, major depression and bipolar disor-
er patients. In order to conﬁrm whether, as in rodents [6],  puncta
xpressing PSA-NCAM in the neuropil have an inhibitory nature,
e have studied the neurochemical phenotype of these elements
sing ﬂuorescence immunohistochemistry and confocal analysis.
. Materials and methods
.1. Samples and histological processing
Frozen 14 m thick coronal sections containing the dorsolateral
refrontal cortex (DLPFC) of patients diagnosed with schizophre-
ia, bipolar disorder, or major depression and normal controls were
btained from the Stanley Medical Research Institute (Bethesda,
D,  USA). All patient records were reviewed by one psychia-
rist and summarized in narrative form, and the information was
ntered into a computerized database by identifying number only.
hen all the information was collected, a DSM-IV psychiatric diag-
osis was made independently by two senior psychiatrists. If there
as disagreement between them, the records were given to a third
enior psychiatrist and a consensus diagnosis was  arrived at [33].
he cohort consists of 15 individuals in each group. The demo-
raphic data and recruitment of these patients has been described
arlier [33] and are summarized in supplemental table 1. The aver-
ge pH measurements of each group was 6.2 and the post-mortem
nterval (PMI) for the bipolar, major depressive, schizophrenia and
ontrol groups were 32.5, 27.5, 33.7, and 23.7 h, respectively. All
rains underwent clinical neuropathological examination by two
europathologists, none demonstrated evidence of neurodegener-
tive changes or other pathological lesions.
Sections were thawed and immediately ﬁxed by immersion in a
olution of paraformaldehyde 2.5% in a lysine–phosphate buffer, pH
.4 for 20 min  at room temperature. The lysine–phosphate buffer
as prepared 1:1 from a solution of phosphate buffer 0.1 M pH 7.4
PB) and a solution 0.2 M of lysine adjusted to pH 7.4 using a solu-
ion of Na2HPO4 0.1 M.  The buffer was mixed with a concentratede Letters 530 (2012) 97– 102
solution of paraformaldehyde 3:1 and 0.214 g of sodium peryodate
was added for each 100 ml  just before use. After ﬁxation, sections
were washed in phosphate buffer (PB, 0.1 M,  pH 7.4) and processed
immediately for immunohistochemistry.
Frozen human samples from the DLPFC, Brodmann area 9, were
also obtained from the Neurological Tissues Bank of the University
of Barcelona. This tissue was used to perform the phenotypical anal-
ysis of PSA-NCAM immunoreactive puncta. Samples were obtained
from ﬁve subjects without any neurological abnormality, the aver-
age age was 59.6 years (42–74) and the time post-mortem before
freezing the samples was  8.5 h (3.5–17.5). The tissue was  unfrozen
and ﬁxed by immersion in a solution of paraformaldehyde 2.5% in
a lysine–phosphate buffer, as described above. After ﬁxation, sam-
ples were washed using PB and 50 m sections were obtained using
a vibratome. Sections were then postﬁxed in the same solution for
20 min. After ﬁxation, sections were washed in PB and maintained
in PB with sodium azide 0.05% at 4 ◦C until used.
All the sections studied passed through the procedures simul-
taneously, to minimize any difference from histochemical and
immunohistochemical protocols themselves.
2.2. Immunohistochemistry for conventional light microscopy
Tissue was  processed for immunohistochemistry as follows.
Brieﬂy, sections were incubated for 1 min  in an antigen unmask-
ing solution (0.01 M citrate buffer, pH 6) at 100 ◦C. After cooling
down the sections to room temperature, they were incubated with
3% H2O2 in phosphate buffered saline (PBS) for 10 min  to block
endogenous peroxidase activity. After this, sections were treated
for 1 h with 5% normal donkey serum (NDS) (Jackson Laborato-
ries) in PBS with 0.2% Triton-X100 (Sigma) and then incubated
at 4 ◦C during 72 h in mouse monoclonal Men-B anti-PSA-NCAM
IgM (1:1400, Abcys), mouse monoclonal anti-SYN IgG (SYN, 1:200,
Sigma), rabbit polyclonal anti-GAD67 (1:500, Chemicon Int.) or
guinea pig anti-VGLUT1 (1:1000, Chemicon Int.) antibodies. After
washing, sections were incubated for 60 min  in biotinylated donkey
anti-mouse IgM, donkey anti-mouse IgG, donkey anti-rabbit IgG or
donkey anti-guinea pig IgG antibodies respectively (Jackson Labo-
ratories, 1:250), followed by an avidin–biotin–peroxidase complex
(ABC, Vector Laboratories) for 30 min  in PBS. Color development
was achieved by incubating in 3,3′-diaminobenzidine tetrahy-
drochloride (DAB, Sigma) and H2O2 for 4 min. PBS containing 0.2%
Triton-X100 and 3% NDS was  used for primary and secondary anti-
bodies dilution. After staining, sections were washed, dehydrated
and mounted with Eukitt.
2.3. Quantiﬁcation of neuropil immunoreactivity
We  determined PSA-NCAM, SYN, GAD67 and VGLUT1
immunoreactivity intensity in the neuropil of the different regions
studied using a previously described methodology [34]. Sections
were examined under bright-ﬁeld illumination, homogeneously
lighted and digitalized using a CCD camera. Photographs were
taken at 20× magniﬁcation and grey levels (GL) were evaluated
using Image J software (NIH). Five images were taken from each
sample.
2.4. Characterization of the phenotype of PSA-NCAM expressing
elements in the neuropil of the human amygdala
In order to characterize the inhibitory nature of the PSA-NCAM
positive elements in the neuropil of the human DLPFC, according
to previous results observed for neuronal somata in this region
[36] and the results obtained in other human regions, such as the
amygdala [37], double ﬂuorescence immunohistochemistry was
performed using antibodies against PSA-NCAM and the marker
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or inhibitory synaptic terminals GAD67. In general, sections were
rocessed as described above, but the endogenous peroxidase block
as omitted. The sections were incubated overnight with mouse
onoclonal IgM anti-PSA-NCAM antibody (Men-B, 1:1400) and
abbit polyclonal anti-GAD67 (1:500, Chemicon Int.). After wash-
ng, sections were incubated with donkey anti-mouse IgM and
onkey anti-rabbit IgG secondary antibodies conjugated with Alexa
88 or Alexa 555 (Molecular Probes, Eugene, OR, USA; 1:200) in
BS containing 0.2% Triton X-100 and 3% NDS. All sections were
bserved under a confocal microscope (Leica, SPE). Z-series of
ptical sections (0.5 m apart) were obtained using sequential
canning mode. One hundred PSA-NCAM immunoreactive puncta
ere analyzed in the DLPFC of different control human samples
n = 4) to determine the co-expression of PSA-NCAM and GAD67.
.5. Data analyses
Data analyses were performed with SPSS v14.0 software (SPSS,
hicago, IL). All values are given as mean densities ± standard error
f the mean (S.E.M.). Effect of post-mortem interval (PMI), brain
H, brain weight, age, suicide, substance-alcohol abuse, side, onset,
ifetime neuroleptic use (in ﬂuphenazine mg  equivalents) or sex
as assessed by Spearman’s correlations in every layer and every
iagnostic group prior to the main analysis. None of the condi-
ions displayed any correlation with the values obtained with the
ifferent markers analyzed.
Signiﬁcant interactions of diagnosis with layer were investi-
ated using multivariate ANOVA of layer. This allowed the effects
f diagnosis to be examined separately in each layer, with planned
omparisons within a single analysis.
. Results
The study of the expression of PSA-NCAM in the dorsolateral
refrontal cortex (DLPFC) conﬁrmed our previous observations
36], showing a laminated pattern of staining in the neuropil. Lay-
rs III–V displayed intense PSA-NCAM expression, while the other
ayers showed only faint expression, which was almost absent in
he white matter. We  have found a similar distribution of expres-
ion when studying the synaptic protein SYN in all the layers of the
uman DLPFC, ﬁnding only a slightly lower expression in layer I.
imilar results have been observed for GAD67 and VGLUT1, markers
f inhibitory and excitatory synapses respectively.
PSA-NCAM immunoreactive structures were found in all the
ayers of the DLPFC. Most of these structures were characterized
s individual puncta, although some processes, which most likely
ere truncated dendrites, could also be found (Fig. 1A). Some
mmunoreactive somata, similar to those we previously described
s belonging to interneurons [36], were occasionally observed in
he DLPFC. The characterization of the phenotype of PSA-NCAM
mmunoreactive puncta in the neuropil reﬂected a high level of
olocalization with GAD67 in the DLPFC (30.9 ± 6.8%, Fig. 1A).
The study of the expression of PSA-NCAM and different synap-
ic markers in the DLPFC (Fig. 1B) showed that PSA-NCAM was  only
educed signiﬁcantly in layers IV and V (p < 0.05) of schizophrenic
atients. For SYN expression, we observed a reduction in layers
II (p < 0.05) and IV (p < 0.01) of patients suffering major depres-
ion. Regarding VGLUT1, we observed decreases in its expression in
ayer V of major depression (p < 0.05) and bipolar disorder patients
p < 0.05). Interestingly, we also found a signiﬁcantly increased
xpression of VGLUT1 in the white matter of schizophrenic
atients. Finally, we observed a reduction in the expression of
AD67 in layers II, III, and IV of bipolar disorder patients (p < 0.05)
nd a reduction in layers II, and IV of schizophrenic patients
p < 0.05).e Letters 530 (2012) 97– 102 99
4. Discussion
The phenotypic characterization of PSA-NCAM immunoreactive
puncta in the human DLPFC has revealed their inhibitory nature.
This result is in accordance with a previous study of our labora-
tory [36], where we have demonstrated the inhibitory nature of
PSA-NCAM expressing somata in this cortical region. PSA-NCAM
expressing somata and neuropil structures displaying an inhibitory
phenotype can also be found in the hippocampus [22], the septum
[13] and the paleocortex and neocortex of adult rats and mice [16],
as well as in the human amygdala [37].
The study of the expression of the different synaptic markers
showed that major depression patients presented a reduction in
SYN (layers III, IV), VGLUT1 (layer V) and GAD67 (layer V) expres-
sion. The reductions in SYN and VGLUT1 expression seem to be
in accordance with the dendritic atrophy of medial PFC (mPFC)
pyramidal neurons observed in animal models of depression, such
as chronic stress [10,25,26].  Although such dendritic atrophy still
remains to be demonstrated in major depression patients, volume
reductions have been reported in this region [24]. These results give
support to the neuroplastic hypothesis of depression, which poses
that changes in neuronal structure and connectivity may  under-
lie the etiology of this disorder and that these changes may be
reverted by antidepressants [7].  In fact, treatment with ﬂuoxetine
increases the level of expression of SYN [34,35] and pharmacolog-
ical manipulation of dopamine D2 receptors with speciﬁc agonists
induces increases in SYN and GAD67 expression in the rat PFC [6].
Our results showing an increase in GAD67 expression are also in
accordance with previous lines of evidence coming from animal
and human studies indicating the involvement of the GABAer-
gic system in the pathophysiology of major depression [20,30].
Using western blot analysis, GAD67 protein expression was also
found signiﬁcantly reduced in the DLPFC of depressed subjects [18].
Moreover, neuroimaging studies have reported reductions in GABA
levels [17,29] in the PFC and post-mortem immunohistochemical
analyses have found reductions in the density and size of certain
interneuronal subpopulations in this region [23,27].
Although in a recent study our laboratory has found that changes
in SYN and GAD67 expression in the amygdala of major depres-
sion patients were accompanied by parallel changes in PSA-NCAM
expression [37], apparently this does not occur in the PFC. Inter-
estingly, similar results have been obtained by our group in mice
subjected to chronic stress, in which PSA-NCAM expression was
altered by this aversive experience in the amygdala [14] but not in
the mPFC (Gilabert-Juan et al., unpublished results).
In schizophrenic patients we  have observed a reduction in the
expression of PSA-NCAM (layers IV and V), and GAD67 (layers II
and IV). These parallel changes of PSA-NCAM and GAD67 may
reﬂect the already reported alterations of cortical inhibitory cir-
cuits in schizophrenia (for a review see [21]); in fact, a recent report
has found that GAD67 mRNA and protein levels are signiﬁcantly
lower in the DLPFC of schizophrenic patients [11]. Additionally,
they also point to the possible involvement of PSA-NCAM in these
alterations in inhibitory neurotransmission, since we have previ-
ously demonstrated that this molecule is exclusively expressed by
interneurons in the PFC of humans [36] and rodents [16,38].  Inter-
estingly, these interneurons have more reduced structural features
and synaptic input than those lacking PSA-NCAM expression [16].
Moreover, both NCAM and the polysialyltransferase ST8SIAII genes
have been associated to schizophrenia [5,31,32] and the number
PSA-NCAM expressing neurons is reduced in the hippocampus
of schizophrenic patients [2].  The present results are similar to
those we have recently found in an animal model for schizophre-
nia (postweaning isolation rearing), in which we have observed
similar decreases in PSA-NCAM and GAD67 expression in the
mPFC (Gilabert-Juan, Nacher, unpublished results). These results
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Fig. 1. (A) Phenotypic characterization of PSA-NCAM expressing puncta in the human dorsolateral prefrontal cortex. Confocal imaging of double-labeled puncta for PSA-NCAM
(in  red) and GAD67 (in green) in layer III of the human dorsolateral prefrontal cortex. Scale bar: 25 m.  (B) Changes in the expression of PSA-NCAM and synaptic markers in
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n which we have found increases in the expression of PSA-NCAM
nd GAD67 [15]. Although we have not observed differences in the
xpression of PSA-NCAM in the amygdala of schizophrenic patients,
ecreases in GAD67 expression were found in its basolateral and
asomedial nuclei [37], in agreement with previous studies show-
ng reduced GAD activity [4] and GABA concentration [30] in this
egion.
The increased expression of VGLUT1 observed in white mat-
er could be related with the higher density of neurons observed
n this region in the brain of schizophrenic patients [8,9], suppor-
ing the hypothesis of alterations in the normal development and
ositioning of cortical neurons in this disorder.isorders: major depression (MD), bipolar disorder (BD) and schizophrenia (SCHZ).
Finally, the samples from bipolar disorder patients displayed
reduction in the expression of VGLUT1 (layer V) and GAD67 (layers
II, III and IV). The explanation for these results is more compli-
cated because bipolar patients have periods of mania followed by
periods of deep depression, which may  result in cyclic changes
in the expression of molecules related to neurotransmission and
neural plasticity, as well as in the structure of neurons in the PFC.
However, the reduction observed in the expression of both excit-
atory and inhibitory contacts indicates that this region is clearly
affected in this disorder.
The limitations of this study are those that are common to
all human post-mortem brain research, which require accounting
for various demographic and clinical variables that may  inﬂuence
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. Conclusions
Synaptic and plasticity markers are altered in the human dorso-
ateral prefrontal cortex of psychiatric disorder patients, showing
hat changes in prefrontocortical networks, specially those involv-
ng interneurons, may  underlie the etiology of these disorders. The
esults point to an impoverishment in the complexity of the cir-
uitry in the prefrontal cortex for all these disorders and, in the case
f schizophrenia, also to an impairment in the plasticity necessary
or normal function.
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ABSTRACT 
 
The alpha-2,8-sialyltransferase II gene (ST8SIAII) map to chromosomal 
region reported as a susceptibility locus to schizophrenia. The promoter region 
of ST8SIAII has been also associated with schizophrenia in different Asian and 
Australian population samples. ST8SIAII encodes an enzyme that catalyzes the 
transfer of polysialic acid to the neural cell adhesion molecule (NCAM), 
regulating finely the function of this molecule which contributes to neuronal 
plasticity. To further support for the involvement of ST8SIAII in the etiology of 
schizophrenia, we carried out a case-control association study with rs3759916, 
rs3759915, rs3759914 and rs2305561 SNPs, in a Caucasian sample of 
Spanish origin, consisting of 508 unrelated schizophrenic patients and 428 
unrelated healthy subjects. In addition, we explored the effect of sex in the 
association between ST8SIAII and schizophrenia, because it has been reported 
that estrogens regulate the post-translational modifications of NCAM by 
controlling the transcription of both polysialyltransferases genes. We did not 
replicate in our sample the positive results found by previous association 
studies using the same SNPs. However when the analysis was carried out 
taking into account the sex of the subjects, the G allele (P = 0.044) and AG 
genotype (P = 0.04) of rs3759916 were significantly associated with the disease 
in the female sample. In the male sample, the ACAG four marker haplotype was 
associated with schizophrenia (P = 0.028). Our study shows ST8SIAII as a 
gene containing susceptibility alleles for schizophrenia with notable differences 
between men and women. 
 INTRODUCTION 
 
The alpha-2,8-sialyltransferases II and IV (st8siaII and st8siaIV) are two  
enzymes that catalyze the transfer of polysialic acid (PSA) to the neural cell 
adhesion molecule (NCAM). These enzymatic activities are crucial in neural 
development, modulating the adhesive properties of NCAM, which are involved 
in cell-cell and cell-extracellular matrix recognition [Rutishauser 2008]. NCAM 
plays important roles in neuronal migration, neurite growth, axon guidance, 
synaptic plasticity [Maness and Schachner 2007], regulation of circadian cues, 
and learning and memory processes [Conboy et al. 2010]. The functions of 
NCAM are fine regulated by the post-translational addition of PSA conferring 
new anti-adhesive properties to the molecule which contributes to neuronal 
plasticity [Rutishauser 2008].  
Different studies in human postmortem samples and in animal models 
have suggested that alterations in PSA-NCAM expression in the Central 
Nervous System (CNS) increases the vulnerability to several psychiatric 
disorders [Barbeau et al. 1995; Gilabert-Juan et al. 2011a; Gilabert-Juan et al. 
2012; Varea et al. 2012]. In addition, the genes coding for both 
polysialyltransferases, ST8SIAII and ST8SIAIV respectively, map to 
chromosomal regions reported as susceptibility loci for schizophrenia and 
bipolar disorders [Maziade et al. 2004; McAuley et al. 2008]. ST8SIAII has been 
also associated to these psychiatric disorders in different studies. In a sample 
from the Japanese population, some single nucleotide polymorphisms (SNPs) 
located in the promoter region of ST8SIAII were associated with schizophrenia 
[Arai et al. 2006]. Moreover, haplotypes constructed with these SPNs and 
others belonging to the same linkage disequilibrium region were associated to 
the disease [Arai et al. 2006]. A similar result was found in a Han Chinese 
sample [Tao et al. 2007] providing further support on the one hand, for the 
potential involvement of this gene in schizophrenia, and on the other hand, that 
an altered level of ST8SIAII expression may be critical, since significant 
association was found with SNPs located in the promoter of this gene. In fact, in 
vitro functional assays showed that a risk promoter haplotype of ST8SIAII has 
significantly higher transcriptional activity than a protective one [Arai et al. 
2006]. Recently, a risk SNP haplotype spanning from 16 kb upstream of 
ST8SIAII to intron 2 was reported in two Australian cohorts suffering from 
schizophrenia and bipolar disorder respectively [McAuley et al. 2012]. 
PSA-NCAM is highly expressed in the CNS during embryonic 
development, being dramatically down regulated after the perinatal period 
[Hildebrandt et al. 1998]. However in adult brains, PSA-NCAM expression is 
 present in several regions where neural plasticity persist, as the hypothalamus, 
the olfactory bulb, the medial prefrontal cortex (mPFC), the hippocampus or the 
amygdale [reviewed in  Bonfanti 2006]. PSA-NCAM expression has been 
associated with different sexual hormones, being the most interesting the 
gonadotropin-releasing hormone (GnRH) [Parkash and Kaur 2005], one of the 
most important molecules in the reproductive life in vertebrates. It has also been 
reported that estrogens regulate the post-translational modifications of NCAM 
by controlling the transcription of both polysialyltransferases genes [Tan et al. 
2009]. Therefore PSA-NCAM may have different impact in brain development 
and maintenance in each sex. Schizophrenia occurs 1.4 times more frequently 
in men than women and typically appears earlier in men [McGrath et al. 2008]. 
The course of the disease is also different between the two sexes, displaying 
premenopausal women a more benign course of disease than men, with less 
severe levels of psychopathology and disability, and with better response to 
antipsychotic medication [reviewed in Kulkarni et al. 2012]. This data suggests 
an important hormonal component in the development of the disease, showing 
a scenario where neural genes, such as ST8SIAII, regulated by sexual 
hormones may contribute to the vulnerability to schizophrenia. 
To further support for the involvement of ST8SIAII in the etiology of 
schizophrenia, we carried out a case-control association study using a sample 
of Spanish origin. Taking into account that this gene is regulated by estrogens, 
we also explored the effect of sex in the association study. 
 
 
 MATERIAL AND METHODS 
 
Subjects 
The sample consisted of 508 unrelated psychotic patients, 185 females 
(36.4%) and 323 males (63.6%) and 428 healthy control subjects, 132 females 
(30.8%) and 296 males (69.2%). Patients came from the psychiatric in-patient 
and out-patient units of the Mental Health Service 4 of the Clinical Hospital, 
University of Valencia, Spain. All patients met DSM-IV criteria for schizophrenia. 
The diagnoses for every patient were confirmed by a consensus meeting with 
the treating psychiatrist and one of the psychiatrists of our research group. 
Patients also had a minimum one-year evolution of the illness and were on 
antipsychotic treatment at evaluation time. The 428 healthy unrelated subjects 
had no history or familial background of psychiatric disorders. To avoid sample 
stratification, these subjects had similar demographic characteristics 
(Caucasian ethnic group, similar age) to the schizophrenic group. They were 
also of Spanish origin. No stratification has been found in the Spanish 
population with the exception of the Canary Islands [Laayouni et al. 2010], 
therefore no allelic differences due to ethnic procedure were expected. Drug 
abuse was also considered among the exclusion criteria. 
All the participants in the study gave their written informed consent to 
participate in this study, approved by the Ethical Committee of Valencia 
University. 
 
SNP Genotyping 
To replicate positive results found between schizophrenia and the 
Sialyltransferase II gene (ST8SIAII) in the Japanese [Arai et al. 2006] and the 
Chinese Han [Tao et al. 2007] populations, three SNPs located in the promoter 
region of ST8SIAII were selected: rs3759914, rs3759915 and rs3759916. In 
addition one SNP, rs2305561, situated in the coding region of ST8SIAII 
affecting the NCAM polysialylation efficiency [Isomura et al. 2011] was also 
analyzed. 
Genomic DNA was isolated from the peripheral blood of patients and 
controls according to standard procedures. SNP genotyping was performed 
through the iPLEX assay on the Mass ARRAY platform (Sequenom, Santiago 
de Compostela, Spain), which allows high throughput genotyping through 
multiplex reactions. Exclusion criteria during quality control of the genotyping 
procedure were the following: (i) Genotyping call rate lower than 99%; (ii) 
Deviations from Hardy-Weinberg Equilibrium (HWE) in the control sample 
(P<0.05). 
  
Statistical Analysis 
QUANTO software v. 1.2.4 [Gauderman 2002] was used to calculate the 
statistical power to find association between the genetic polymorphisms and the 
risk for schizophrenia in our study. This power was 54% to detect a risk allele 
over rare allele frequencies (0.05-0.5) and assuming an odds ratio (OR) of 1.5 
with 95% confidence intervals (CI). We also set the prevalence of schizophrenia 
at 1% and the inheritance model as overdominant. 
Genotypes were assessed for HWE in both patient and control samples 
by applying a χ2 test implemented with SNPator software [Morcillo-Suarez et al. 
2008]. Differences in the allelic and genotypic frequencies between patients and 
controls were evaluated with a χ2 test via SNPator. Bonferroni test for multiple 
comparisons was applied to correct all the reported P-values. 
Regarding the haplotype analysis, haplotypes were constructed with the 
four SNPs and compared between patients and controls using SNPator 
package. Frequencies of the four-marker haplotypes were estimated through a 
retrospective likelihood algorithm and compared between patients and controls. 
A Bonferroni multiple test correction was applied taken into account the number 
of haplotypes in each case.  
 
RESULTS 
 
Table 1 shows the allelic and genotypic frequencies of the ST8SIAII 
polymorphisms analyzed, as well as the P-values obtained from association 
analyses between these polymorphisms and schizophrenia. Whole sample and 
the sample grouped by gender were considered to perform the association 
study. No significant differences in the allelic or genotypic frequencies between 
cases and controls were detected in the total sample. Meanwhile some positive 
results were found when we carried out the analyses taking into account the sex 
of the subjects. At the allelic level, there was a significant association between 
the G allele of rs3759916 and the disease in the female sample (χ2 = 6.514, P = 
0.011; corrected P = 0.044). Among 132 control women none of them has this 
allele, while nine of the 185 women with schizophrenia are G carriers. In the 
male subgroup, a significant association was found with the G allele of 
rs2305561 polymorphism, but this association did not overcome the multiple 
test correction (χ2 = 4 .201, P = 0.04; corrected P = 0.16). Concerning the 
genotypic analyses, the AG genotype of rs3759916 was associated significantly 
 to the disease in women respect to the AA genotype of this SNP (χ2 = 6.609, P 
= 0.01; corrected P = 0.04). As can be seen in Table 1, there were no 
individuals with the GG genotype in our sample. In men, a positive association 
was observed between schizophrenia and the GG genotype respect to CC+CG 
genotypes of rs2305561, but this association was not significant after Bonferroni 
correction (χ2 =3 .966, P = 0.046; corrected P = 0.18). 
 
Haplotype analysis showed no significant differences between cases and 
controls in the total sample. However, we found again positive association when 
the sample was grouped by gender (Table 2). In women, the GCAG haplotype  
covering rs3759916, rs3759915, rs3759914 and rs2305561 was associated to 
the disease, but it lost the statistical significance after Bonferroni correction (χ2 
= 5.018, P = 0.025; corrected P = 0.15). In the men subsample, the ACAG 
haplotype was associated with the disease retaining the significant association 
after multiple test corrections (χ2 = 8.007, P = 0.0047, corrected P = 0.028). 
 
 
DISCUSSION 
 
Schizophrenia is considered as a sexually dimorphic disorder because 
significant differences in the incidence and course of disease between men and 
women are reported [Kulkarni et al. 2012]. Besides gender, many other factors 
are associated with augmented risk to suffer schizophrenia [van Os and Kapur 
2009], although the overall mechanism underlying this disease is poor 
understood. According to the neuro-developmental hypothesis of schizophrenia 
[Weinberger 1996], abnormalities in neural plasticity during certain stages of 
brain development may increase significantly the risk of developing the disease. 
Because PSA-NCAM is a major molecular actor of plasticity of the nervous 
system, it has become an attractive candidate to explore. Even more since 
ST8SIAII and ST8SIAIV, which encode the enzymes that catalyze the transfer 
of PSA to NCAM, are regulated by estrogens [Tan et al. 2009]. ST8SIAII map to 
chromosome 15q25-26, a region reported as including a susceptibility gene for 
schizophrenia [Maziade et al. 2004]. Furthermore, a significant association was 
found between ST8SIAII and the disease in two Asian samples [Arai et al. 2006; 
Tao et al. 2007] and recently in one Australian cohort [McAuley et al. 2012]. 
These associations were found with SNPs located in the promoter region of 
ST8SIAII, suggesting that the dysregulation of the expression of this gene may 
increase the risk to suffer schizophrenia.  
 
 Because no association between ST8SIAII and schizophrenia was 
reported in the Caucasian population, we explored in a Spanish sample the 
involvement of this gene as a risk factor for schizophrenia. A previous attempt 
to replicate in European ancestry samples the significant results found in the 
Australian schizophrenia cohort was not successful [McAuley et al. 2012] 
because data did not reach statistical significance. Nevertheless, we did not 
replicate the positive results found either by Arai et al. [2006] with respect to 
rs3759916 and rs3759914 or by Tao et al [2007] regarding rs3759915 in our 
sample. Differences in the allelic frequencies between the different population 
samples might explain these results. In fact, the alleles associated with 
schizophrenia in each of the two Asian samples, show lower frequencies in the 
Spanish cohort. Alternatively, allelic heterogeneity that characterizes complex 
disease could also explain these discrepancies. However when the association 
analysis was carried out taking into account the sex of the subjects, interesting 
results were found. In the women sample, the G allele (P = 0.044) and the AG 
genotype (P = 0.04) of rs3759916 was significantly associated with 
schizophrenia, suggesting that this allele is a risk factor for the disease in 
females of the Spanish population. Therefore the A allele might be a protective 
factor for schizophrenia in females of this population. In the men subgroup, the 
frequency of the G allele is very similar in healthy controls and in patients 
(1.18% and 0.92% respectively). This was also reported in the Chinese cohort 
with frequencies of 35.6% in controls and 33.9% in patients, so that no 
association was obtained for this SPN in this population [Tao et al. 2007]. It 
would be interesting to know whether in the Chinese population also occur an 
interaction between sex and the polymorphism rs3759916 concerning the 
vulnerability to schizophrenia. This polymorphism is located 200 base-pairs 
downstream from a binding sequence of a glucocorticoid receptor (GR) gene, a 
transcriptional factor implicated in sexual features. 
 
To further confirm the involvement of ST8SIAII in schizophrenia, 
rs2305561 was also genotyped in the Spanish population. This SNP is located 
in the coding region of this gene, concretely in exon 5 [Arai et al. 2006], and 
shows functional significance because each allele has different efficiency of 
NCAM polysialylation [Isomura et al. 2011]. Therefore chain length and quantity 
of NCAM polysialylation could vary depending on the rs2305561 genotype 
affecting its biological function. Nevertheless, no association between 
rs2305561 and schizophrenia has been reported [Arai et al. 2006]. The same 
result was found in our sample, although the G allele and the GG genotype 
were more frequent in the cases than in controls in the male subset. However, 
 this association was lost after the Bonferroni test correction (P = 0.16 and 0.18 
for allelic and genotypic frequencies respectively). Since this test is particularly 
stringent, significance may be lost for this polymorphism that may be a real risk 
factor. In fact, cells expressing the G allele of rs2305561 may have a 
significantly decreased amount of PSA on NCAM when compared with cells 
expressing the C allele [Isomura et al. 2011]. All these results suggest, on the 
one hand, that the G allele of the rs2305561 polymorphism is a likely risk factor 
for schizophrenia and on the other hand, that it has become a risk factor in 
males of the Spanish population. Again it would be interesting to analyze this 
interaction in other populations in order to confirm our results.  
 
The haplotypic study indicated a risk haplotype ACAG in the men sample 
of the Spanish population (P = 0.028), while no haplotypes significantly 
associated with schizophrenia were found in the women sample of this 
population. Interestingly, the risk haplotype reported in Japanese sampled 
population [Arai et al. 2006] share the same alleles at rs3759916, rs3759915 
and rs3759914 positions, although the frequency of the haplotype ACA is lower 
in our sample than in the Japanese one. 
 
In this paper we point out the importance of taking into account the 
gender of the subjects in association studies in mental illness in general and in 
schizophrenia in particular. Several mental disorders affect differently each sex, 
specifically there are more men than women affected in schizophrenia and the 
contrary is observed in depression [Viveros et al. 2012]. Regarding PSA-NCAM, 
a correlation between this molecule and the cells secreting GnRH has been 
demonstrated [Chalivoix et al. 2010]. Furthermore, estrogen is one of the 
transcriptional regulators of both polysialiltransferases genes, ST8SIAII and 
ST8SIAIV [Tan et al. 2009]. Besides ST8SIAII, there are several studies 
pointing out sex differences in other genes involved in schizophrenia [Gilabert-
Juan et al. 2011b; Goes et al. 2010; Hoenicka et al. 2010]. 
 
Finally, we acknowledge that our study has the typical limitations of a 
small sample study. The sample size became reduced when the sample was 
divided by gender decreasing the power of the analysis. Nevertheless we found 
interesting sex-specific associations to schizophrenia in ST8SIAII and we 
replicated partially former studies studying this gene in other populations. Our 
study shows ST8SIAII alleles as a susceptibility factors for schizophrenia with 
notable differences between genders. The role of this gene and the high 
number of interactions that it has with different neuronal pathways suggest 
 polysialiltransferases as attractive molecules to be studied in the field of the 
psychiatric disorders. Deep studies in the global expression mechanisms and in 
the regulation of polysialiltransferases have to be done in order to achieve more 
knowledge about their role in the neurodevelopment and in the brain 
maintenance. 
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 TABLES 
Table1. Allelic and Genotypic Frequencies of the ST8SIAII Polymorphisms analyzed.  
a
Genotype P  value  with the overdominant model of inheritance 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Polymorphisms 
Allele Counts 
(frequency) 
P 
value 
P value 
after 
Bonferroni 
correction 
Genotype Counts (frequency) 
P 
valuea 
P value 
after 
Bonferroni 
correction 
TOTAL 
SAMPLE 
rs3759916 
Schizophrenia 
Control 
A 
1001(0.98) 
849(0.99) 
G 
15(0.02) 
7(0.01) 
0.19 0.76 
AA 
493(0.97) 
421(0.98) 
AG 
15(0.03) 
7(0.02) 
GG 
0(0.0) 
0(0.0) 
0.19 0.76 
rs3759915 
Schizophrenia 
Control 
C 
62(0.06) 
37(0.04) 
G 
954(0.94) 
815(0.96) 
0.091 0.36 
CC 
4(0.01) 
0(0.0) 
CG 
54(0.11) 
37(0.09) 
GG 
450(0.86) 
389(0.91) 
0.066 0.26 
rs3759914 
Schizophrenia 
Control 
A 
1008(0.99) 
854(0.99) 
G 
2(0.002) 
2(0.002) 
0.87 1 
AA 
503(0.99) 
426(0.99) 
AG 
2(0.004) 
2(0.005) 
GG 
0(0.0) 
0(0.0) 
0.87 1 
rs2305561 
Schizophrenia 
Control 
C 
140(0.14) 
140(0.16) 
G 
872(0.86) 
710(0.84) 
0.11 0.44 
CC 
7(0.01) 
6(0.01) 
CG 
126(0.25) 
128(0.3) 
GG 
373(0.74) 
291(0.69) 
0.97 1 
FEMALES 
rs3759916 
Schizophrenia 
Control 
A 
361(0.98) 
264(1.0) 
G 
9(0.02) 
0(0.0) 
0.011 0.044 
AA 
176(0.95) 
132(1.0) 
AG 
9(0.05) 
0(0.0) 
GG 
0(0.0) 
0(0.0) 
0.01 0.04 
rs3759915 
Schizophrenia 
Control 
C 
17(0.05) 
8(0.03) 
G 
353(0.95) 
254(0.97) 
0.33 1 
CC 
2(0.01) 
0(0.0) 
CG 
13(0.07) 
8(0.06) 
GG 
170(0.92) 
123(0.94) 
0.23 0.92 
rs3759914 
Schizophrenia 
Control 
A 
366(0.99) 
264(1.0) 
G 
2(0.005) 
0(0.0) 
0.23 0.92 
AA 
182(0.99) 
132(1.0) 
AG 
2(0.01) 
0(0.0) 
GG 
0(0.0) 
0(0.0) 
0.23 0.92 
rs2305561 
Schizophrenia 
Control 
C 
55(0.15) 
38(0.15) 
G 
311(0.85) 
224(0.85) 
0.85 1 
CC 
5(0.03) 
1(0.007) 
CG 
45(0.25) 
36(0.27) 
GG 
133(0.73) 
94(0.72) 
0.21 0.84 
MALES 
rs3759916 
Schizophrenia 
Control 
A 
640(0.99) 
585(0.99) 
G 
6(0.01) 
7(0.01) 
0.66 1 
AA 
317(0.98) 
289(0.98) 
AG 
6(0.02) 
7(0.02) 
GG 
0(0.0) 
0(0.0) 
0.66 1 
rs3759915 
Schizophrenia 
Control 
C 
45(0.07) 
29(0.05) 
G 
601(0.93) 
561(0.95) 
0.13 0.52 
CC 
2(0.006) 
0(0.0) 
CG 
41(0.13) 
29(0.1) 
GG 
280(0.86) 
266(0.99) 
0.26 1 
rs3759914 
Schizophrenia 
Control 
A 
642(1.0) 
590(0.99) 
G 
0(0.0) 
2(0.003) 
0.14 0.56 
AA 
321(1.0) 
294(0.99) 
AG 
0(0.0) 
2(0.007) 
GG 
0(0.0) 
0(0.0) 
0.14 0.56 
rs2305561 
Schizophrenia 
Control 
C 
85(0.13) 
102(0.17) 
G 
561(0.87) 
486(0.83) 
0.04 0.16 
CC 
2(0.006) 
5(0.02) 
CG 
81(0.25) 
92(0.31) 
GG 
240(0.74) 
197(0.67) 
0.046 0.18 
 Table 2. ST8SIAII haplotypes significantly associated to schizophrenia in the Spanish 
population sample. 
 
 
 
Haplotype Frequency  
rs3759916 rs3759915 rs3759914 rs2305561 Control Schizophrenia 
P 
value 
P value after 
Bonferroni 
correction 
FEMALES G C A G 0% 1.89% 0.025 0.15 
MALES A C A G 0.92% 3.56% 0.0047 0.028 
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CHRONIC STRESS MODEL 
 
In the first and second articles, a model of chronic stress was performed 
based on one of the most accepted strategy to generate chronic anxiety and 
depression models. The stressor consisted in the immobilization of mice for 1 
hour per day during 21 days. Transgenic mice expressing GFP in a subset of 
inhibitory neurons (GIN mice) were used. In these animals we have studied by 
means of qRT-PCR the expression of several genes related to inhibitory 
transmission and of PSA synthesizing enzymes. The expression of GAD67, 
synaptophysin and PSA-NCAM was also studied in Medial (Me), CentroMedial 
(CeM) and BasoLateral (BLa) amygdaloid nuclei using immunohistochemistry. 
Furthermore, we have analyzed the dendritic arborization and the density of 
dendritic spines of interneurons in the BLa nucleus of the amygdala and in the 
mPFC. The number of GAD67 and PSA-NCAM expressing somata was also 
estimated in the mPFC.  
 
The analysis showed that chronic stress did not induce changes in body 
weight gain in our model. Considering the whole amygdala, mRNA expression 
analysis revealed a reduced expression of St8SiaII and GAD67 genes. These 
alterations were in contrast with those found in the mPFC, were we found an 
increase in the expression of NCAM, synaptophysin and GABAAα1 genes. PSA-
NCAM expression was significantly reduced in the CeM nucleus, GAD67 and 
synaptophysin in the Me nucleus. Finally, chronic stress also reduced dendritic 
arborization in amygdala GAD-GFP expressing interneurons, while increasing 
it in the mPFC. No changes in dendritic spine density were found in GAD-GFP 
expressing interneurons in any of these two regions. 
 
The present results in mice confirm previous studies on the effects of 
chronic stress on amygdaloid PSA-NCAM expression in rats and expand them 
studying the expression of the enzymes responsible of its polysialylation. These 
effects on PSA-NCAM expression are paralleled by changes in molecules 
related to inhibitory transmission, but not by structural changes in amygdaloid 
interneurons. For the mPFC, the results show that interneurons in the mPFC of 
adult mice undergo dendritic remodeling after chronic stress. This remodeling 
is accompanied by significant changes in the number of neurons expressing 
GAD67 and in the expression of different molecules related to inhibitory 
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neurotransmission and neuronal plasticity. Apparently, the decrease in GAD67 
expressing neurons is not due to apoptosis but to changes in the expression of 
this GABA synthesizing enzyme.  
 
Therefore, our studies support the idea that inhibitory networks in the 
mPFC are also targets of chronic stress and that their alteration may also 
contribute to the behavioral and cognitive impairments induced by this 
aversive experience. 
 
PSA-NCAM is implicated in the response to chronic stress in the amygdala 
The distribution of PSA-NCAM expression in the amygdala and mPFC 
of GIN mice is similar to that described previously in a different mouse strain 
(Nacher et al., 2010) and in rats (Nacher et al., 2002b). As it has been 
demonstrated for many PSA-NCAM expressing structures in the cerebral cortex 
(excluding those of immature neurons) (Gomez-Climent et al., 2011; Nacher et 
al., 2002a; Nacher et al., 2002b;  Varea et al., 2005), many PSA-NCAM 
expressing neurons in the amygdala express markers of interneurons and lack 
expression of molecules exclusively found in principal neurons. Consequently, 
changes in PSA-NCAM expression should primarily affect the structure of 
interneurons, rather than that of principal neurons. It is possible then, that the 
stress-induced reductions in PSA-NCAM expression showed by this study in 
the amygdala affect the connectivity of certain amygdaloid interneurons, 
leaving more plasma membrane extension free for the establishment of new 
synaptic contacts. Another non-excluding possibility is that, given its anti-
adhesive properties, the reduction in PSA-NCAM expression may limit the 
ability of certain interneurons to remodel their structure in response to different 
stimuli. However, it is possible that these structural changes occur in an earlier 
time window during the stress procedure, in which changes in PSA-NCAM 
expression occur in a different direction, or only in certain amygdaloid nuclei 
and, consequently, we may have missed them studying the amygdala as a 
whole. The influence of PSA-NCAM on amygdaloid interneurons may also 
occur by the interference of the PSA in certain signaling cascades mediated by 
NCAM, especially those affecting inhibitory circuits (see Maness and 
Schachner, 2007;  Rutishauser, 2008 for review). Future experiments 
manipulating PSA-NCAM expression are needed to understand whether this 
molecule plays a role in the remodeling of amygdaloid interneurons. 
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Our results also suggest that the decrease in polysialylation detected in 
the amygdala after chronic stress may be caused by the observed 
downregulation of polysialyltransferase St8SiaII expression, since St8SiaIV 
mRNA levels are not affected. These results are interesting, because the analysis 
of single polysialyltransferase knockout mice revealed that most PSA-NCAM 
expressing structures in the amygdala of adult control mice are polysialylated 
by St8SiaIV (Nacher et al., 2010). However, it is possible that, although St8SiaIV 
may function as the “main” polysialyltransferase in the amygdala during 
normal circumstances, St8SiaII may take care of the addition of PSA to NCAM 
when the system is challenged, for instance by stress. The observed reductions 
in PSA-NCAM expression in the amygdala after chronic stress must have 
consequences on behaviors dependent on this cerebral region. In fact, previous 
studies in naive rodents with reduced PSA-NCAM expression indicate a 
potentiation of amygdala-dependent behaviors: PSA depletion in the amygdala 
of rats results in enhanced fear extinction (Markram et al., 2007) and St8SiaII 
knockout mice displayed increased aggression (Calandreau et al., 2010). 
 
Regarding the mPFC, the present results indicate that PSA-NCAM is not 
directly implicated in the changes we have described in this region. First, the 
GAD67-EGFP expressing interneurons in which the structural features have 
been analyzed did not show PSA-NCAM expression in their somata, neurites or 
in the puncta located in their projection fields in layers I and II. This absence of 
PSA-NCAM expression has been observed both in control and in chronically 
stressed mice. Second, no changes in the number of PSA-NCAM expressing 
cells or in the expression of the mRNA of polysialyltransferases have been 
observed after chronic stress. It is, however, possible that changes in PSA-
NCAM expression in the mPFC occur before 21 days of chronic stress in 
interneuronal populations different from the one studied in the present study. 
 
Synaptophysin is altered under the stress conditions   
There are no previous reports showing changes in synaptophysin 
expression or in synaptic density in the amygdala after chronic stress. Our 
finding of a reduction in synaptophysin expression in the medial amygdala 
may indicate a reduction in active synapses, because the expression of this 
synaptic vesicle membrane protein is linked to synaptic remodeling (Greengard 
et al., 1993) and it is considered a reliable index of synaptic density (Eastwood 
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and Harrison, 2001;  Masliah et al., 1990). Since this decrease coincides with the 
previously reported reduction in dendritic spine density in principal neurons of 
the medial amygdala (Bennur et al., 2007), it is possible that some of the lost 
synapses corresponded to those established on the lost spines. However, we 
have not observed increases in synaptophysin expression in the basolateral 
amygdala, where the density of spines in principal neurons is increased after 
chronic stress (Mitra et al., 2005). Another possibility is that the synapses that 
disappear after stress were inhibitory. This would be in agreement with the 
parallel reductions observed in GAD67 expressing elements in the medial 
amygdala. In fact, different studies have demonstrated that stress can induce 
amygdala activation, affecting inhibitory neurotransmission, which in turn has 
an important role in stress-induced synaptic plasticity (Davis et al., 1994). 
Moreover, an inverse relationship has been found between inhibitory tone and 
behavioral anxiety in the basolateral nucleus of the amygdala (Roozendaal et 
al., 2009). In fact, electrophysiological experiments in amygdala slices have 
shown that stress levels of corticosterone can reduce inhibitory 
neurotransmission and increase the excitability of principal amygdaloid 
neurons (Duvarci and Pare, 2007). However, these results and our findings on 
the expression of molecules related to inhibitory neurotransmission are 
apparently in contrast with reports of a reduced response of the amygdala to 
corticotropin releasing factor (CRF) after chronic stress (Sandi et al., 2008). CRF 
increases the excitability of principal neurons in the BLA (Rainnie et al., 1992) 
and, consequently, a reduced response to this factor may result in decreased 
excitability. Further analyses evaluating the expression of CRF and their 
receptors in relation to inhibitory neurotransmission during stress are necessary 
to understand these complex interactions. 
 
Regarding the alterations in synaptophysin expression in the mPFC, it is 
important to note that although a previous report has failed to find changes in 
the levels of this synaptic protein (Carvalho-Netto et al., 2011), a significant 
increased expression of the SYN gene in the total mPFC has been found in this 
thesis. This difference may be due to the fact that Carvalho-Netto et al. studied 
the whole PFC, while we only focused in its medial region. In fact, the effects of 
chronic stress on the structure of pyramidal neurons in the orbitofrontal cortex, 
another region of the prefrontal cortex, are opposite to those in the mPFC 
(Liston et al., 2006) and this may mask the overall results in synaptophysin 
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expression. However, detailed studies on the synaptic input of pyramidal and 
inhibitory neurons must be performed to shed light on this intricate matter. 
 
The chronically stressed mice show changes in the expression of molecules 
related to inhibitory transmission 
The changes in GABAergic neurotransmission described in this thesis 
were only restricted to GAD67 expression in the amygdala, whereas in the 
mPFC they affected the numbers of GAD67 and GAD67-EGFP expressing 
somata, GABAAα1 mRNA expression but not to GAD67 expression. 
 
The effects observed in GAD67 expression in the amygdala may be 
mediated by the monoaminergic system, since it is known that stress enhances 
the release of monoamines in the amygdala (Goto et al., 2007; Maier and 
Watkins, 2005) and these monoamines, in turn, affect amygdaloid inhibitory 
circuits (Braga et al., 2004; Marowsky et al., 2005). The stress-induced changes 
in the expression of GAD67 in the amygdala occur in parallel to the 
downregulation of PSA-NCAM expression. Changes in PSA-NCAM expression 
may promote remodeling of inhibitory circuits, which may lead to the observed 
decrease in GAD67 expression.  
 
A previous report has described increases of GAD65 or GAD67 mRNAs 
in the hippocampus after chronic immobilization stress (Bowers et al., 1998), but 
we have not found differences in the expression of these mRNAs in this thesis. 
It is possible that changes in mRNA expression occur before 21 days, since the 
study of Bowers et al., used a 15 days paradigm. On the other hand, previous 
studies, found decreased GABA levels measured with HPLC in the PFC after 3 
weeks of chronic mild stress (Shalaby and Kamal, 2009). A previous report has 
also found a decrease in the number of parvalbumin cells in the hippocampus 
of tree shrews after chronic stress (Czeh et al., 2004). Another possible 
explanation for the decrease in GAD67 expressing interneurons found in our 
study may be cell death. In fact, a previous study found that the number of 
apoptotic cells was increased in the cerebral cortex and the hilus of adult tree 
shrews after chronic psychosocial stress (Lucassen et al., 2001) and this has been 
suggested as an explanation for the loss of hippocampal parvalbumin 
expressing cells (Czeh et al., 2004). However, we find this possibility unlikely, 
unless it occurred sooner during the stress procedure, since we have not found 
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evidences of apoptosis or of degenerated interneurons in our material. In other 
way, it may occur an overactivation of a subpopulation of interneurons and the 
consequent inhibition of excitatory neurons and other subpopulations of 
interneurons. Our results in the mPFC showing a decrease in the number of 
GAD67 and GAD67-EGFP expressing somata suggest an imbalance in the 
expression of this GABA synthetizing enzyme. 
 
The analysis of the molecules related to inhibitory neurotransmission by 
qRT-PCR in the mPFC has only found a significant increase in the expression of 
the GABAAα1 receptor gene. The function of this receptor appears to be 
necessary to mediate the effects of chronic stress in the structural remodeling of 
principal neurons, at least in the hippocampus, because treatment with specific 
agonists prevents dendritic atrophy in CA3 pyramidal neurons (Magarinos et 
al., 1999). It may be possible that the increase in expression of GABAA receptor 
constitutes an adaptive response directed to augment the function of these 
receptors and to counteract deleterious effects of stress on mPFC circuitry. This 
response may also counteract the decreased binding to GABAA receptors 
described after chronic stress in rodents (Gruen et al., 1995) and in post-
traumatic stress disorder (PTSD) patients (Bremner et al., 2002; Geuze et al., 
2008).  
 
Our results in the mPFC show an increase in the expression of NCAM 
mRNA after chronic stress. A similar study did not find changes in this 
parameter in the PFC using in situ hybridization, although it described a 
reduction of NCAM mRNA in the hippocampus (Venero et al., 2002), a region 
where decreases in NCAM protein expression have also been reported after 
chronic stress (Sandi et al., 2001). However, it has to be taken into account that 
these measures were obtained in the whole prefrontal cortex and not only in the 
mPFC as in our study. The increase in NCAM expression after chronic stress 
may lead to increased cell adhesion and it can influence the different 
intracellular signaling cascades mediated by this protein (Maness and 
Schachner, 2007). This increase in NCAM expression may have a 
neuroprotective role against the effects of stress, since reduced levels of this 
protein have been found to increase the vulnerability to behavioral alterations 
induced by this aversive experience: NCAM heterozygous mice (Jurgenson et 
Results and Discussion · 167 
 
 
 
al., 2012) and conditional NCAM-CAMKII mice (Bisaz and Sandi, 2012) display 
increased immobility in the tail suspension test. 
 
The effects of chronic stress in mPFC interneuron structure are opposite to those 
found in the basolateral amygdala 
 This aversive experience induces opposite effects on the structure of 
principal neurons in these two regions (Radley et al., 2004; Vyas et al., 2002). In 
this thesis opposite effects have also been observed in interneurons: a 
significant reduction in dendritic arborization in interneurons of the basolateral 
and lateral amygdala and a significant increase in the dendritic arborization of 
mPFC interneurons. This is, to our knowledge, the first report describing 
dendritic remodeling in interneurons after chronic stress. All the previous 
studies have been focused on the structure of principal neurons. Particularly, in 
the basolateral amygdala, chronic stress induces dendritic hypertrophy of 
stellate and pyramidal neurons (Vyas et al., 2002), and a chronic stress 
paradigm similar to that used in our study induces dendritic atrophy and 
reductions in spine density in pyramidal neurons of mPFC of rats (Radley et al., 
2004). However, we have not found differences in spine density in the 
subpopulation of interneurons studied in the mPFC or amygdala suggesting 
that the structure of these postsynaptic elements is not affected by this stress 
paradigm in this interneuron subpopulation.  
 
 The dendritic growth of principal neurons in the basolateral amygdala 
has been interpreted as a structural strengthening of excitatory 
neurotransmission, which may represent a cellular substrate for enhanced 
anxiety (Roozendaal et al., 2009). In the same way, the retraction of the 
dendrites of interneurons, which may also reduce inhibition on principal cells, 
can also contribute to this strengthening of excitatory neurotransmission. 
Unfortunately, we have not been able to study interneuron structure in the 
centromedial nucleus, where significant changes in PSA-NCAM expression 
have been detected, because very few interneurons express GFP in this nucleus 
in GIN mice. The atrophy of pyramidal neurons in the mPFC has been 
interpreted as a structural weakening of excitatory neurotransmission, which 
may represent an adaptive cellular substrate for responding to the increase in 
excitatory neurotransmission elicited during the first phases of stress (Lowy et 
al., 1995). In fact, the dendritic atrophy of principal neurons in the hippocampus 
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after chronic stress is paralleled by a decrease in the density of excitatory 
synapses on these cells (Sousa et al., 2000; Sandi et al., 2003). 
 
 It is tempting to interpret the hypertrophy of the dendrites of mPFC 
interneurons, as another attempt of mPFC circuitry to minimize this 
overexcitation. An increased dendritic surface may favor the formation of 
synaptic contacts on mPFC interneurons. However, we do not know yet 
whether new synapses are established on this expanded dendritic surface and, 
if so, whether they are excitatory or inhibitory. Solving these questions is 
essential to understand what is the role of the stress-induced interneuronal 
remodeling. It is also very important to determine the sequence of the events 
that lead to the scenario that we observe after 21 days of stress: Is the 
interneuronal hypertrophy subsequent to the decrease in inhibitory 
neurotransmission suggested by the reduction in the number of GAD67 and 
GAD67-GFP expressing somata or viceversa? Are these two independent 
phenomena? Do changes in interneuron structure in the mPFC occur before, 
simultaneously or after the changes described in pyramidal neuron structure? 
Although, obviously, further experiments analyzing different time points along 
the chronic stress are necessary to elucidate these questions, it is interesting to 
note that a recent study by Keck et al. (2011) suggests that structural changes in 
inhibitory neurons may precede structural changes in excitatory circuitry in the 
visual cortex following sensory deprivation.  
 
Our analysis of the phenotype of enhanced green fluorescence protein 
(EGFP) expressing neurons in the mPFC of GIN mice reveals that they belong 
exclusively to those expressing somatostatin. According to a recent report (Xu 
et al., 2010), the interneurons analyzed structurally in our study cannot be 
chandelier or basket cells, which always express parvalbumin. Since most of the 
neurons in the mPFC of GIN mice are located in layers II, III and upper V, and 
their axons arborize profusely in superficial layers, we are confident that most 
of them have to be Martinotti cells, as it has previously suggested in the 
somatosensory cortex of this strain of transgenic mice (Ma et al., 2006). 
Martinotti cells can also express calbindin and calretinin in addition to 
somatostatin and they never express NPY or parvalbumin (Xu et al., 2010). 
Martinotti cells are interneurons whose axons mainly target the apical dendritic 
tree of pyramidal neurons (Markram et al., 2004) and, interestingly, this apical 
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region is the one that shows the dendritic retraction after chronic stress (Radley 
et al., 2004). Consequently, the dendritic hypertrophy that we observe in these 
interneurons may be related to the shrinkage of the apical region of pyramidal 
neurons. However, studies directed to evaluate structural remodeling in the 
axonal projection of EGFP expressing interneurons in superficial layers are 
needed to understand their relationship to the dendritic atrophy of principal 
neurons. 
 
Chronic stress in experimental animals is one of the most accepted 
models of chronic anxiety and depression (McEwen, 2000) and there is a clear 
link between prefrontal cortex and amygdala dysfunction with mood disorders, 
such as major depression (Brody et al., 2001) or posttraumatic stress disorder 
(Bremner, 2005). Consequently, the present results may increase our 
understanding of the molecular and structural plasticity associated to the 
development of anxiety and mood disorders. This plasticity may be a substrate 
for the increases in anxiety-like behaviors, cognitive changes and mood 
alterations observed in this animal model and in these psychiatric disorders. In 
fact, several lines of evidence coming from both animal and human studies 
indicate the involvement of the GABAergic system in the pathophysiology of 
major depression (Krystal et al., 2002; Sanacora et al., 1999). Neuroimaging 
studies have reported reductions in GABA levels in the prefrontal cortex 
(Hasler et al., 2007; Sanacora et al., 1999). Reduced GABA concentrations were 
also demonstrated in the plasma and cerebrospinal fluid in depression 
(Brambilla et al. 2003) and GAD67 protein expression was significantly reduced 
in depressed subjects (Karolewicz et al., 2010). Moreover, similar to what we 
have found in our chronically stressed mice, post-mortem morphometric 
analyses in major depression patients have found reductions in the density and 
size of GABAergic interneurons immunoreactive for calbindin (Rajkowska et 
al., 2006) and calretinin (Oh et al., 2012) in the PFC. Table 4 summarizes the 
main results obtained in this thesis about the chronic stress model. 
 
 Table 4. Summary of results in the chronic stress model 
Stress PSA-NCAM(+) Arborization Spines Gene expression 
Protein 
density Somata 
amygdala 38% decrease = ↓St8SiaII, GAD67 
↓PSA-NCAM, 
GAD67, SYN  
mPFC No increase = ↑NCAM, SYN, GABAAα1  
↓GAD67 
=PSA-NCAM 
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ISOLATION AND DUAL SCHIZOPHRENIA MODELS 
 
In the third article the expression of molecules related to inhibitory 
neurotransmission and structural plasticity was studied in rats subjected to 
post-weaning isolation rearing, an animal model that reproduces several core 
symptoms of schizophrenia. The expression of PSA-NCAM, NCAM, 
synaptophysin, GAD67, GAD65, St8SiaII and St8SiaIV was studied using qRT-
PCR and immunohistochemistry. 
 
An  increased expression of GAD67 was found in the three amygdaloid 
nuclei, Me, CeM and BLa, and the same increase was observed in the expression 
of PSA-NCAM in the BLa nucleus, without detectable changes in 
synaptophisin, NCAM or GAD65 expression. The mRNA measures did not find 
significant changes in any of the studied genes (GAD67, GAD65, SYN, NCAM, 
St8SiaII, St8SiaIV).  
 
There is an overexpression of inhibitory molecules in the amygdala of social 
isolation rats 
Very few studies have analyzed the expression of molecules related to 
synaptic transmission in the amygdala of isolation-reared rodents. This thesis 
shows that the expression of GAD67, but not GAD65, protein was increased in 
different amygdaloid nuclei in isolation-reared rats. By contrast, no differences 
were found in mRNA expression, which may be due to the masking effect of 
total GAD67 mRNA when using whole amygdala extracts. Our findings are in 
agreement with those of a recent study, which did not find differences in 
GAD65 protein expression in the amygdala of isolation-reared Sprague–Dawley 
rats (Lim et al., 2011). The present results indicating an increase in GAD67 
expression are in contrast with those reported in the amygdala of human 
schizophrenic patients. These postmortem studies showed reduced GAD 
activity (Bird et al., 1977), GABA concentration (Spokes et al., 1980) and GAD67 
expression (Varea et al., 2012), which are consistent with an increased activation 
of the amygdala in schizophrenia. Consequently, we should be cautious when 
using isolation-reared rats as an animal model of schizophrenia, because while 
some of its features may correspond to those observed in human patients, some 
of them may be substantially different. 
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Also in agreement with Lim et al. (2011), no differences in the expression 
of synaptophysin were found in the amygdala of isolation-reared animals. 
These results are also consistent with previous studies describing no differences 
in the number of synapses in the medial amygdala (Ichikawa et al., 1993). 
 
The differences in PSA-NCAM expression observed in our study may be 
related to structural changes in neurons, given the anti-adhesive properties of 
this molecule (Rutishauser, 2008; Sandi, 2004). However, this structural 
plasticity should be limited initially to interneurons, because, as it has been 
demonstrated for many PSA-NCAM expressing structures in the cerebral cortex 
(excluding those of immature neurons) (Gomez-Climent et al., 2011; Nacher et 
al., 2002a;  Varea et al., 2005), many PSA-NCAM expressing neurons in the 
amygdala express markers of interneurons and lack expression of molecules 
exclusively found in principal neurons as it has been described in the stress 
model study. Consequently, changes in PSA-NCAM expression should 
primarily affect the structure of interneurons, rather than that of principal 
neurons. In this line, it has been recently reported in our laboratory that PSA-
NCAM expressing cortical interneurons have reduced synaptic input and 
decreased dendritic arborization and spine density when compared with 
neighboring interneurons lacking PSA-NCAM (Gomez-Climent et al., 2011). It 
is possible then, that the increases in PSA-NCAM expression observed in the 
present thesis affect the connectivity of certain amygdaloid interneurons, 
leaving less plasma membrane extension free for the establishment of synaptic 
contacts. Whether these changes in PSA-NCAM expression are related to the 
increase in GAD67 expression still remains to be explored. Another non-
excluding possibility is that, given its anti-adhesive properties, the increase in 
PSA-NCAM expression may facilitate the structural remodeling of certain 
interneurons in response to different stimuli. 
 
It is interesting to note that the increase in PSA-NCAM expression is only 
significant in the basolateral amygdala, a region considered critical in the 
pathophysiology of schizophrenia (Benes, 2010). This increase in PSA-NCAM 
expression may be due to an increase in the polysialylation of pre-existing 
NCAM molecules, because an increment of this protein was only found in the 
medial amygdala of the isolation-reared rats. However, no parallel increments 
in any of the two NCAM polysialyltransferases were detected, which may mean 
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that the increased polysialylation of NCAM in the basolateral amygdala has 
occurred at an earlier age. 
 
The present results indicate that discrete but significant changes occur in 
the amygdala of isolation-reared rats, involving molecules related to structural 
plasticity and inhibitory neurotransmission. However, the direction of these 
differences is not similar to that observed in schizophrenic patients. 
Consequently, although this paradigm has been confirmed as a suitable model 
to study schizophrenia, because it reproduces some of its core defects (Fone and 
Porkess, 2008), it also may present some differences, which should be taken into 
account and explored further when establishing comparisons. 
 
The dual model of schizophrenia has weight alterations, volume reductions of 
mPFC and hippocampus and an increase of immature neurons in the hippocampus 
In this thesis we have also developed a “double hit” animal model of 
schizophrenia using the same rat strain, combining both, isolation and N-
methyl-D-aspartate (NMDA) receptor blockade during perinatal development. 
We have described an increased weight gain in rats reared in isolation 
compared to those reared in groups, indicating an effect of the housing. These 
results are in agreement with previous studies, which reported similar changes 
in female Sprague Dawley rats (Hermes et al., 2011; Ness et al., 1995). Although 
we have not found changes in body weight in adulthood induced by the 
perinatal MK-801 injection, treated rats showed less weight when weighed at 
P21. This is in accordance with other reports using different perinatal MK-801 
treatments, which have consistently found transient lower body weights that 
normalized in adolescence or in adulthood (Stefani and Moghaddam, 2005; Su 
et al., 2011).   
 
In regard to volumetric changes, our results are in agreement with 
previous reports describing a decrease in mPFC volume in Lister Hooded rats 
reared in isolation (Day-Wilson et al., 2006; Schubert et al., 2009). Our study 
expands these previous findings, showing that the volume changes in the 
mPFC appear to be due to reductions in the prelimbic and infralimbic cortices, 
but not in the cingulate cortices. Another interesting result of the present thesis 
is that the hippocampal volume was also reduced in the “double hit” model, 
although we found that this effect was only caused by the MK-801 injection. 
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These volumetric reductions in the “double hit” model are extremely important, 
because they are very similar to those found consistently in schizophrenia 
(Levitt et al., 2010; Yoshida et al., 2011).  
 
One aspect of structural plasticity, which may be relevant to the 
hippocampus, is the presence of alterations in adult neurogenesis. Although 
these alterations are far from explaining the etiology of schizophrenia, they may 
contribute to the hippocampal aspects of this disorder (Kempermann, 2011). A 
study in adult human postmortem tissue has found reduced amounts of 
proliferating cells in the hippocampus of schizophrenic patients (Reif et al., 
2006). This is in contrast with our results in the “double hit” model, showing an 
increase of immature granule neurons (due to social isolation rearing) and no 
changes in the number of proliferating cells. These results may appear to be in 
conflict with those found in schizophrenic patients. However, it has to be noted 
that a significantly higher incidence of granule cells with basal dendrites has 
been found in these human brains (Lauer et al., 2003) and that the presence of 
basal dendrites has been described as a characteristic of immature granule cells, 
at least in rodents (Nacher et al., 2001; Shapiro et al., 2005). 
 
Inhibitory neurotransmission is also altered in the “double hit” model 
Several lines of evidence point to alterations in inhibitory circuits as one 
of the main factors to explain the neurobiological basis of schizophrenia (Benes 
and Berretta, 2001; Lewis et al., 2005). Reduced expression of the GAD67 mRNA 
in the PFC (Akbarian et al., 1995; Guidotti et al., 2000, Hashimoto et al., 2007; 
Torrey et al., 2005) and the hippocampus (Thompson Ray et al., 2011) is one of 
the most consistent findings in postmortem studies of individuals with 
schizophrenia. Similar decreases in GAD67 protein expression in the PFC and 
the hippocampus of schizophrenics have been found (Torrey et al., 2005), 
including those reported in the fourth article of this thesis. The results of this 
model partially agree the findings in schizophrenic brains, showing a 
significant decrease of GAD67 protein expression in layers V and VI of the 
mPFC, although no changes were detected in the hippocampus. However we 
did not detect differences in the level of GAD67 mRNA, suggesting a tissue-
specific posttranscriptional regulation mechanism or mRNA downregulations 
prior to the age at which our animals were sacrificed. The alterations in mPFC 
GAD67 protein expression were present in the “double hit” model, although 
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they were induced only by MK-801 perinatal injection. Interestingly, previous 
reports using perinatal treatments with NMDA receptor antagonists have failed 
to find significant differences in GAD67 expression (Facchinetti et al., 1993). It is 
possible that this discrepancy with the present results may be due to differences 
in the strain (Wistar) or the dosis/duration of the treatment (chronic treatment 
for 22 days) used by Facchinetti et al. (1993).  
 
Schizophrenia is associated with different alterations in certain 
interneuronal subpopulations, specially parvalbumin expressing cells, which 
may have an important impact on the physiology of pyramidal cells (see Lewis 
et al., 2012 for review). The number of parvalbumin expressing interneurons 
does not appear to be reduced in schizophrenic patients, at least in the PFC, but 
they exhibit reduced expression of parvalbumin mRNA and lower density of 
parvalbumin expressing puncta in certain layers, among other abnormalities at 
the presynaptic and postsynaptic level (see Beneyto and Lewis, 2011 for 
review). The “double hit” model developed in this thesis also shows alterations 
in parvalbumin expressing cells in the mPFC. The number of these interneurons 
is reduced significantly in the infralimbic cortex, although trends toward 
decreases were also found in the rest of regions studied. This effect was due to 
MK-801 treatment, as well as to the interaction of the two hits and it is in 
accordance with previous reports describing similar reductions after acute 
perinatal treatment with MK-801 (Coleman et al., 2009; Wang et al., 2007). It is 
probable that this reduction in the number of parvalbumin expressing cells is 
due to the extensive cell death caused by the perinatal NMDA antagonist 
administration during perinatal development (see Lim et al., 2012 for review). 
However, we have not found evidence of cell death at the time of sacrifice. 
Although we have not found alterations in the expression of parvalbumin 
mRNA in the present study, we have observed differential changes in calbindin 
and calretinin expression, which certainly make necessary future experiments to 
evaluate more closely the subpopulations of interneurons expressing these 
calcium binding proteins. Although apparently the calretinin subpopulation is 
not affected in schizophrenic patients, the calbindin subpopulation may be 
altered (see Lewis and Hashimoto, 2007 for review). 
 
Our study on the expression of c-Fos in the mPFC also gives support to 
the idea that prefrontocortical inhibition is decreased in the “double hit” model 
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and, consequently, this may lead to an excessive activation of excitatory 
neurotransmission, since we have found an increase in the expression of this 
marker of cell activity in the nuclei of pyramidal neurons. Interestingly, the 
increase in c-Fos expression is found in the same region, the prelimbic cortex, 
where a significant reduction in parvalbumin expressing interneurons has been 
observed. 
 
Although our results show an interaction, which prevents the 
observation of changes in ErbB4 mRNA in the “double hit” model, we still find 
very interesting that social isolation alone is capable of decreasing ErbB4 
expression. This is the first report describing this decrease in the social isolation 
schizophrenia model. ErbB4 and its ligand Nrg1 have been described as risk 
genes for schizophrenia (Buonanno, 2010; Norton et al., 2006) and their 
signaling controls the development of inhibitory cortical networks, regulating 
the connectivity of certain interneuronal populations, particularly parvalbumin 
expressing basket and chandelier cells (Fazzari et al., 2010). Consequently, 
alterations in ErbB4 during postnatal development and adolescence may 
interfere with the final establishment of cortical connectivity, specially 
connectivity involving inhibitory neurons. In addition, we found a similar 
decrease in PSA-NCAM and GAD67 expression in the deep layers (V and VI) of 
the mPFC in the “double hit” model. These results, in connection with those 
described above, provide a putative link between changes in inhibitory 
neurotransmission and structural plasticity. Changes in PSA-NCAM expression 
also occur in parallel to the stress-induced dendritic remodeling of 
interneurons, at least in the amygdala, as it has been described above. 
Moreover, the reductions in PSA-NCAM and GAD67 expression observed in 
the “double hit” model are similar to those found in the mPFC of schizophrenic 
patients. No changes in the expression of NCAM or that of the 
polysialyltransferases have been found, suggesting that this cell adhesion 
molecule is apparently unaffected in this model and that changes in the 
expression of the enzymes responsible for the addition of PSA to NCAM may 
have occurred previously to sacrifice or that the reduction of PSA-NCAM is due 
to other factors, such as an enhancement of its removal from the plasma 
membrane. 
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Although many of the parameters analyzed in the present study appear 
to act through independent mechanisms, we find that, using their combination, 
this “double hit” model can be a very valuable experimental tool to mimic a 
wider spectrum of specific symptoms and alterations in schizophrenia, specially 
those affecting inhibitory neurotransmission, and to serve as a testing platform 
for novel treatments directed to this devastating disorder. Table 5 summarizes 
the results obtained in the two studied models of schizophrenia. 
 
     Table 5. Summary of results in the two schizophrenia models. 
Schizophrenia 
models Volume 
CaMKII 
(c-Fos +) DCX(+) 
PV (+) 
Somata 
Gene 
Expression 
Protein  
Density 
amygdala -- -- -- -- = 
↓GAD67 
↓PSA-NCAM 
↓NCAM 
mPFC ↓ ↑ -- ↓IL 
↑CB 
↓CR 
↑↓ErbB4 
↓GAD67 
↓PSA-NCAM 
hippocampus ↓ -- ↑  = ↓PSA-NCAM 
 
 
 
STUDIES IN HUMAN SAMPLES 
 
The article “Alterations in the expression of PSA-NCAM and synaptic 
proteins in the dorsolateral prefrontal cortex of psychiatric disorder patients” is 
an analysis of post-mortem sections of the dorsolateral PFC samples from the 
Stanley Neuropathology consortium, which includes controls, schizophrenia, 
bipolar and major depression patients. The aim of this study is to find potential 
alterations in the expression of PSA-NCAM, GAD67, SYN and vesicular 
glutamate transporter 1 (VGLUT1) proteins.  
 
In the human PFC PSA-NCAM is expressed in interneuronal somata and 
in neuropil elements belonging to interneurons. The analysis of PSA-NCAM 
and GAD67 expression in the material of the Stanley Neuropathology 
consortium revealed that the expression of both molecules were reduced in 
schizophrenic patients, while an increase in the expression of VGLUT1 was 
found in the white matter. Depressed patients showed a decrease in SYN and 
VGLUT1 expression. By contrast, bipolar disorder patients showed a reduction 
in VGLUT1 and GAD67 expression. 
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Major depression patients have a reduction in the expression of excitatory 
markers 
The reductions in SYN and VGLUT1 expression found in the mPFC of 
major depression patients seem to be in accordance with the dendritic atrophy 
of mPFC pyramidal neurons observed in animal models of depression, such as 
chronic stress (Cook and Wellman, 2004; Radley et al., 2004; 2006). Nevertheless 
in our model of chronic stress we found an increase in SYN mRNA, which may 
be due to a feedback regulation effect of the gene expression. These results give 
support to the neuroplastic hypothesis of depression, which poses that changes 
in neuronal structure and connectivity may underlie the etiology of this 
disorder and that these changes may be reverted by antidepressants (Castren, 
2005).  
 
A previous study from our laboratory found that changes in SYN and 
GAD67 expression in the amygdala of major depression patients were 
accompanied by parallel changes in PSA-NCAM expression (Varea et al., 2012). 
However,  this apparently does not occur in the PFC. In fact, we have obtained 
similar results in the mice subjected to chronic stress, in which PSA-NCAM 
expression was altered by this aversive experience in the amygdala, but not in 
the mPFC. 
 
Schizophrenic patients have diminished expression of inhibitory markers 
In schizophrenic patients we have observed a reduction in the expression 
of PSA-NCAM (layers IV and V), and GAD67 (layers II and IV). These parallel 
changes of PSA-NCAM and GAD67 may reflect alterations of cortical inhibitory 
circuits in schizophrenia (for a review see Lewis et al., 2012); in fact, a recent 
report has found that GAD67 mRNA and protein levels are significantly lower 
in the DLPFC of schizophrenic patients (Curley et al., 2011). Additionally, they 
also point to the possible involvement of PSA-NCAM in these alterations in 
inhibitory neurotransmission, since we have previously demonstrated that this 
molecule is exclusively expressed by interneurons in the PFC of humans (Varea 
et a., 2007c) and rodents (Gomez-Climent et al., 2011; Varea et al., 2005). 
Interestingly, as we have mentioned above, these interneurons have reduced 
structural features and synaptic input than those lacking PSA-NCAM 
expression (Gomez-Climent et al., 2011). Moreover, the number of PSA-NCAM 
expressing neurons is reduced in the hippocampus of schizophrenic patients 
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(Barbeau et al., 1995). These results are similar to those we have found in the 
“double hit” model for schizophrenia, in which we have observed decreases in 
PSA-NCAM and GAD67 expression in the mPFC. By contrast, they are opposite 
to those found in the amygdala of the social isolation model, in which we have 
found increases in the expression of PSA-NCAM and GAD67.  
 
The increased expression of VGLUT1 observed in the white matter of the 
PFC of schizophrenic patients could be related to the higher density of neurons 
observed in this region (Connor et al., 2009; 2011), supporting the hypothesis of 
the existence of alterations in the normal development and positioning of 
cortical neurons in this disorder.  
 
 Bipolar disorder patients have reductions in the expression of excitatory and 
inhibitory markers 
Finally, samples from bipolar disorder patients displayed a reduction in 
the expression of VGLUT1 (layer V) and GAD67 (layers II, III and IV). The 
explanation for these results is more complex, because bipolar patients have 
periods of mania followed by periods of deep depression, which may result in 
cyclic changes in the expression of molecules related to neurotransmission and 
neural plasticity, as well as in the structure of neurons in the prefrontal cortex. 
However, the reduction observed in the expression of both excitatory and 
inhibitory contacts indicates that this region is clearly affected in this disorder.  
 
It is important to notice that the use of some antipsychotics or 
antidepressants by the patients included in the Stanley Neuropathology 
Consortium may also influence the expression of the different markers 
analyzed in this thesis. In fact, chronically administered antidepressants 
increase the expression of PSA-NCAM and SYN in the mPFC of rodents (Varea 
et al., 2007a; 2007b). Similarly, the antipsychotic haloperidol decreases the 
expression of PSA-NCAM, SYN and GAD67 in the rodent mPFC (Castillo-
Gomez et al., 2008). Table 6 shows the differences in the protein expression in 
each layer of the mPFC of the postmortem brains. 
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            Table 6. Summary of results in the postmortem brain study 
Psychiatric 
Disorder PSA-NCAM SYN VGLUT1 GAD67 
Major Depression = = ↓V ↓V 
Bipolar Disorder = ↓III ↓IV ↓V 
↓II 
↓III 
↓IV 
Schizophrenia ↓IV ↓V = = 
↓II 
↓IV 
              II, III, IV and V refer to the layers of the mPFC 
 
The last article included in this thesis describes an association study of 
the ST8SIAII gene with schizophrenia in a Spanish population. The objective of 
this study was to replicate the association found previously in Oriental 
populations, but taking into account the “sex” variable in the sample. 
Schizophrenia is considered a sexually dimorphic disorder because significant 
differences in the incidence and course of the disease between men and women 
have been reported (Kulkarni et al., 2012). 
 
Previous studies found a significant association between ST8SIAII and 
schizophrenia in two Asian samples (Arai et al., 2006; Tao et al. 2007) and one 
Australian cohort (McAuley et al., 2012). These associations were found with 
SNPs located in the promoter region of ST8SIAII, suggesting that deregulation 
of ST8SIAII expression may increase the risk to suffer schizophrenia. In 
addition, ST8SIAII maps to chromosome 15q25-26, a region reported as 
including a susceptibility gene for schizophrenia (Maziade et al., 2005).  
 
Allelic and genotyping association of rs3759916 SNP to schizophrenia in the 
Spanish female population 
Because no association between ST8SIAII and schizophrenia was 
reported in the Caucasian population, we explored in a Spanish sample the 
involvement of this gene as a risk factor for schizophrenia. A previous attempt 
to replicate in European ancestry samples the significant results found in the 
Australian schizophrenia cohort was not successful (McAuley et al., 2012), 
because data did not reach statistical significance. Nevertheless, we did not 
replicate the positive results found either by Arai et al (2006) with respect to 
rs3759916 and rs3759914 or by Tao et al. (2007) regarding rs3759915 in our 
sample. Differences in the allelic frequencies between the different population 
samples might explain these results. In fact, the alleles associated with 
schizophrenia in each of the two Asian samples, show lower frequencies in the 
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Spanish cohort. Alternatively, allelic heterogeneity that characterizes complex 
disease could also explain these discrepancies. However, when the association 
analysis was carried out taking into account the sex of the subjects, interesting 
results were found. In the women sample, the G allele (P = 0.044) and the AG 
genotype (P = 0.04) of rs3759916 was significantly associated with 
schizophrenia, suggesting that this allele is a risk factor for the disease in 
females in the Spanish population. Therefore the A allele might be a protective 
factor for schizophrenia in females of this population. In the men subgroup, the 
frequency of the G allele is very similar in healthy controls and in patients 
(1.18% and 0.92% respectively). This was also reported in the Chinese cohort 
with frequencies of 35.6% in controls and 33.9% in patients, so that no 
association was obtained for this SPN in this population (Tao et al., 2007). It 
would be interesting to know whether in the Chinese population also occurs an 
interaction between sex and the polymorphism rs3759916 concerning the 
vulnerability to schizophrenia. This polymorphism is located 200 bp 
downstream from a binding sequence of a glucocorticoid receptor (GR), a 
transcriptional factor implicated in sexual features. 
 
To further confirm the involvement of ST8SIAII in schizophrenia, 
rs2305561 was also genotyped in the Spanish sample. This SNP is located in the 
coding region of this gene, concretely in exon 5 (Arai et al., 2006), and shows 
functional significance because each allele has different efficiency of NCAM 
polysialylation (Isomura et al., 2011). Therefore chain length and quantity of 
NCAM polysialylation could vary depending on the rs2305561 genotype 
affecting its biological function. Nevertheless, no association between rs2305561 
and schizophrenia has been reported (Arai et al., 2006). The same result was 
found in our sample, although the G allele and the GG genotype were more 
frequent in the cases than in controls in the male subset. However, this 
association was lost after the Bonferroni test correction (P = 0.16 and 0.18 for 
allelic and genotypic frequencies respectively). Since this test is particularly 
stringent, significance may be lost for this polymorphism that may be a real risk 
factor. In fact cells expressing the G allele of rs2305561 may have significantly 
decreased amount of PSA on NCAM when compared with cells expressing the 
C allele (Isomura et al., 2011). All these results suggest, on the one hand, that the 
G allele of the rs2305561 polymorphism is a likely risk factor for schizophrenia 
and on the other, that it has become a risk factor in males of the Spanish 
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population. Again it would be interesting to analyze this interaction in other 
populations in order to confirm our results.  
 
A ST8SIAII haplotype is associated to schizophrenia in the Spanish male 
population 
The haplotypic study indicated a risk haplotype ACAG in the men 
sample of the Spanish population (P = 0.028), while no significant haplotypes 
associated with schizophrenia were found in the women sample of this 
population. Interestingly the risk haplotype reported in Japanese sampled 
population (Arai et al., 2006) share the same alleles at rs3759916, rs3759915 and 
rs3759914 positions, although the frequency of the haplotype ACA is lower in 
our sample than in the Japanese one. 
 
In this thesis we point out the importance of taking into account the 
gender of the subjects in association studies in mental illness in general and in 
schizophrenia in particular. Several mental disorders affect differently each sex, 
specifically there are more men than women affected in schizophrenia and the 
contrary is observed in depression (Viveros et al., 2012). Regarding PSA-
NCAM, a correlation between this molecule and the cells secreting GnRH has 
been demonstrated (Chalivoix, 2010). Furthermore, estrogen is one of the 
transcriptional regulators of both polysialyltransferase genes ST8SIAII and 
ST8SIAIV (Tan, 2009). Besides ST8SIAII, several studies pointing out sex 
differences in other genes involved in schizophrenia (Goes et al., 2010; 
Hoenicka et al., 2010; Gilabert-Juan et al., 2011).  
 
Finally, we acknowledge that the present study has the typical 
limitations of a small sample study. The sample size became reduced when the 
sample was divided by gender decreasing the power of the analysis. 
Nevertheless we found interesting sex-specific associations to schizophrenia in 
ST8SIAII and we replicated partially former studies analyzing this gene in other 
populations. Our study shows ST8SIAII as a susceptible gene for schizophrenia 
with notable differences between sexes. The role of this gene and the high 
number of interactions that it has with different neuronal pathways suggest 
polysialyltransferases as attractive molecules to be studied in the field of the 
psychiatric disorders. Deeper studies in the global expression mechanisms and 
in the regulation of polysialyltransferases have to be done in order to achieve 
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more knowledge about their role in the neurodevelopment and in the brain 
maintenance. Table 7 summarizes the association results in the Spanish sample. 
 
      Table 7. Association study results 
Sample rs3759916 rs3759915 rs3759914 rs2305561 Haplotype 
Total -- -- -- -- -- 
Females Allelic Genotypic -- -- -- GCAG 
Males -- -- -- Allelic Genotypic ACAG 
      in bold significant results after multiple test correction 
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1. Enhanced green fluorescence protein (EGFP) expressing cells in the 
medial prefrontal cortex (mPFC) of adult mice correspond mainly to a 
subpopulation of Martinotti interneurons. 
 
2. Chronic stress in adult mice induces dendritic hypertrophy in EGFP 
expressing neurons of adult GFP-expressing Inhibitory Neurons (GIN) 
mice. 
 
3. Chronic stress in adult mice decreases the number of interneurons 
expressing GAD67 and GAD-EGFP in the mPFC.  
 
4. Chronic stress causes dendritic hypotrophy of EGFP expressing BLa 
amygdaloid interneurons. 
 
5. Chronic stress induces a decrease in molecular markers of plasticity and 
inhibitory neurotransmission (NCAM, synaptophysin and GABAA alpha 
receptor) in the amygdala of adult GIN mice. 
 
6. Postweaning social isolation rearing in Lister Hooded rats induces 
increases in the expression of GAD67, PSA-NCAM and NCAM in 
different amygdaloid nuclei. 
 
7. The combination of a perinatal injection of the NMDA receptor 
antagonist MK-801 and a postweaning social isolation rearing in Lister 
Hooded rats is a “double hit” animal model of schizophrenia, which 
reproduces a wider spectrum of structural and molecular alterations 
than any of the single models by itself. 
 
8. The “double hit” model developed in this thesis, presents reductions in 
the volumes of the mPFC and the hippocampus. 
 
9. The “double hit” model shows a reduction in the number of 
parvalbumin positive cells and alters calbindin, calretinin and ErbB4 gene 
expression with reductions in PSA-NCAM and GAD67 molecules in the 
mPFC. PSA-NCAM is also decreased in the hippocampus. 
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10. The “double hit” model shows an increased number of immature 
granule neurons expressing doublecourtin in the hippocampus. 
 
11. The “double hit” model shows an increased number of neurons 
coexpressing the immediate early gene “c-fos” and the marker of 
excitatory neurons “CaMKII” in the mPFC. 
 
12. Synaptic and plasticity markers are altered in the human dorsolateral 
prefrontal cortex of psychiatric disorder patients. PSA-NCAM is reduced 
in schizophrenic patients, synaptophysin in patients of major depression, 
VGLUT1 in depressive and bipolar patients, and GAD67 in all of them.  
 
13. rs3759916 polymorphism of ST8SIAII gene, situated in the promoter 
region, is associated to schizophrenia in the Spanish female population, 
and an haplotype of these gene is also associated in the Spanish male 
population. This result suggests ST8SIAII as a susceptibility factors for 
developing schizophrenia affecting differently depending on the sex of 
the individual. 
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